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Sulfoximine Chemistry 
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1  Sulfoximine Chemistry 
 
1.1  General Introduction 
 
Sulfoximine chemistry started in the late 1940’s with the discovery of methionine 
sulfoximine1 (Figure 1). Subsequently, many asymmetric reactions using chiral 
sulfoximines have been developed,2 and intensive biological and physiological studies of 
sulfoximines have been performed.3 Their versatility originates mainly from a unique 
combination of features of this functional group as for example chirality, carbanion 
stabilization, nucleofugacity, basicity, nucleophilicity, and a low redox potential. Recent 
examples where several of these characteristics have been exploited include several 
asymmetric syntheses of prostacyclin analogs,4,5 which utilize transition metal mediated 
cross-coupling reactions of vinylic and allylic sulfoximines with organometallics for the 
formation of key C-C bonds. The sulfoximines have wider applications as chiral 
auxiliaries6 and as catalysts in asymmetric synthesis.7,8 
 
 
 
Figure 1.1 Methionine sulfoximine 
 
1.2 Introduction to vinyl and allyl sulfoximines 
 
Among the various sulfoximines ‘vinyl sulfoximines’ and ‘allyl sulfoximines’ have found 
many applications in asymmetric synthesis9,10.  
RN
S
R1
O
Ph
R
RN
S
O
Ph
R1
R2
vinyl sulfoximine allyl sulfoximine
* *
 
 
Figure 1.2 Vinyl and allyl sulfoximines 
Me
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Vinyl sulfoximines have been prepared for the following reasons:  
(a) As precursors for allylic sulfoximines to which they can be isomerized11 
 
R S
Ph
NMeO
R S
Ph
NMeO
DBU, MeCN
60 °C  
 
Figure 1.3 Isomerization of vinyl sulfoximines to allyl sulfoximines 
 
(b) As Michael acceptors in conjugate addition reactions12 
 
Tol
S
O
NPhth
p
OH
NHMeMe
Ph
+
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p N
Me
Me
Ph
OH
- 30 °C
 
 
Figure 1.4 Conjugate addition to vinyl sulfoximines 
 
(c) As substrates for Diels -Alder and 1,3-dipolar cycloaddition reactions13 
 
S
NTs
O p Tol
CHCl3  D, 50 h
96 %
+
SO SO
NTs
p Tol
NTs
p Tol
+
endo : exo = 97 : 3
(4 : 5)
 
Figure 1.5 Diels-Alder reaction of vinyl sulfoximines 
 
Similarly, allyl sulfoximines have important applications. A [2,3] -sigmatropic 
rearrangement of allyl sulfoximine gives more stable allyl sulfinamides. In 1994, Gais et 
al. published a study of the thermal rearrangement of two enantiopure substituted 
derivatives (Figure 1.6).14 
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Ph S
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Ph N
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R Me
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N
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R Me
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+
 
Figure 1.6 [2,3]-sigmatropic rearrangement of allyl sulfoximines14 
 
The most important application of allyl sulfoximines is their conversion to chiral 
allyltitanium complexes followed by a reaction with aldehydes and imines, which yields 
sulfoximine-substituted homoallylic alcohols2a,11 and amines15 respectively. The first 
allyltitanium complex was synthesized by Reggelin et al. (Figure 1.7).2a Later Gais et. al. 
prepared various allyltitanium complexes  with different titanium reagents and also 
determined their structures16 in solution and in the crystal. 
 
R1 S
N
O
p
Ph
CH3
TiX3
* *
Tol
S
O
Tol
N
p
(R)Val'
n
Ti(OiPr)3
R1 S
Ph
R2
R3 NMeO
Ti(NEt2)3
R1 = H
R1 = i-Pr, Me, Ph;  R2 = H; R3 = Me
n = 1, 2
R1 S
Ph
R2
R3 NMeO
Ti(OiPr)2
2
R1 = i-Pr, Me, Ph;  R2 = H; R3 = H 
 
Figure 1.7 Allyltitanium complexes 
 
Noteworthy examples of sulfonimidoyl-substituted allyltitanium(IV) complexes are II 
and III11 (Figure 1.8), which have found application in the asymmetric synthesis of a 
number of compounds including g,d-unsaturated a-amino acids,15 bicyclic a-amino  
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acids,17a,b g-hydroxy b-amino acids,17c homopropargylic alcohols,17d homoallyl alcohols 
and unsaturated prolines.18 
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Figure 1.8 Applications of sulfonimidoyl–substituted allyltitanium (IV) complexes. 
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CHAPTER 2 
 
Asymmetric synthesis of alkenyl aziridine carboxylates via in situ 
generation of allyl aminosulfoxonium ylides and a-imino ester 
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2     Asymmetric synthesis of alkenyl aziridine carboxylates via 
in situ generation of allyl aminosulfoxonium ylides and a-
imino ester 
 
2.1 Introduction 
 
2.1.1 Aziridine Chemistry 
 
The synthesis of chiral compounds in optically pure form represents a major challenge in 
organic chemistry. Much emphasis is placed on the elaboration of naturally occuring 
starting materials and on the development of techniques for enantioselective 
transformations of achiral substrates. In this regard, chiral aziridines are an attractive 
class of compounds.19,20 Aziridines I (Figure 2.1) are saturated three-membered 
heterocycles containing one nitrogen atom. This class of compounds dates back to 1888, 
when Gabriel (unwittingly) synthesized the parent member.21 Since then a variety of 
methods22 have been developed for asymmetric synthesis of enant iomerically pure (or 
highly enriched) aziridine derivatives. The chemistry of aziridines is dominated by ring-
opening reactions,23 the driving force of which is the relief of ring strain. By suitable 
choice of substituents on the carbon and nitrogen atoms, excellent stereo- and 
regiocontrol can be attained in ring-opening reactions with a wide variety of 
nucleophiles, including organometallic reagent.23b 
 
N
R1
R2 R3
R4 R5
N
R1
R2
R3 R4
R7R5
R6
N
R1
R2 CO2R5
R3 R4
Aziridine I Vinylaziridine II Aziridine-2-carboxylate III
 
 
Figure 2.1: Chiral substituted aziridines 
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Among the variously functionalized aziridines, vinylaziridines24 II and aziridine 
carboxylates25 III have been increasingly exploited as versatile building blocks for the 
stereoselective synthesis of biologically and synthetically important compounds.26 
Vinylaziridines have found many synthetic applications because of their high reactivity 
and ability to undergo a variety of rearrangements27 (Figure 2.2) and to function as 
carbon electrophiles. Ring-opening reactions of vinylaziridines can be effected by various 
carbon and heteroatom nucleophiles to produce a variety of functionalized amines. For 
example, vinylaziridines upon diborane reduction give allyl amines,23a organocopper 
mediated ring opening gives diastereomerically pure (E)-alkene dipeptide isosteres23b,c, 
treatment with oxygen nucleophiles gives vic-amino alcohols, which is the key step for 
the synthesis of threo- and erythro-sphingosines28. Halogen atoms can be 
stereoselectively introduced by ring-opening of g-aziridinyl-a ,b-enoates. The 
isomerizarion of vinylaziridines is widely used in organic synthesis. Important 
isomerizations are shown below.29  
 
Y
X
R
X
Y
R
Y
X
R1
R3R2
Y
XR
1 R3
R2
1. aza-[3,3]-Claisen rearrangement27a 2. Pyrroline formation27b
3. aza-[2,3]-Wittig rearrangement27c
(X or Y = N)
N
R1
R3
R2
N
H
R1
R3
R2
N
R1
R3
R2 H
N
H
R1
R3
R2
N
Ph
R2
R1
R2
NHR1
N
R2
R1
HH
R3
N
R2
R1
HH
R3
4. [1,5]-hydrogen shift27d
5. rearrangement with an aryl group29 6. epimerization27e
(X or Y = N) (X or Y = N) (X or Y = N)
 
 
Figure 2.2: Isomerization of vinylaziridines.27 
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Similarly, chiral nonracemic cis- and trans-aziridine-2-carboxylates30 are interesting 
aziridines. In addition to the normally expected reactions at the nitrogen atom and the C-2 
carboxylic group, the C-3 and C-2 positions can undergo a variety of nucleophilic ring-
opening reactions (Figure 2.3). 31 
 
N
R1
R2
R3
CO2R
R4
Reaction at N-1 nitrogen Deprotonation and
electrophilic substituion (R3 = H)
Nucleophilic
ring opening
Azomethine ylide formation
Reaction at carboxylic group
 
 
Figure 2.3:  Reactions of aziridine carboxylates 
 
The aziridine-2-carboxylates32 are considered amino acids, not only because of the ease 
with which they are converted into acyclic a- and b- amino acids, but also because of the 
pronounced biological activities resulting from their incorporation into peptides as special 
amino acid units. In addition, a naturally occuring aziridine-2-carboxylic acid33 has also 
been reported.  
 
Chiral alkenyl aziridine carboxylates have also been reported as useful substrates for the 
synthesis of chiral building blocks in organic synthesis. A few of their applications are 
described below. In 1995 Davis et al. demonstrated an enantioselective synthesis of (R)-
(-)-dysidazirine, which is cytotoxic to L1210 cells and inhibits the growth of Gram 
negative bacteria and yeast, from an enantiomerically pure alkenyl aziridine carboxylate34 
(Figure 2.4).  
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N
CO2Me
S
R
Op-Tolyl
R = n-C12H25
1) LDA/-78 °C
2) MeI
3) H2O
N
CO2Me
R
H
R = n-C12H25  
Figure 2.4: Synthesis of (R)-(-)-dysidazirine 
 
Alkenyl aziridine carboxylates were found to be useful starting materials for the synthesis 
of sphingosines. In 2005 Ishikawa et al. reported the synthesis of D-erythro-sphingosine 
from an alkenyl aziridine carboxylate28 (Figure 2.5). 
 
N
CO2tBu
Bn
C13H27
TsOH.H2O
THF/H2O
HO NHBn
CO2tBuC13H27
HO NHBn
CO2tBuC13H27
+
6 steps
HO NH2
CH2OHC13H27
D-erythro-sphingosine  
 
Figure 2.5: Synthesis of D-erythro -sphingosine 
 
In 2001 Davis et al. employed alkenyl aziridine carboxylates for the synthesis of 
quaternary amino acids synthesis, which have important biological activity35 (Figure 2.6). 
 
H
N
CO2Me
H OBn
H2/Pd/C
THF
n-Pr
CO2Me
H2N OBn
 
 
Figure 2.6: Synthesis of quaternary amino acids from alkenyl aziridine carboxylates 
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2.1.2 Aziridine natural products 
 
Natural products containing an aziridine ring have been found.36 The best known and first 
to be discovered are the mitomycin antitumor antibio tics, known to possess an aziridine 
ring since the 1960s,37 and several others have been isolated since. There are even few 
examples of naturally occurring aziridines, where the mode of action of these compounds 
has been studied in detail. The biochemical reactions used for the formation of the 
aziridine ring remain a mystery. The important aziridine natural products are 
mytomycins, azinomycins, ficellomycin, dicarboxyaziridine, miraziridine A, azicemicins, 
maduropeptin, madurastatins, and (2S,3S)-dicarboxyaziridine29 (Figure 2.7). Where as 
azinomycin A38 is an example of a natural product that contains an ‘alkenyl aziridine’ 
analogue, miraziridine and (2S,3S)-dicarboxyaziridine39 are examples for natural products 
being ‘aziridine carboxylate’ analogues. 
 
N N
X
H3C
O
O
O
O
NH2
OCH3
Y
Mitomycin A: X = OMe, R = H
Mitomycin C: X = NH2,  R = H
Porfiromycin: X = NH2,  R = Me
O O
H
N
O
N
N
H
O
HO
O
H3CO
Azinimycin A
H2N
O
H
N
N
OH
HN
N
HH2N
O
Ficellomycin
O
N
O
OH
X
Y
OH
NH
O
O NH2
FR-66979:   X = H, Y = OH
FR-900482: X, Y = O
O
N
H
N
H
O
HO
H
N
OH O
N
H
H
N
O
OH
O
NH
NH2HN
O
Miraziridine
N
HO2C
H
H
CO2H
(2S,3S)-dicarboxyaziridine
H
 
 
Figure 2.7: Aziridine natural products 
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It has been proposed that aziridines may be more widespread in biological systems than is 
generally realized. Many drugs such as ephedrine and pronethalol and endogenous 
metabolites such as adrenaline contain a b-aminoalcohol moiety, which may act as a 
precursor to an aziridine metabolite that may explain the known carcinogenicity of some 
compounds such as pronethol.40 
 
2.1.3 Synthesis of aziridines 
 
A variety of routes to chiral non–racemic aziridines have been described,41, 32a most of 
which rely either on the availability of enantiomerically pure starting materials from 
natural sources (amino acids, carbohydrates, hydroxy acids) or on asymmetric 
transformations of C-C or C-N double bonds (Figure 2.8).42 
 
N
R1
R3
R2
R4
X
PhI=NX
XNHOAc, Ti(IV)
R1
R4
R2
R3
X
N R4
R3
R1
R2
LnM
X
N R4
R3
R2Y
R2
R1
Br
R1 R2
X
N R4
R3
H2NX
Br
R2
R3
R1
HO
NHX
R1
R3
R4PX
SOCl2,
RSO2Cl
O
R2
R3
R1
R4
MN3
PPh3
HO
OH
R1
R3
H2NX
SOCl2, [O]
 
 
Figure 2.8: Methods for the synthesis of aziridines 
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The biological significance and chemical versatility of non-racemic aziridines make them 
one of the most useful synthetic intermediates. Synthetic methodologies for the 
preparation of aziridines include nitrene addition43 to olefins, carbene and ylide addition 
to imines,44 and cyclization of 1,2-amino alcohols, 1,2-amino halides, and 1,2-azido 
alcohols37 (Figure 2.8). Darzens-type reaction45 and Gabriel-Cromwell reaction46 are 
other well-documented reactions for aziridine synthesis. 
 
A few asymmetric syntheses of alkenyl aziridine carboxylates have been reported. 
Recently Sweeney et al. reported an asymmetric aziridine synthesis by using an aza -
Darzens reaction of N-diphenylphosphinylimines with chiral enolates (Figure 2.9). 
Although the method gives high diastereoselectivities in the preparation of alkenyl 
aziridine carboxylates, the yields were poor in all the cases.47 
 
S
N
O
Br
O O
1) LiHMDS, THF, -78 °C
2)
N
H H
R
RO
RC
Dpp
(RC=(2S)-Camphorsultam)
(i)  R = H, 47% yield, cis: trans = 100:0; ee: •99 %
(ii) R = Me, 40% yield, cis: trans = 0:100; ee: •99 %
N
R R
P(O)Ph2
 
 
Figure 2.9: Synthesis of alkenyl aziridine carboxylates 
 
Hanessian et al. reported another efficient asymmetric synthesis of alkenyl aziridine 
carboxylates in 2001.48 The method is based on the application of a C2-symmetrical chiral 
chloroallyl phosphonamide as depicted in Figure 2.10.  
N
P
N O
Me
Me
Cl
1) NaHMDS
2) CO2tBu
N
OBn
N
CO2tBu
N
P
N O
Me
Me
OBn
Yield =40 to 78 %
(only isomer formed)
 
Figure 2.10: Synthesis of alkenyl aziridine carboxylates 
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In 2001 Ishikawa et al. found that treatment of guanidinium bromides with aryl or alkenyl 
aryl aldehydes in the presence of a base directly afforded 3-aryl (or alkenyl aryl) 
aziridine-2-carboxylates in high yields with moderate to excellent trans  
diastereoselectivity49 (Figure 2.11). 
 
MeN NMe
NPh CO2tBu
Br
N
CH2O2tBu
Ph
SiO2
42 - 92 % yield; 46-95% de; > 77% ee
Ph Ph
OHC
R
R
 
 
Figure 2.11: Synthesis of alkenyl aziridine carboxylates by Ishikawa et al.49 
Davis et al. developed an asymmetric synthesis of alkenyl aziridine carboxylates by 
sulfinimine mediated Darzens-type reaction as shown in the Figure 2.12.34 
N
CO2Me
S
R
Op-Tolyl
p-Tolyl
S
N
R
O Br
OLi
OMe
-78 °C, 67%
only isomer formed with • 98% ee 
 
Figure 2.12: Synthesis of alkenyl aziridine carboxylates by Davis et al.34 
 
Although a few methods for asymmetric alkenyl aziridine carboxylates synthesis were 
reported in the literature, the extension of any of those methods to a variety of substituted 
alkenyl aziridine carboxylates was not successful in terms of yield. 
 
2.2 Present work 
 
2.2.1 Aim 
 
As mentioned in the earlier section, chiral alkenyl aziridine carboxylates have found 
valuable applications in organic synthesis. Hence the asymmetric synthesis of such 
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compounds is an interesting task. In 2002, Gais et al. disclosed a method for the highly 
regio– and diastereoselective aminoalkylation of the allylic sulfoximines 1a-d with N-
tert-butylsulfonyl (Bus) a-imino ester 350 leading to the formation of the (syn,E)-
configured b-alkyl-g,d-unsaturated a-amino acid derivatives 4a-d.15 Thus, titanation of 
the lithiated allylic sulfoximines 1a-d with Cl(Ti(OiPr)3 afforded the corresponding 
bis(allyl)titanium complexes 2a-d which reacted with the N-Bus a-imino ester 3 with 
high regio- and diastereoselectivities, preferentially at the g-position, to give the syn-
configured b-alkyl-g,d-unsaturated a-amino acid derivatives 4a-d in good yields (Scheme 
2.1). Formation of (S ,R,E)-configured homoallylic amines 4a-d entails Si,Re ,E-processes 
of the a-imino ester 3 with the (R,R)-configured bis(allyl)titanium complexes (R,R)-2a-d. 
 
R S
Ph
NMeO
1) 1.1 eq  nBuLi
2) 2.1 eq ClTi(OiPr)3
R S
Ph
NMeO
Ti(OiPr)2
2
N
EtO2C
Bus3) 1.1 eq
EtO2C
S
Ph
N
R
NMeO
Bus
3
1a-d
a: R = Ph; b: R = i-Ph; c: R = cHex; d: R = t-Bu
2a-d
4a-d
H
 
 
Scheme 2.1: Aminoalkylation of allylic sulfoximines. 
 
Furthermore, Gais et al. described the synthesis, structure and application of chiral 
conjugated N-titanium allyl aminosulfoxonium ylides of type I (R2 = H, R3 = Ti(NEt2)3) 
(Figure 2.13).16 The investigations of  I were supplemented by ab initio calculations of 
the conjugated allyl aminosulfoxonium ylide I (R1 = Me, R2 = H, R3 = Me). The hitherto 
unknown chiral allyl S-ylides of type I (R3 = Me) should be of considerable synthetic 
interest. A number of highly useful transformations of I can be envisioned based on the 
chemistry of the corresponding alkyl aminosulfoxonium ylides.2a Although chiral alkyl S-
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ylides are well established reagents,51 only a few examples of chiral conjugated allyl 
sulfonium ylides had been described.52  
 
R1 S
Ph
N(Me)R3O
R2
N
EtO2C
SO2tBu
R1I II
 
 
Figure 2.13 Chiral allyl aminosulfoxonium ylides and alkenyl aziridine carboxylates 
 
Thus, we have developed an interest in the synthesis of chiral ylides of type I and wished 
to apply them in the synthesis of enantio enriched alkenyl aziridine carboxylates of type 
II, for which only a few enantioselective syntheses had been described53 as mentioned in 
the foregoing section. 
  
An attempt was made to synthesize ylides of type I by treatment of the amino–substituted 
sulfoxonium salt 5a with DBU. It was thought that the resulting ylide would then react 
with an electrophile, an aldehyde for example. Thus, the amino–substituted sulfoximine 
4a was treated with Meerwein’s salt in CH2Cl2 at room temperature in order to produce 
the corresponding sulfoxonium salt 5a,16 which was then treated with DBU in the 
presence of benzaldehyde under the same reaction conditions in the expectation of 
formation of I and its reaction with benzaldehyde, Scheme 2.2. Surprisingly, however the 
reaction yielded a cis/trans-mixture of the alkenyl aziridine carboxylates cis-6a/trans-6a 
with good yields and good cis-diastereoselectivity. The sulfinamide 7 was isolated in 
good yield with ³98% ee.  
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EtO2C
S
Ph
N
Ph
NMeO
Bus
1) Me3OBF4
2) DBU
H
EtO2C
S
Ph
N
Ph
NMe2O
Bus H
BF44a 5a
3) PhCHO
N
Bus
H
EtO2C
H
Ph
cis-6a /trans-6a
Ph
S
O
NMe2
7
+ EtO2C
N
Ph
Bus H
+PhCHO
O
Ph
(expected)(observed)
- 7
EtO2C
S
Ph
N
Ph
NMe2O
Bus H
I
2) DBU
3) PhCHO
 
 
Scheme 2.2: Reaction of aminosulfoxonium salt 5a with DBU in the presence of 
benzaldehyde 
 
At the same time Tiwari, a former coworker of Prof. Gais, independently studied the 
reaction of the sulfoxonium salts 5a-e with different bases. He observed that the salts 
undergo a facile migratory cyclization to afford the 3,4-dehydro prolines 8a-e upon 
treatment with KF54 (Scheme 2.2). He also observed the formation of a cis/trans-mixture 
of the alkenyl aziridine carboxylate cis-6b/trans-6b upon treatment of the sulfoxonium 
salt 5b with DBU in CH2Cl2. 
 
5.0 eq KF
DCM : H2O = 65 : 1
N
R
Bus
CO2Et
Ph
S
O
NMe2
+EtO2C
S
Ph
N
R
NMe2O
Bus H
BF4
a: R = Ph; b: R = iPr; c: R = cHex; d: R = tBu; e: R = Me
5a-e 8a-e 7
DBU
N
Bus
H
EtO2C
H
iPr
Ph
S
O
NMe2
+
cis-6b/trans-6b 7  
 
Scheme 2.3: Reactivities of the sulfoxonium salts 5 towards bases  
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The formation of prolines from the sulfoxonium salts 5a-e was reported recently by Gais 
et al.57 The above mentioned results of intial experiments toward aziridine formation and 
Tiwari’s observation suggested an asymmetric synthesis of alkenyl aziridine carboxylates 
6 from amino–substituted sulfoximines 4 with the formation of their corresponding salts 
5 followed by treatment with DBU. 
 
2.2.2 Results and Discussion 
 
2.2.2.1 Retrosynthetic analysis 
 
As illustrated in the foregoing section, the asymmetric synthesis of aziridines has been 
accomplished by several methods. Although some of these methods are very efficient for 
the synthesis of alkenylaziridines and aziridine carboxylates, they are not so well suited 
for preparing alkenylaziridine carboxylates 6 in good yields with high enantioselectivity. 
We therefore focused our interest on the asymmetric synthesis of alkenylaziridine 
carboxylates by following the retrosynthetic analysis shown in Scheme 2.4. 
 
EtO2C
S
Ph
N
R
NMe2O
Bus H
BF4
N
EtO2C
Bus
R
N
EtO2C
Bus
R
+
EtO2C
S
Ph
N
R
NMeO
Bus H
R S
Ph
NMeO
cis - 6a-d trans - 6a-d
5a-d4a-d1a-d
N
EtO2C
Bus
+
3
R S
Ph
NMe2O
9a-d
a: R = Ph; b: R = i-Pr; c: R = cHex; d: R = t-Bu
 
 
Scheme 2.4: Retrosynthetic analysis of alkenyl aziridine carboxylates 
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Key to the facile conversion of the vinyl aminosulfoxonium salts 5a-d via the allyl 
aminosulfoxonium ylides 9a-d to vinylaziridines is the ability of the aminosulfoxonium 
group to act as both a powerful carbanion-stabilizer and an excellent nucleofuge.55,17d The 
cis- and trans- alkenylaziridine carboxylates 6a-d were realized from the corresponding 
vinyl aminosulfoxonium salts 5a-d, which in turn can be derived from 4a-d by 
methylation with Me3OBF4. The vinyl aminosulfoximine derivatives 4a-d can be 
achieved from the allylic sulfoximines 1a-d, the synthesis of which has been reported by 
Gais et al.11 starting from (+)-(S)-N,S-dimethyl-S-phenyl sulfoximine 10.10b 
 
2.2.2.2 Asymmetric synthesis of allyl sulfoximines 
 
The synthesis of the vinyl aminosulfoxonium salts 5a-d commenced with the preparation 
of allylic sulfoximines 1a-d. The known allylic sulfoximines 1a-d were prepared without 
the isolation of intermediates from the enantiomerically pure (S)-N,S-dimethyl-S-phenyl 
sulfoximine 1056-57 and the corresponding aldehydes by the inverse Peterson-olefination 
and isomerization as described previously11 (Scheme 2.5). The lithiomethyl sulfoximine 
derived from 10 was treated with aldehydes in order to get the hydroxy sulfoximines 11a-
d, which were in situ treated with ClCOOMe to form the corresponding chloroformates. 
Treatment of the chloroformates with DBU gave the vinyl sulfoximines 12a-d in good 
yields. The vinyl sulfoximines were then reacted with DBU in MeCN at 60 °C for 5 days 
to obtain a mixture of the allyl sulfoximines E-1a-d and Z-1a-d in good yields.11 Flash 
column chromatography gave the pure E-allyl sulfoximine 1a-d in >70% yield along 
with a mixture of the E- and Z-allyl sulfoximines, which were separated by preparative 
HPLC. 
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H3C
S
Ph
NCH3O 1) 1.1 eq nBuLi
2) 1.1 eq
R S
Ph
OLi NCH3O
R
H
O
3) 1.1 eq ClCOOMe
4) 1.1 DBU
10
R S
Ph
NCH3O 5) 1.2 eq DBU, MeCN
60 °C
R S
Ph
NCH3O
12 a-d E - 1a-d
+ Z - 1a-d
a: X = Ph, b: X = iPr, c: X = cHex, d: X = tBu
11a-d
 
 
Scheme 2.5: Synthesis of allylic sulfoximines 
 
Table 2.1. Synthesis of allyl aminosulfoximines 
 
1 R Yield of 
E-(1) 
Total Yield 
(E + Z) (%) 
a Ph 71 71 
b iPr 75 90 
c cC6H11 82 91 
d tBu 86 86 
 
2.2.2.3 g-Aminoalkylation of allyl sulfoximines 
 
Schleusner investigated the reactivity of the bis(allylsulfoximine)titanium complexes 2a-
d towards imines (Scheme 2.6).58 Treatment of the allylic sulfoximine 1a-d in THF at – 
78 °C with 1.1 equiv of n-BuLi resulted in the lithiated sulfoximines which were 
subsequently transmetalated to the corresponding titanium complexes with 1.2 equiv of 
ClTi(OiPr)3. The allyltitanium complexes were treated with 1.1 equiv of N-Bus a-imino 
ester 3 at -78 °C in THF following the addition of 1 equiv of ClTi(OiPr)3. The second 
equiv of ClTi(OiPr)3 was added in order to ensure the completion of the reaction.15 The 
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reaction of the bis(allylsulfoximine)titanium complexes 2a-d with N-Bus a-imino ester 3 
took place with high regio- and diastereoselectivities and in good yields to afford the 
(syn,E)-configured b-alkyl-g,d-unsaturated a-amino acid derivatives 4a-d. Formation of 
the (S ,R,E)-configured homoallylic amines 4a-d entails Si,Re ,E processes of a-imino 
ester 3 with the (R,R)-configured bis-(allyl)titanium complexes (R,R)-2a-d (Table 2.2).  
 
R S
Ph
NCH3O 1) 1.1 eq n-BuLi
2) 1.1 eq ClTi(Oi-Pr)3
R S
Ph
NCH3O
Ti(O-i-Pr)2 2
N
SO2t-Bu
O
EtO
3) 1.1 eq
S
Ph
NCH3O
O
EtO
R
NH
Bus
4a-d
1a-d
2a-d
> 98 % de, > 98 %ee
a: R = Ph; b: R = i-Pr; c: R = cHex; d: t-Bu
3
 
 
Scheme 2.6: Aminoalkylation of allyl sulfoximines 1a-d  
 
Table 2.2. Synthesis of amino substituted sulfoximines 4a-d 
 
titanium complex R amino acid derivative dra yield (%) drb  
2a Ph 4a ³95:5 82 ³98:2 
2b iPr 4b ³95:5 82 ³98:2 
2c cC6H11 4c ³95:5 77 ³98:2 
2d tBu 4d ³95:5 84 ³98:2 
a dr values of the sulfoximines 4a-d determined from the crude reaction mixture. b dr values of the 
sulfoximines 4a-d determined after recrystallization. 
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The N-Bus a-imino ester 3 is not commercially available. However much efforts have 
been made towards the optimization of the synthesis of 3.50  
 
2.2.2.4 Synthesis of N-Bus a-Iminoester 3 
 
The N-tert-butylsulfonyl a-imino ester 3  was prepared from the commercially available 
di-tert-butyl disulfide 13. The disulfide was oxidized with H2O2 to obtain sulfinate 14  
which was not isolated but treated with SO2Cl2 to afford the sulfinyl chloride 15 in 92 % 
yield. Treatment of 15 with NaN3 in MeCN in the presence of a small amount of H2O at 
elevated temperatures by the slow addition of the sulfinyl chloride to a suspension of the 
azide gave amide 16 in 89% yield.59 This method was originally described by Kresze for 
the synthesis of the N-tolylsulfonyl imino ester (Scheme 2.7).59 Then amide 1660 was 
treated with 1.6 equiv of SOCl2 at reflux temperature in toluene for 8-10 h to afford the 
tert-butylsulfonyl isothiocyanate 17 , which was not isolated but treated with excess of 
freshly distilled ethyl glyoxylate (2 equiv) at 80 °C and refluxed at 120 °C for 2.5 days. 
This gave the imino ester 3 as yellow oil in 92% yield based on amide 17.50 
S S
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MeCN, H2O
S NH2
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Scheme 2.7:  Synthesis of N-Bus a-Iminoester 3 
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2.2.3 Asymmetric synthesis of alkenyl aziridine carboxylates from 
aminosulfoxonium salts 5 
 
In order to generate the allyl aminosulfoxonium ylides the corresponding sulfoximines 
4a-d have to be activated by transforming them into their corresponding salts 5a-d 
(Scheme 2.8), the synthesis of which is well established.17a,61 The vinyl sulfoximines 4a-
d upon treatment with Me3OBF4 (1.1 equiv) in CH2Cl2 afforded the N-dimethylated 
alkenyl aminosulfoxonium salts 5a-d in ³ 95 % yield. The salts thus obtained were 
subjected to a DBU (1.1 equiv) treatment in dry CH2Cl2 at room temperature, which 
afforded the corresponding alkenyl aziridine carboxylate derivatives 6a-d (Scheme 2.8) 
in less than 5 min in high yields, over 90% in all cases, with good diastereoselectivities 
and medium to high enantioselectivities. The ee-values were determined by chiral HPLC 
(Table 2.3). 
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Scheme 2.8: Synthesis of alkenyl aziridine carboxylates 6a-d from amino alkylated 
aminosulfoxonium salts 5a-d via ylides 9a-d 
 
The cis-aziridines 6a-d were formed as the major isomers and the trans-aziridines 6a-d 
as the minor isomers. The enantioselectivity of the formation of the cis-configured 
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aziridines is significantly higher than that of their trans -configured isomers. A 
mechanistic rationalization for the diastereo- and enantioselectivities is given later in this 
chapter. 
 
Table 2.3: Synthesis of alkenyl aziridine carboxylates 6a-d from amino alkylated 
aminosulfoxonium salts 5a-d via ylides 9a-d 
 
cis trans vinyl 
sulfoximine 
(4) 
R aziridines 
(6) 
cis:trans 
yield 
(%) 
eea 
(%) 
yield 
(%) 
eea 
(%) 
yield 
(%) 
sulfin- 
amide (7) 
yield 
(%) 
a Ph 93:7 94 ³98 82 30 5 96 
b iPr 91:9 91 92 76 26 6 93 
c cC6H11 90:10 93 71 75 48 9 94 
d tBu 91:9b 94 50 - 5 - 94 
a Determination by HPLC. 6a: Chiralpack-AD; 6 b and 6 d: Chiracel OD-H; 6c: Chiralpack-IA.  
b Inseparable mixture. 
The cis/trans-aziridine 6a-d mixtures were not separable by column chromatography. 
However, preparative HPLC afforded the pure cis- and trans- aziridines except in the 
case of 6d. It seems noteworthy that both the cis- and trans -configured aziridines have an 
E-configurated double bond. The conversion of vinyl aminosulfoximines 4a-d to vinyl 
aziridines 6a-d, respectively, has also been carried out with similar results without 
isolation of 5a-d. Besides aziridines cis-6a-d and trans-6a-d, sulfinamide 7 of ³98% ee 
was isolated in each case in high yields. The sulfinamide 7 can be converted to (S)-S , N-
dimethyl-S-phenyl sulfoximine (10) with ³98%.17d 
 
2.2.4 Mechanistic consideration of the aziridine formation from salts   
5a-d 
 
The formation of the E-configured vinylaziridine carboxylates 6a-d from the vinyl 
aminosulfoxoium salts 5a-d can be rationalized as shown in Scheme 2.9.The vinyl 
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aminosulfoxonium salts 5a-d are highly soluble in CH2Cl2 and the addition of DBU to 
this solution causes a deprotonation of the aminosulfoxonium salts 5a-d at the N-atom to 
which the strong electron with–drawing Bus-group is attached. Deprotonation is followed 
by a fragmentation to give the conjugated allyl aminosulfoxonium ylides 9a-d and the N-
Bus a-imino ester 3. Subsequently ylides 9a-d combine with the imino ester 3 , in a 
different manner with formation of the C-N and C-C bonds to afford the aziridines 6a-d 
and sulfinamide 7.  
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Scheme 2.9: Mechanistic considerations of aziridine formation 
 
It is noteworthy that the reactions of the vinyl aminosulfoxonium salts 5a-d depend on 
the nature of the base used. Scheme 2.9 shows the aziridine formation from the salts 5a-d 
upon treatment with DBU in CH2Cl2. It is very interesting to note that prolines 8a-d were 
formed from the same salts 5a-d upon treatment with KF54 in CH2Cl2-H2O, as described 
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by Tiwari and Lindenmaier. The explanation for the base dependence of the reaction 
course is rationalized below.  
 
2.2.4.1 Effect of base on the reactivity of vinyl aminosulfoxonium salts 
5a-d 
 
The formation of the proline derivatives 8a-d from the corresponding vinyl 
aminosulfoxonium salts 5a-d can be explained as follows (Scheme 2.10). The vinyl 
aminosulfoxonium salts 5a-d are highly soluble in CH2Cl2. Thus solid KF, water and 
CH2Cl2 form a three-phase system and it is assumed tha t an anion exchange between 5a-
d and KF occurs. That means F- displaces the counter ion BF4- from the salts 5a-d.62 The 
F- ion could then cause a deprotonation of the aminosulfoxonium salts 5a-d at the g-
position (the allylic proton is the most acidic proton in the molecule) with formation of 
the corresponding allyl aminosulfoxonium ylides Z-18a-d.16 The ylides Z-18a-d will be 
protonated at the a-position to form the thermodynamically more stable allyl 
aminosulfoxonium salts Z-19a-d. Then because of the high nucleofugacity of the allylic 
aminosulfoxonium group,17a salts Z-19a-d could undergo a cyclization following a 
deprotonation of the sulfonamide group by the F- ion with formation of the 
corresponding prolines 8a-d and sulfinamide 7. There is evidence suggesting that the 
reaction of 5a-d with the KF could also give to small amount of the isomeric allyl 
aminosulfoxonium ylides E-18a-d and subsequently the allyl aminosulfoxonium salts E-
19a-e. Salts E-19a-e, which cannot cyclize, may however be, in equilibrium with Z-19a-
e.52 
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Scheme 2.10: Rationalization of the formation of the 3,4-dehydro prolines 
 
The above mechanism implies that the allylic proton is the most acidic proton in the vinyl 
aminosulfoxonium salts 5a-e due to the presence of the sulfoxonium group. Hence the F- 
ion can easily deprotonate the allylic position of the sulfoxoium salt 5a-e. Successive 
transformations then afford prolines as shown in scheme 2.10. Whereas the same vinyl 
aminosulfoxonium salts when treated with DBU undergoes a different reaction sequence 
from the Scheme 2.10, but follows a different reaction pathway as shown in Scheme 2.9 
resulting in alkenyl aziridine carboxylates 6a-d formation.  
 
Decisive for the product formation, aziridine or proline, is the position of the 
deprotonation of salts 5a-d upon treatment with base. It is understandable that the allylic 
proton is the most acidic proton of the salts 5a-d due to the activation by the amino 
sulfoxonium group. Hence one can assume that bases will first tend to deprotonate at the 
allylic position. But another important factor is the size and basicity of the base. The 
allylic proton of the salts 5a-d is not only the most acidic but also the most hindered 
proton. Hence only a small base like F- can attack on this proton, where as the bulky base 
DBU cannot attack on this proton.  So DBU attacks the salts at the sterically less 
hindered amino group, which will lead to a fragmentation followed by the formation of 
alkenyl aziridines 6 as shown in scheme 2.9. To strengthen this argument, the salt 5a was 
treated with another bulky base, di-isopropyl ethylamine (DIEPA). The aziridines cis-6a 
and trans-6a were isolated with similar de values and in good yields. 
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2.2.5 Aziridine formation from aminosulfoxonium salts 5 under 
different conditions 
 
After having observed the formation of cis/trans-mixtures of aziridines from the vinyl 
aminosulfoxonimium salts 5a-d by treatment with DBU in  CH2Cl2 at room temperature, 
it was of interest to increase the diastereoselectivity by carrying out the aziridination 
under different reaction conditions. The vinyl sulfoximine 4a was taken as the substrate. 
The sulfoximine 4a was first activated by methylation with Me3OBF4, which resulted in 
the quantitative formation of salt 5a. Salt 5a was then treated with DBU and diisopropyl 
ethyl amine (DIPEA) in different solvents and at different temperatures (Scheme 2.11). 
Similar results were observed under various conditions as shown in the Table 2.3. 
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Scheme 2.11: Aziridination under different reaction conditions 
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Table 2.4. Aziridination with 4a under different reaction conditions 
 
entry solvent base temp cis-4a/ 
trans-4a 
yield (%) Remarks 
1 DCM DBU rt 93:7 94 - 
2 DCM DBU 0° C 92:8 92 - 
3 CCl4 DBU rt 93:7 93 - 
4 CCl4 DIEPA rt 93:7 94 - 
5 CCl4 DIEPA 0° C 91:9 93 - 
6 DCM DBU -78° C 92:8 - Reaction was not 
complete 
7 DCM DBU 50° C - - Decomposition of 
products was 
observed 
 
Therefore, it is approved that treatment of the salts 5 with a bulky base will lead to 
aziridine formation and furthermore that solvent and temperature show only minor effects 
on the stereoselectivity of aziridine formation. 
 
2.2.6 Determination of the relative configuration of the alkenyl 
aziridine caboxylates 
 
The absolute configuration of the chiral centers of the vinyl aminosulfoximines 4a-d is 
known but that of the aziriridines 6a-d is not known and predictions are difficult to make. 
None of the aziridines was crystalline. Thus it was desided to determine the absolute 
configuration of the cis- and trans- aziridines cis-6a and trans-6a by chemical 
correlation. First the relative configuration of the cis- and trans-aziridines 6a-d was 
determined based on their NMR spectra. 1H NMR spectroscopy confirmed that the 
double bond of both the cis- and trans- airidines 6a-d had the E-configuration since it 
showed coupling constants (J) above 15 Hz in all the cases. Furthermore the 2,3-cis-
aziridines cis-6a-d showed J(Ha ,Hb) values of ˜ 7.14 Hz which are larger than the  
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J(Ha ,Hb) values (J ˜ 3.84 Hz) of the 2,3-trans-isomers trans-6a-d. This is in accordance 
with literature observation.63 Besides that NoE measurements confirmed that cis-6a-d 
have the cis- and trans-6a-d the trans-configuration (Figure 2.14).  
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Figure 2.14: NoE measurements of cis-6a and trans-6a 
 
In the case of the major isomer cis-6a, an NoE was observed between Ha and Hb 
meaning that they are cis to each other. In addition an Noe was observed between H b and 
Hd, which proves the E-configuration of the double bond. However no NoE was observed 
between Hc and Hd, as they are trans to each other. Similarly, in the case of the minor 
isomer, no NoE was observed between Ha and Hb but a strong NoE was observed 
between Ha and Hc , which means that the minor isomer has the 2,3-trans-configuration.  
 
2.2.6.1 Determination of the absolute configuration of alkenyl 
aziridine carboxylates 
 
The absolute configuration of cis-6a and trans-6a was determined by converting them 
into the known a-amino acid 23.64 The a-amino acid 23 was originally synthesized by 
Davis et al. by a sulfinimine-mediated asymmetric Strecker reaction65 as shown in 
Scheme 2.12. 4-Phenylbutaraldehyde was condensed with commercially available (S)-
(+)-p-toluenesulfinamide (20) and Ti(OEt)4 to give sulfinimine (S)-(+)-21. Next, the 
sulfinimine was treated with EtAl(O-iPr)CN, generated in situ by addition of 1.0 equiv of 
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i-PrOH to 1.5 equiv of diethylaluminum cyanide (Et2AlCN), to give the amino nitrile 22  
with 70% de. Since the sulfinyl group controls the stereoselective Re-face addition of 
CN, (SS,S)-(+)-22 was obtained as the major diastereoisomer.66 The diastereomeric 
aminonitriles were separated by flash chromatography and the major diastereomer was 
treated with 4 N HCl-EtOH. This treatment not only removed the sulfinyl group, but also 
hydrolyzed the nitrile and gave the a-amino acid ((S)-(+)-23.  
 
p-Tolyl
S
NH2
O
(S)-(+)-20
O
Ph
5 eq Ti(OEt)4
N
Ph S
p-Tolyl
O
Et2AlCN
i-PrOH
HN
Ph S
p-Tolyl
O
CN
(S)-(+)-21 (SSS)-22
4 N HCl/EtOH
NH2
Ph
CO2Et
(S)-(+)-23  
 
Scheme 2.12: Synthesis of the a-amino acid (S)-(+)-23 by Davis et al. 
 
We envisioned a conversion of aziridines cis-6a and trans-6a to the a-amino acid (S)-(+)-
23. It has been reported that vinyl aziridines readily undergo hydrogenolysis with 
H2/Pd(0).67 The ring-opening takes place at the C-atom bearing the vinyl group without 
disturbing the other aziridine ring C-atom. Hence the aziridine cis-6a was subjected to a 
hydrogenolysis with H2/Pd/C, which gave the N-Bus protected a-amino acid 24. Finally, 
treatment of 24 with CF3 SO3H afforded the N-Bus deprotected a-amino acid 23 in 91% 
yield. Thus aziridine cis-6a was transformed into the saturated a-amino acid 23 in > 90% 
yield. 
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Scheme 2.13: Transformation of aziridines cis-8a and trans-8a to amino acid derivatives 
23 and 24 
 
The a-amino acid derivative 23, obtained from cis-8a of =98% ee, showed an optical 
rotation value of [a]D23 = -13.6°, similar in magnitude to that of the reported value of 
[a]D20 = +14.5° by Davis et al64 for (S)-23, but with the opposite sign of rotation. This 
confirms that our a-amino acid 23 is R-configurated at the a-position. That means that 
the cis-aziridine 6a has the (R,R)- configuration. In the same way aziridine trans-6a was 
transformed to the N-Bus a-amino acid 24 in 93% yield. It showed a similar optical 
rotation, [a]D23 = + 4.7°, as the N-Bus a-amino acid 24 , [a]D23 = + 5.1°, synthesized from 
aziridine cis-6a. Thus both the cis- and the trans-aziridines have the same configuration 
(R-) at the C-2 position. Hence the absolute configuration of the trans-aziridine 6a is 
2R,3S. 
 
2.2.7 Synthesis of the enantiomeric alkenylaziridine carboxylates 
 
In order to complete the aziridine synthesis, the enantiomeric aziridine derivatives ent-
cis-6b and ent-trans-6b were prepared from the (R)-S ,N-dimethyl-S-phenyl sulfoximine 
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(10). As described in the section 2.2.2.2 the corresponding (RS)-configured allyl 
sulfoximine (RS)-1b was synthesized by addition-elimination-isomerisation route.7 From  
 
(RS)-1b the bis(allyl)titanium complex (RS)-2b was prepared, followed by g-amino 
alkylation with the N-Bus a-amino acid 3 , which gave (R,S ,E,RS)-vinyl sulfoximine 
derivative 4b. The vinyl sulfoximine derivative was methylated with Me3OBF4 and 
treated with DBU, in a one pot transformation, to afford the cis/trans-aziridine mixture 
(ent-cis-6b/ent-trans-6b) in >90 % yield with 92:8 diastereoselectivity. The ee values 
were determined by chiral-HPLC (Chirasildex CB) and observed (cis: 89% ee; trans : 
85% ee) from that of the aziridines synthesized from the (S)-sullfoximine (RS-10).  
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Scheme 2.14: Synthesis of vinyl aziridine carboxylate ent-cis/trans-6b from (RS)-10 
 
2.2.8 Recycling of sulfinamide 
  
The alkenyl aziridine carboxylates cis-6a-d and trans-6a-d as well as sulfinamide 7 of ³ 
98 % ee were isolated in high yields. Thus a conversion of 7 to the sulfoximine 10 , the 
starting material for the synthesis of allylic sulfoximines 1a-d, was desirable. Gais et al. 
had previously shown that treatment of sulfinamide 7 with MeMgCl gives sulfoxide 2517d 
with inversion of configuration, and it was isolated with ³ 98 % ee in 93 % yield 
(Scheme 2.15). Bach et al. have described the conversion of 25 to sulfoximine 1068 as 
shown in the scheme 15. 
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Scheme 2.15: Recycling of sulfinamide 7 
 
2.3 Stereoselective synthesis of cis-alkenyl aziridine methanol 
derivatives by Pd(0) catalyzed isomerization 
 
Because of the formation of mixtures of cis- and trans-aziridines 6a-d, both having the 
same configuration at C-2, a convergent conversion of the cis/trans-mixtures of the 
aziridines to the cis-configured aziridines was sought.27d 
 
In 1996 Ibuka et al. determined the thermodynamic stabilities of 2,3-cis- and 
2,3-trans-N-methanesulfonyl- or N-(arenesulfonyl)-3-alkyl-2-vinylaziridines using 
ab initio calculations.69,70 Since the energy difference in the gas phase was calculated to 
give an equilibrium ratio of 94:6 (2,3-cis-26: 2,3-trans-26) at 0 °C, it was expected that 
the Pd(0)-catalyzed equilibrated reaction of N-activated 
2,3-trans-3-alkyl-2-vinylaziridines 27 would give the 2,3-cis-isomers 26 as shown in 
the Scheme 2.16. Indeed, the thermodynamically less stable trans-2-vinylaziridines 27 
upon treatment with 5 mol% Pd(PPh3)4 in THF at 0 °C isomerizes to the more stable 
cis-isomers 26  via the p-allyl palladium(II) intermediates 28 , 29 , and 30 following 
p-s-p mechanism.69 
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Scheme 2.16: Pd(0)-catalyzed isomerization of trans-vinyl aziridine to cis-vinyl 
aziridine 
 
Taking these results into consideration, it was expected that the Pd(0) -catalyzed 
equilibrated reaction of the N-Bus 2,3-trans -3-ethylcarboxy-2-(E)-alkenyl aziridine 
(trans-6b) would give the corresponding 2,3-cis-isomer (cis-6b). Hence the trans-
vinylaziridine carboxylate (6b) was subjected to a Palladium-catalyzed isomerization 
reaction by treatment with 5 mol % Pd(PPh3)4 in THF at 0 °C. Unfortunately, only the 
diene 31 was isolated in 95% yield after 18 h (Scheme 2.17).  
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Scheme 2.17: Reaction of vinyl aziridine carboxlate trans-6b with Pd(PPh3)4 
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This observation is in accordance with results obtained by Matano et al. They found that 
trans-2-(2,2-dimethyl-1-oxopropyl)-3-(E)-(2-phenylethenyl)-1-tosylaziridine upon 
treatment with Pd(PPh3)4 in DMSO at 50 °C gives the dieneamine71 (Figure 2.15).  
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Figure 2.15.  Synthesis of diene aminoketone by Matano et al.71 
 
The reason for the formation of the diene is the presence of an acidic proton adjacent to 
the carbonyl group, which can be easily transferred to the intermediate Pd(II)-complex 
during the catalytic cycle, resulting in elimination rather than substitution. Hence it was 
decided to reduce the ester group of the trans-vinylaziridine carboxylate 6b to alcohol 
group before subjecting it to a Pd(0)-catalyzed equilibration. 
 
Thus, the trans-vinylaziridine carboxylate 6b was treated with a freshly prepared solution 
of DIBAL-H72 (1.2 equiv) in dry CH2Cl2 at 0 °C for 3 h, which gave the alcohol 32  in 
90% yield (Scheme 2.18). Alcohol 32 was then protected as the silyl ether trans-33 by 
treatment with TBDMSCl and imidazole in dry CH2Cl2 at 0 °C for 2 h (89 % yield). 
Similarly, the silyl protected cis-alkenylaziridine methanol derivative cis-33 was prepared 
with 90 % overall yield in two steps. 
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Scheme 2.18: Synthesis of cis/trans-silyl protected alkenyl aziridine methanol 
derivatives 
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To our delight, treatment of the 2,3-trans-configured alkenyl aziridine trans-33  with 5 
mol % of Pd(PPh3)4 in THF at 0 °C gave the cis-configured isomer cis-33 with ³ 98 % de 
in 84% yield. The optical rotation value of cis-33 obtained by the Pd(0) isomerization 
was the same as a probe of cis-33 (Scheme 2.19) synthesized directly from the cis-
alkenyl aziridine carboxylate (cis-6b). 
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Scheme 2.19: Pd(0)-catalyzed equilibration reaction 
 
Similarly, a mixture of cis-6b/trans-6b was converted to the silyl protected cis-33/trans-
33 via cis-32/trans-32 and treated with 5 mol % of Pd(PPh3)4. Aziridine cis-33 was 
isolated with ³ 98% de in 81% overall yield, in 18 h, as shown in scheme 2.19. To 
summarize the Pd(0)-isomerization reaction, the trans-(E)-aziridine 33 was transformed 
into cis-(E)-aziridine 33 with ³ 98 % de in good yield.  
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Scheme 2.20: Stereoselective synthesis of cis-alkenyl aziridine methanol derivatives 
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Surprisingly, however, the E-configured aziridine cis-(E)-33 was formed and not the Z-
configured isomer cis-(Z)-33 which would have been expected on the basis of the 
reaction of a p-s-p-isomerization mechanism. 
 
Ibuka et al. investigated the Pd(0) isomerization of substituted vinyl aziridines in order to 
see how the double bond configuration changes during the reaction. They treated various 
N-arylsulfonyl-alkenyl aziridines73 with Pd(PPh3)4.  
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Figure 2.16: N-arylsulfonyl-alkenyl aziridines 
 
Exposure of the alkenyl aziridine trans-E-34 to a catalytic amount of Pd(PPh3)4 in dry 
THF at 15 °C for 15 h yielded an 85.09 : 5.12 : 9.79 : < 0.01 mixture of cis-E-34, cis-Z-
34, trans-E-34 , and trans-Z-34 in which the new isomer cis-E-34 dominated (Figure 
2.17). Within the limits of experimental error, essentially identical results were obtained 
by treatment of the isomeric aziridines cis-E-34, cis-Z-34 , and trans-Z-34 under the same 
reaction conditions.3 The optical activity of cis-E-34 was the same before and after 
Pd(PPh3)4 equilibrated reaction. In the same way, when a catalytic amount of Pd(PPh3)4 
 
THEORETICAL PART  
 39 
was employed in the equilibration of cis-Z-35 , trans-E-35, and trans-Z-35 the desired cis-
E-35 was obtained with a selectivity as high as 9:1 [cis-E-35:( cis-Z-35+ trans-E-35+ 
trans-Z-35)]. Similarly, the Pd(PPh3)4 catalyzed reaction of cis-Z-36 , trans-E-36 , and 
trans-Z-36 provided 94:0.5:5.5:<0.001 mixtures of four stereoisomers cis-E-36 , cis-Z-36 , 
trans-E-36 , and trans-Z-36. 
 
From these results, it is evident that Pd(0)-catalyzed reactions led to an equilibrium of all 
the possible stereoisomers, the ratio of which is function of  their relative stabilities. 
Clearly the thermodynamic stabilities of the trans-(Z)-isomers trans-Z-34 , trans-Z-35 , 
and trans-Z-36 are lower than those of the corresponding cis-(E)-isomers cis-E-34, cis-E-
35, and cis-E-36. In addition, it is apparent that the greater steric bulk of the nitrogen 
protecting group (Mts) and the alkyl group (iPr) on the aziridine ring tended to afford 
considrably higher ratios of the desired N-arylsulfonyl-alkenyl aziridines. 
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Figure 2.17 Pd(0)-catalyzed isomerization reaction 
 
Ibuka et al. proposed that the Pd(0)-catalyzed isomerization reaction involves an 
equilibrium between the four p-allyl-Pd-complexes74 A-D as shown in Figure 2.17. 
Strangely, however, nothing was said about the possible mechanism of the 
interconversions of A-D, which cannot be formed purely by a p-s-p-mechanism.  
 
The stereochemical outcome of the Pd-catalyzed isomerizations disclosed above can be 
explained as follows. The transformation of A to D and B to C can proceed via p-s-p  
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interconversion.74,75 However, the transformations of A to C, B to C, A to B and C to D 
canot be explained by a p-s-p interconversion. Because the Pd–catalyzed isomerization 
cannot go through a standard mechanism without changing the double bond 
configuration. But these transformations can be explained as follows. Similar to 
nucleophilic addition in allylic substitutions, the electrophilic allyl system bound to Pd(II) 
can react with a Pd(0) complex. The Pd(0) complex adds to the free p-face of the allyl 
ligand and displaces the Pd(II) complex on the backside (Figure 2.18).76a Therefore, this 
process results in an inversion of configuration at all three allyl carbon atoms in contrast 
to apparent allyl rotation that does not change the configuration of the allyl ligand.76  
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Figure 2.18: Pd(0) -catalyzed allyl exchange  
 
Hence, it can be explained that the Pd(0)-catalyzed transformations of trans-E-alkenyl 
aziridine carboxylates, trans-E-6a-e, to the cis-E-alkenyl aziridine carboxylates, cis-E-
6a-e, proceeds without changing the double bond configuration.  
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2.4 Conclusions 
 
We have devised a method for the generation of conjugated acyclic allyl 
aminosulfoxonium ylides and successfully applied them in the asymmetric synthesis of 
chirally pure cis/trans-N-tert-butylsulfonyl substituted-3-alkenyl aziridine-2-ethyl 
carboxylates in good yields with good diastereoselectivities and with moderate to good 
enantioselectivities. The advantage of this synthesis is that it provides access to aziridines 
having both the vinyl and the ester functionality , for which only a few enantioselective 
syntheses had been described in the literature. Interestingly 1-alkenyl (dimethylamino) 
sulfoxonium salts show a synthetically highly useful dichotomy in their reactivity toward 
different bases. Sterically small bases like F- produces proline derivatives where as bulky 
bases like DBU produces aziridine derivatives. Finally it was shown that palladium-
catalyzed equilibrated reactions of mixtures of cis/trans-(E)-alkenyl aziridines afford the 
desired cis-(E)-alkenyl aziridines with good yields. 
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CHAPTER 3 
 
Asymmetric synthesis of alkenyl aziridine carboxylates by treatment of 
allyl aminosulfoxonium ylides with a-imino ester 
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3    Asymmetric synthesis of alkenyl aziridine carboxylates by 
treatment of allyl aminosulfoxonium ylides with a-imino ester 
 
3.1 Introduction 
 
The formation of the alkenyl aziridine carboxylates cis-6a-d and trans-6a-d in the 
reaction of the amino-substituted aminosulfoxonium salts 5a-d with DBU suggested 
another entry to the same aziridines by preparing the allyl aminosulfoxonium ylides 9a-d 
from alkenyl aminosulfoxonium salts separately followed by a treatment with the N-Bus 
a-imino ester 3. 
 
3.1.1 Chiral conjugated allyl sulfonium ylides 
 
Although chiral alkyl S-ylides are well established reagents,77,29 only a few examples of 
chiral conjugated allyl sulfonium ylides had been described.78 In 2003 Aggarwal et al. 
reported the synthesis of chiral allyl sulfur ylides and applied them to the synthesis of 
alkenyl oxiranes, which proceeded with low yields but with good selectivities.78a (Figure 
3.1) 
 
S R
O
R1 R2
BF4
O
KOH
O
R1
RR2
R = CH=CH2;
       C(Me)=CH2;
       C(Me)=CHPh
       CH=CPh2
R1 = H; R2 = Ph
51 to 93 % yield; 92 to >99% ee
 
Figure 3.1: Aggarwal’s chiral allyl sulfonium ylide 
 
The first enantioselective synthesis of vinyl oxiranes from aldehydes and chiral allyl 
ylides was described by Metzner et al. in 2002. 78b The chiral allyl ylides were prepared 
from allyl halides and chiral sulfides as shown in Figure 3.2. 
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S R1R1
+ X R3
R2
R1 = Me, Et X = I, Br
R2 = H, Me
R3 = H, Ph
R2, R3 = (CH2)4
S
R1
R1
R3
R2
X
ArCHO
NaOH
tBuOH: H2O
9: 1
O
Ar
R3R2
Y = 60 - 85 %
trans/ cis = 2.2:1 to •50:1þ
ee upto 84 %  
 
Figure 3.2: Metzner’s application of chiral allyl sulfonium ylides 
 
In 1995, Gladysz et al. carried out an enantioselective synthesis of organosulfur 
compounds via [2,3] rearrangements of chiral ylides derived from di(allyl)and 
di(propargyl) sulfide complexes78c (Figure 3.2).  
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R2
R1
R1
R2
R2
H
X = TfO , BF4
R1 = H, Me
R2 = H, Me
Y = 79 - 92%
de upto 99.5%  
Figure 3.3: Gladysz et al. application of chiral allyl sulfonium ylide 
 
3.1.2 Aminosulfoxonium ylides 
 
Sulfur ylides are now well established as reagents for organic synthesis. In large part the 
synthetic achievements with these reagents originated from the work of Corey and 
coworkers.79 Later in 1968 Johnson et al. introduced a new series of oxosulfonium salts 
and their ylides.80 Johnson et al. prepared the dimethyl amino aryloxosulfonium 
alkylidenes and applied them as nucleophilic alkylidene transfer reagents in order to 
prepare epoxides and cyclopropanes81 (Figure 3.4). 
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- ArS(O)NMe2
 
Figure 3.4. Johnson’s aminosulfoxonium ylides  
 
3.2 Results and Discussion 
 
3.2.1  Retrosynthetic analysis 
 
The proposed mechanism for aziridination detailed in the foregoing chapter is based on 
the involvement of allyl aminosulfoxonium ylides 9a-d as reactive intermediates, which 
combine with the N-Bus a-iminoester 3 to furnish alkenyl aziridine carboxylates cis-6a-d 
and trans -6a-d. Hence it can be assumed that the allyl sulfoxonium ylides 9a-d can 
perhaps be derived directly from the corresponding allyl sulfoximines 1a-d. We therefore 
focused on the asymmetric synthesis of alkenyl aziridine carboxylates 6 directly from the 
allyl sulfoximines in a much shorter route (Scheme 3.1). The synthesis of the same 
alkenyl aziridine carboxylates by this shortened route would bypass the synthesis of the 
bis(allyl) titanium complexes 2a-d and thus that of the g-amino-substituted 
vinylsulfoximines 4a-d.  
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++
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3
1a-d  
 
Scheme 3.1: Retrosynthetic analysis of alkenyl aziridine carboxylates 
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The synthesis of the allyl sulfoximines 1a-d from (S)-N,S-dimethyl-S-phenyl sulfoximine 
(10) has already been described in the previous chapter (cf. Scheme 2.5). 
 
3.2.1.1 Synthesis of allyl (dimethylamino)sulfoxonium salts 
 
The attempted synthesis of allyl (dimethylamino)sulfoxonium salts 37 commenced with 
the preparation of allylic sulfoximines as already described in the previous chapter (cf. 
Scheme 2.5). Then, the allyl sulfoxomine 1b was treated with 1.1 equiv of Me3OBF4 to 
first methylate the sulfoximine group. But the methylation resulted in only 50% 
conversion of 1b according to 1H NMR spectroscopy; a dimethylamino signal was 
observed at d 3.08 ppm, with a similar integral value as the allyl sulfoximine NMe signal 
(d 2.74 ppm). A 1:1 mixture of allyl aminosulfoxonium salt 37 and unreacted starting 
allyl sulfoximine 1b was isolated upon aqeous workup after 3 h. The ratio of the products 
was almost the same even after treatment of 1b with an excess of Me3OBF4. It was 
speculated that after methylation with Me3OBF4, the a-proton of the allyl sulfoxonium 
salt 37  becomes acidic enough to react with the basic allyl sulfoximine 1b resulting in the 
formation of a N-protonated sulfoxonium salt (Scheme 3.2). This N-protonated 
aminosulfoxonium salt does not react with Me3OBF4, and complete N-methylation is no 
longer being possible. After the aqueous workup the N-protonated aminosulfoxonium salt 
hydrolyses to give the starting allyl sulfoximine 1b. Thus, only 50% of the allyl 
sulfoximine 1b reacts with Me3OBF4 and the rest reacts with the proton to form the N-
protonated allyl sulfoxonium salt.  
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Scheme 3.2: Reaction of allylic sulfoximine 1b with Me3OBF4 
 
3.2.2 Synthesis of allyl (dimethylamino)sulfoxonium salts from vinyl 
sulfoximines 
 
The functionalized vinyl sulfoximines 4a-d reacted readily with Me3OBF4 under 
methylation of the N-atom of the sulfoximine group (cf. Scheme 2.2). It was expected 
that the vinyl sulfoximines 12b-e would also react with Me3OBF4 to form the vinyl 
aminosulfoxonium salts 38b-e. Because of the acidic allylic proton, it should be possible 
to deprotonate 38b-e with a base like DBU resulting in the formation of allylic ylides 
9b-e. 
  
R S
Ph
NMe2O
R S
Ph
NMe2O
BF4
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Ph
NMeO
R S
Ph
NMe2O
38b-e 12b-e
9b-e
b: R = iPr; c: R = cHex; e: R = Me
 
 
Scheme 3.3: Synthesis of allyl aminosulfoxonium ylides from vinyl sulfoximines 
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3.2.2.1 Asymmetric synthesis of alkenyl aziridine carboxylates 
 
To our delight, the vinyl sulfoximines 12b, 12c, and 12e11 reacted readily with Me3OBF4 
(1.2 equiv) at 0 °C in 2 h and afforded the corresponding vinyl aminosulfoxonium salts 
38b, 38c , and 38e (98% yield by NMR). The synthesis of the vinyl sulfoximines 12b, 
12c, and 12e from (S)-N,S-dimethyl-S-phenyl sulfoximine (10) and the corresponding 
aldehydes was carried out without isolation of the corresponding intermediates. The 
lithiated (S)-sulfoximine was reacted with the respective aldehydes to produce the 
corresponding b-alkoxy sulfoximines (cf. Scheme 2.5). Salts Li-11b, Li-11c , and Li-11e  
were trapped, in situ , by treatment with ClCOOMe followed by the addition of DBU, 
which afforded the (E)-configured vinyl sulfoximines in 89%, 95%, and 78% yields, 
respectively.7 
 
R S
Ph
NMeO
S
Ph
NMeO
1) n-BuLi
2) RCH2CHO
3) ClCOOMe
4) DBU(S)-10 (S)-12b-e
b: R = i-Pr; c: R = c-Hex; e: R = Me  
 
Scheme 3.4: Synthesis of vinyl aminosulfoximines 
 
The vinyl aminosulfoxonium salts 38b-e, obtained from the corresponding vinyl 
sulfoximines 12b-e upon treatment with Me 3OBF4 (Scheme 3.5), were then treated with 
the N-Bus a-imino ester 3  (1.1 equiv) followed by the addition DBU (1.3 equiv).  This 
gave mixtures of aziridines cis-8b-e/trans-8b-e along with sulfinamide 7 within 30 min. 
Column chromatography afforded mixtures of cis-/trans-aziridines 6b-e in 70%, 68% and 
65 % yields, respectively, along with the sulfinamide 7 (³ 98% ee) in good yields (Table 
3.1).  
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R
Bus
N
EtO2C
R
Bus
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Ph
NMe2O
BF4
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Ph
NMeO 1) Me3OBF4
3) DBUDCM
+
Ph
S
NMe2
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+
N
EtO2C
Bus2)
3
12b-e 38 b-e
cis-6b-e trans-6b-e 7
b: R = i-Pr; c: R = c-Hex; e: R = Me
 
 
Scheme 3.5: Synthesis of alkenyl aziridine carboxylates from vinyl sulfoximines and the 
imino ester 3 
 
Table 3.1. Synthesis of alkenyl aziridine carboxylates from 1-alkenyl aminosulfoxonium 
salts and 3 
 
vinyl 
sulfoximine
(12) 
R aziridines 
(6b-e) 
cis:trans 
yield 
(%) 
cis 
eea (%) 
 
trans 
eea (%) 
 
sulfinamide 
(7) 
b iPr 64:36 70 76 49 92 
c cC6H11 70:30 68 47 45 90 
e Me 60:40b 65 65 -c 90 
a Determined by HPLC, Chiralpack-IA. b Inseparabile mixture. c Could not be determined 
 
The conversion of 12b-e to the aziridines 6b-e, respectively, has also been carried out 
with similar results without isolation of 38b-e. By this shortened route the aziridines were 
obtained in good yields but with moderate diastereoselectivities and with low to moderate 
enantioselectivities. The diastereoselectivities and enantioselectivities of the aziridine 
formation from the vinyl aminosulfoxonium salts 38b and 38c in the presence of N-Bus 
a-imino ester 3 are significantly lower (Table 3.1) than those derived from the amino 
alkylated aminosulfoxonium salts 5b and 5c , where the imino ester 3 is generated in situ. 
Finally as illustrated in the foregoing section, a mixture of cis-6b/trans-6b was 
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stereoselectively transformed into cis-33 with ³98 % de via cis-32/trans -32 and cis-
33/trans-33 in 80 % overall yield.  
 
3.3 Synthesis of alkenyl aziridine carboxylates from a substituted allyl 
aminosulfoxonium ylide 
 
Because of the high reactivity of the unsubstituted ylides 9a-d towards the imino ester 3, 
it was of interest to see whether an allyl ylide carrying an alkyl group at the C-atom can 
be generated and to study its reactivity. Thus, the Ca-methyl-substituted vinyl 
sulfoximine 3982 was prepared starting from the vinyl sulfoximine 12b. The vinyl 
sulfoximine 12b was lithiated at the a-position83 with n-BuLi in THF at - 78° C and the 
solution was allowed to warm to 0° C over 45 min, which was then cooled to -78° C and 
quenched with an excess of MeI to afford the a-methyl substituted vinyl sulfoximine 39  
in 95% yield (Scheme 3.6). 
 
S
Ph
O NMe 1) n-BuLi, THF
- 78° C
2) MeI
S
Ph
O NMe
12b 39  
 
Scheme 3.6: Synthesis of a a-substituted vinyl sulfoximine 
 
Having obtained the Ca-methylated vinyl sulfoximine 39 , it was methylated by a 
treatment with Me 3OBF4 at 0° C, which gave the amino sulfoxonium salt 40 in 98% 
yield. Salt 40 was then treated with DBU in the presence of the N-Bus a-imino ester 3  at 
0° C. This furnished the methyl-substituted allyl aminosulfoxonium ylide which readily 
reacted with 3 to produce aziridines cis-41 and trans-41 in a ratio of 60:40 in 81% yield. 
Besides aziridines cis-41  and trans-41 , sulfinamide 7 of ³98% ee was isolated in 92% 
yield. Pure cis-41 was obtained by preparative HPLC, but pure trans-41 could not be 
obtained.  
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Scheme 3.7: Synthesis of alkenyl aziridine carboxylate from a substituted allyl 
aminosulfoxonium ylide 
 
3.4 Synthesis of cycloalkenyl aziridine carboxylates from cyclic 1-
alkenyl sulfoximines and imino ester 3 
 
3.4.1 Retrosynthetic analysis of cycloalkenyl aziridine carboxylates 
 
The synthesis of the alkenyl aziridine carboxylates cis-6b-e and trans-6b-e from the vinyl 
sulfoximines 12b-e via their corresponding salts 38b-e and the N-Bus a-imino ester 3 
suggested the possibility of a similar synthesis of cyclic alkenyl aziridines cis-45a-d and 
trans-45a-d from cyclic 1-alkenyl sulfoximines 42a-d84 and 3 (Scheme 3.8).  
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Scheme 3.8: Retrosynthetic analysis of cycloalkenyl aziridine carboxylates 
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The required cyclic 1-alkenyl sulfoximines 42a-d can be derived from the (S)-N,S-
dimethyl-S-phenyl sulfoximine (10) by the addition-elimination route.11 
 
3.4.2 Synthesis of cyclic 1-alkenyl sulfoximines 
 
The cyclic 1-alkenyl sulfoximines 42a-d84 can be prepared on a preparative scale because 
of the ready availability of the cycloalkanones and the enantiomerically pure (S)-N,S-
dimethyl-S-phenyl sulfoximine (10). Addition of the lithiomethyl derivative of 1011 to the 
corresponding cycloalkanones, which is well-exemplified mainly through the work of 
Johnson et al.,2c led to the corresponding hydroxy sulfoximines which were not isolated 
but treated with ClCOOMe followed by DBU at -78 °C according to the reported 
experimental procedure,84 which afford the cyclic vinyl sulfoximines 42a-d along with 
small amounts of the cyclic allyl sulfoximines 47a-d. The pure cyclic vinyl sulfimines 
were obtained by column chromatography in 73%, 82%, 80% and 75% yield, 
respectively.84  
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Scheme 3.9: Synthesis of cyclic 1-alkenyl sulfoximines 
 
3.4.3 Synthesis of cycloalkenyl aziridine carboxylates 
 
According to the synthetic strategy for aziridines 37a-d, the first step is the activation of 
the N-methyl sulfoximine group of the cyclic alkenyl sulfoximines 42a-d with Me3OBF4. 
Hence, based on our earlier observations the cyclic 1-alkenyl sulfoximines were treated 
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with Me3OBF4 in CH2Cl2 at 0 °C, which gave the (dimethylamino)sulfoxonium salts 43a-
d in quantitative yields (Scheme 3.10). The salts thus obtained were treated with DBU in 
CH2Cl2 to generate the corresponding cyclic aminosulfoxonium ylides 44a-d, the key 
intermediates, in the presence of the N-Bus a-imino ester 3. To our delight, the cyclic 
aminosulfoxonium ylides 44a-d also combined with the imino ester 3 and afforded the 
cycloalkenyl aziridine carboxylates cis-45a-d and trans-45a-d with low 
diastereoselectivities and medium enantioselectivities in good yields (Table 3.2). Besides 
the aziridines the sulfinamide 7 (³ 98 % ee) was isolated in good yield in each case. 
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Scheme 3.10: Synthesis of cycloalkenyl aziridine carboxylates from cyclic 1-alkenyl 
                        sulfoximines and imino ester 3 
 
Table 3.2. Synthesis of cycloalkenyl aziridine carboxylates 
 
cis trans vinyl 
sulfoximine
(42) 
n aziridine 
(45) 
cis:trans 
yield 
(%) eea 
(%) 
yield 
(%) 
eea 
(%) 
yield 
(%) 
Sulfinamide
(7) 
a 1 60:40b 70 79 - 90 - 80 
b 2 60:40 73 76 42 56 28 81 
c 3 60:40 71 78 41 57 26 76 
d 4 50:50 66 70 29 25 30 70 
a Determined by HPLC, Chiralpack-IA. b Inseparable mixture. 
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In fact, the conversion of 42a-d to cis-45a-d and trans-45a-d could also be carried out 
with similar results without isolation of the salts 43a-d. The 2,3-cis/trans-pair of chiral 
aziridines were obtained in a 3:2 ratio, respectively, in the case of cyclopentenyl, 
cyclohexenyl and cycloheptenyl aziridine derivatives, where as in the case of the 
cyclooctenyl aziridine derivative the cis/trans ratio was 1:1. The cis- and trans- 
configuration was assigned based on the 1H NMR data. In the case of the 2,3-cis-
aziridines the J(H2 ,H3) values were ˜ 7.66 Hz, and in the case of 2,3-trans-aziridines the 
J(H2,H3) values were ˜ 3.85 Hz. This is in accordance with the literature values63 for cis 
and trans aziridine derivatives.  
 
3.5 Mechanistic considerations of the alkenyl aziridine carboxylates 
formation from allyl aminosulfoxonium ylides and 3 
 
The formation of the acyclic alkenyl aziridine carboxylates cis-6b-e and trans-6b-e from 
the aminosulfoxonium salts 38b-e and the cycloalkenyl aziridine carboxylates 45a-d 
from the cyclic aminosulfoxonium salts 43a-d, respectively, through a treatment with 
DBU and a-imino ester 3 can be mechanistically described as shown in Scheme 3.11. 
Methylation of the acyclic and cyclic alkenyl sulfoximines 12b-e and 42a-d with 
Me3OBF4 gave the (dimethylamino) sulfoxonium salts 38b-e and 43a-d, respectively. 
When these salts 38b-e and 43a-d were treated with DBU a deprotonation took place at 
the g-position producing the highly reactive allyl ylides 9b-e and 44a-d, respectively, 
which react with the N-Bus a-imino ester 3 to afford the corresponding cis/trans-
aziridine derivatives 6b-e and 45a-d along with sulfinamide 7. 
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Scheme 3.11: Mechanism for aziridine formation from the allylic sulfoxonium ylides  
9b-e and   44a-d by combining with 3 
 
It is assumed that the first step of the aziridine formation is the stereoselective addition of 
the allylic aminosulfoxonium ylides 9b-e and 44a-d to the imino ester 3 to form a 
betaine, while establishing a new C-C bond. The second step will be the irreversible anti 
attack of the N-atom on the carbon bearing the amino sulfoxonium group, to eliminate 
sulfinamide 7. The reason for the observed stereoselective addition of the allylic 
aminosulfoxonium salts 38b-e and 43a-d on the imino ester 3 can be explained as 
described below. 
 
3.5.1 Mechanistic consideration of the stereoselective aziridination 
 
In the literature, the ylide aziridination is regarded as a two-step process.85 Although the 
detailed mechanistic pathway is not clear, we propose the following mechanism for the 
stereoselective attack, which allows the generation of enantiomerically enriched aziridine 
derivatives (Figure 3.5). As shown in path A, the aminosulfoxonium ylide 9b-e, 44a-d 
attacks the N-Bus a-iminoester 3 from the Si-face, where the allylic chain of the ylide 
and the ester group of the imino ester are facing opposite sides, also the bulky N-Bus 
group is on the side of smallest substition, oxygen, of sulfoxonium sulfur as shown in the 
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Figure 3.4. Hence it is the most favorable direction of addition of sulfoxonium ylide 9b-e, 
44a-d to the imino ester 3  as it is evidenced by the formation of the major (2R,3R)-cis-
6b-e,45a-d enantiomer. On the other hand when the sulfoxonium ylide 9b-e, 44a-d adds 
to the imino ester 3 from the Re- face, following path B, the allylic substitution of the 
ylide and the ester functionality of the imine are trans to each other but the Bus group of 
the imine and the dimethylamine group of the sulfoxoniumylide approach from the same 
side, which is sterically not favourable. Hence, path B which produces a (2S,3S)-ent-cis-
6b-e,44a-d aziridines is not a facile approach. Thus the major cis-enantiomer obtained 
from path A and has the (2R,3R)-configuration. 
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Figure 3.5: Stereoselective formation of cis-aziridines 
 
Similarly, the formation of the trans-major and the trans-minor enantiomers from the 
allylic aminosulfoxonium ylide and the N-Bus a-imino ester 3 can be explained as 
follows. The sulfoxonium ylide 9b-e, 44a-d adds to the imino ester from the Si-face 
having both the allylic side chain of the ylide and the ester group of the imino ester on the 
same side to follow path C, in order to form trans-aziridine derivative trans-6b-e, 45a-d. 
But during this addition the Bus substituent of the imine approaches towards the oxygen 
of the sulfoxonium group, hence the steric orientation of the N-Bus is favoured during 
this addition but the allylic functionality and the ester functionality undergo steric 
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interactions. When following path D, the allylic substitution of the ylide and the ester 
substitution of the imine experience unfavourable steric interactions and also the N-Bus 
group and the dimethyl amino substituent of the sulfoxonium group are approaching from 
the same side. Since this addition is the most hindered approach path D will lead to the 
formation of the minor enantiomer of the trans-aziridine derivative ent-trans-6b-e, 45a-d.  
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Figure 3.6: Stereoselective formation of trans-aziridines 
 
3.6 Conclusions 
In summary, we have achieved a highly efficient asymmetric synthesis of N-Bus 
protected acyclic and cyclic alkenylaziridine carboxylates by a reagent controlled 
asymmetric synthetic approach. There are only two reports of reagent-controlled 
asymmetric aziridination in the literature. We succesfully applied the cyclic allylic 
sulfoxonium ylides for aziridination and synthesized a variety of cyclic alkenylaziridine 
carboxylates. The tert-ylides were generated in situ  and applied successfully for the 
chirally pure tert- substituted aziridine derivatives in a one pot reaction with good yields 
and diastereoselectivities. 
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CHAPTER 4 
 
Michael addition of thiophenol to vinyl sulfoximines 
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4  Michael addition of thiophenol to vinyl sulfoximines 
 
4.1 Introduction 
 
4.1.1 Michael addition of vinyl sulfoximines 
 
The Michael addition is one of the efficient methods in organic synthesis for the 
formation of carbon-carbon, carbon-sulphur, carbon-oxygen, carbon-nitrogen and carbon-
phosphorous bonds.86 The Michael addition of a ,b-unsaturated sulphur derivatives has 
been reported in the case of sulphones,87 sulphoxides,78a,88 and sulphimides.89 However, 
in the case of vinyl sulfoximines the conjugate addition reactions had not been well 
explored until the end of mid-1980s. A serious obstacle present at that time was the rather 
limited number of efficient routes to isomerically pure vinyl sulfoximines. With the 
number of methods for the preparation of these compounds growing, the number of their 
successsful applications in organic synthesis steadily increased. a, b-Unsaturated 
sulfoximines have unique properties: the double bond is strongly activated, as in the case 
of the sulphonyl group, towards nucleophilic addition; moreover, the presence of a chiral 
sulphur atom could lead in principle to the occurence of asymmetric induction and/or 
kinetic resolution. Michael addition of variety of nucleophiles to a, b-unsaturated 
sulfoximines has been studied. 
 
One of the first successful asymmetric conjugate addition of carbon nucleophiles to a 
chiral vinyl sulphoximines appeared in 1986.90 Pyne et al. synthesized the (+) -
norephedrine derived 1-alkenyl sulphoximines via the corresponding diastereomeric 
sulfinamides (Figure 4.1). Conjugate additions of organolithium reagents and Gilman-
cuprates (R2CuLi) occured from the Si-face of C-2 whereas organocopper compounds 
(RCu) attacked the double bond from its Re-side. The attained diastereoselectivities were 
quite high (80-96% de) and were explained by a complexation model involving the 
sulfoximine heteroatoms as well as the methoxy group of the auxiliary.91,92 
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Figure 4.1. Conjugate addition of organometallic reagents to chiral vinyl sulfoximines 
 
In 1979 Annunziata et al. published the kinetic resolution of the N-phthaloyl vinyl 
sulfoximine by using (-)-ephedrine as the nucleophile (Figure 4.2).93 The enantiomer 
differentiating conjugate addition reaction enriched the unsaturated starting material to 
46% ee. 
 
S
O
PhthN
Tolp +
NHMe
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0.5 eq
- 30 °C
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Ph
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OH
 
 
Figure 4.2. Aza-Michael addition of amines to vinyl sulfoximines 
 
Taking this precedent as a starting point, Tye et al. investigated the generality of the 
conjugate addition of nitrogen nucleophiles into vinyl sulfoximides.94  
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Figure 4.3.  Aza-Michael addition of amino acids to vinyl sulfoximines. 
 
In 1998 Reggelin et al. combined the diastereoselective reactions of titaned allyl 
sulfoximines with a diastereoselective cyclisation yielding highly substituted 
diastereomerically pure pyrrolidines92 (Figure 4.4). 
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Figure 4.4. Intramolecular aza-Michael addition to vinyl sulfoximines 
 
 In 2003, Gais et al. studied the intramolecular carbamate amination of d-hydroxy-a ,b-
unsaturated sulfoximines to form diastereomerically pure oxazinone derivatives (Figure 
4.4).17d 
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Figure 4.4. Intramolecular aza-Micahel addition to vinyl sulfoximine 
 
In 1988 Meth-Cohn et al. described the synthesis of epoxy sulfoximines via  conjugate 
addition of tBuOOLi to vinyl sulfoximines. In 1993 the same author together with 
Jackson reported the synthesis of a series of epoxy sulfoximines by a slight modification 
of the above mentioned nucleopilic epoxidation procedure (-50 °C instead of -20 °C 
(Figure 4.5).95  
 
O
S
Ph
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Ph
tBuOOLi
- 50 °C
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Ph
TsN
Ph
O
one single diastereomer 
 
 
Figure 4.5. Oxo-Michael addition to vinyl sulfoximines 
 
 
4.2 Present Work 
 
4.2.1 Aim 
 
From the above discussion it is clear that alkenyl sulfoximines can act as Michael 
acceptors toward various nucleophiles. However the range of neucleophiles for the 
conjugate addition of alkenyl sulfoximines has yet to be explored. Hence, asymmetric 
Michael addition of vinyl sulfoximines is still a topic of considerable interest. For a study 
of such reactions the important point to be considered is the electrophilic nature of the 
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sulfoximine group. It has been reported that the substituent present on nitrogen atom 
greatly effects the electrophilicity of the sulfoximine group.2a  
 
Recently, C. F. Yao et al. reported the iodine-catalyzed Michael addition of mercaptanes 
to a ,b-unsaturated ketones under solvent-free conditions96a (Figure 4.6). They 
demonstrated a simple and efficient me thodology to prepare a wide variety of Michael 
adducts using iodine in catalytic amounts. This environmentally benign process for the 
generation of Michael adducts represents a suitable option to the existing procedures with 
different substitution.  
R
R1
O
R3
R2
R4SH+
I2 (5 mol%)
Neat
R
R1
O
R3
SR4
R1  
 
Figure 4.6.  Michael addition of mercaptanes under solvent free conditions 
 
The above-mentioned mercaptane conjugate addition under solvent free conditions 
encouraged us to study a similar reaction of vinyl sulfoximines.  
 
R1SH+
Neat
R S
Ph
NMeO
R S
Ph
NMeO
S
Ph
 
 
Figure 4.7.  Conjugate addition of mercaptane to vinyl sulfoximine 
 
4.2.2 Results and Discussion 
 
4.2.2.1 Michael addition to simple vinyl sulfoximines 
 
To study the conjugate addition of mercaptanes to vinyl sulfoximines, the simple N-
methyl vinyl sulfoximines 12b and 12d were selected and treated with 1 equiv of 
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thiophenol together with 25 mol% iodine, at room temperature under argon atmosphere. 
Even after stirring the reaction mixture for 8 h no product formation was observed. 
 
 
+
Neat
R S
Ph
NMeO
R S
Ph
NMeO
S
Ph
PhSH
(25 mol %) I2
12b,d
b:  R = iPr; d: R = tBu
(1 equiv)
 
 
Scheme 4.1: Thia-Michael addition of vinyl sulfoximine 
 
However, trea tment of the vinyl sulfoximines 12b,d with excess thiophenol (6 equiv) 
together with iodine (25 mol%) gave sulfides 38b and epi-38b as well as 38d and epi-
38d, respectively, in almost quantitative yields. The diastereoselectivity was found to be 
approximately 2 : 1 in both cases. The synthesis of the vinyl sulfoximines 12b,d has 
already been described in the chapter 2, Scheme 2.5. 
 
+
Neat
R S
Ph
NMeO
R S
Ph
NMeO
S
Ph
PhSH
(25 mol %) I2
12b,d b:  R = iPr; d: R = tBu
(6 equiv)
38b,d and epi-38b,d
1-2 h, rt
(quantitative yield)
 
 
Scheme 4.2:  Thia-Michael addition of vinyl sulfoximine 
 
Further studies of the reaction of vinyl sulfoximine 12b,d with thiophenol were carried 
out in the absence of iodine and sulfides 38b,d and epi-38b,d were also obtained. 
Therefore iodine has no effect on the Michael addition of thiophenol to vinyl 
sulfoximines (Figure 4.3). 
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Scheme 4.3:  Thia-Michael addition to vinyl sulfoximines 
 
4.2.2.2 Mechanism of the Michael addition of thiophenol to vinyl 
sulfoximines 
 
A possible mechanism for the thia-Michael addition of the alkenyl sulfoximines is shown 
in Scheme 4.4. Thiophenol (pKa ˜ 10.3) protonates the N-atom of the sulfoximine 12 to 
give the aminosulfoxonium salt (pKa ˜ 10). Then the thiophenolate ion attacks the double 
bond to form a C-S bond and generate the ylide, which is protonated by thiophenol to 
generate thiophenolate ion. The thiophenolate ion takes the proton from the sulfoxonium 
N-atom of the sulfide formed to give a diastereomeric mixture of sulfides (38 and epi-38) 
and thiophenol. Hence the reaction cycle continues to furnish the sulfides 38 and epi-38.  
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Scheme 4.4:  Mechanism for the addition of thiophenol to vinyl sulfoximines 
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4.2.2.3 Michael addition of thiophenol to functionalized vinyl 
sulfoximines 
 
Having developed a facile synthesis of sulfides 38b,d and epi-38b,d from the 
corresponding simple vinyl sulfoximines 12b,d, it was of interest to see whether this 
method could also be applied to the highly functionalized vinyl sulfoximines such as the 
d-sulfoximine substituted g,d-unsaturated a-amino acid derivatives 4a-b, the synthesis of 
which has already been described in the chapter 2, Scheme 2.6. Thus, the vinyl 
sulfoximine 4b was treated with 6 equiv of thiophenol at room temperature under argon 
atmosphere. Interestingly, the reaction was completed in 3 h and furnished the sulfides 
39b and epi-39b in a ratio of 4:1 in 90% yield. The pure  sulfides 39b and epi-39b were 
obtained by flash chromatography in 71% and 13% yield, respectively.  
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Scheme 4.5: Thia–Michael addition of the functionalized vinyl sulfoximine 4b 
 
The sulfides 39b and epi-39b are colourless crystalline compounds. Single crystals of the 
major diastereomer 39b were obtained in EtOAc/n-hexane solvent system and its 
structure was determined the X-ray crystal analysis (Figure 4.8). The X-ray structure 
showed that the newly created chiral center in 39b has R-configuration. 
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Figure 4.8. Structure of sulfide 39b in the crystal 
 
 
The vinyl sulfoximine 4a was also treated with 6 equiv of thiophenol at room temperature 
under argon atmosphere. Greatifyingly, the reaction was completed in 1 h and gave 
sulfide 39a as a single diastereomer with complete conversion of the starting material 4a. 
But unfortunately while removing the excess thiophenol by flash column 
chromatography, the sulfide 39a underwent a slow reverse Michael-addition reaction to 
give back the starting material 4a and, thus, prohibiting the isolation of 39a in pure form. 
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Scheme 4.6: Thia–Michael addition of thiophenol to the functionalized vinyl sulfoximine 
4a 
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The preference for the ‘Re-face’ attack of thiophenol to the vinyl sulfoximines 4a,b can 
be rationalized as follows by considering the crystal structure of 4b. The structure of 4b58 
shows that the S-phenyl group, N-Bus group and the ester group together provide for a 
concave side of the vinyl sulfoximine 4b whereas the isopropyl group is on the convex 
side (Figure 4.9).  
 
Figure 4.9. Structure of the amino-substituted vinyl sulfoximine 4b in the crystal 
 
The structure of 4b shows that the bulky ester and the phenyl group of sulfoximine group 
block the Si-face of the double bond, where as the isopropyl group blocks the Re-face to a 
less extent. It is assumed that the sulfide 4b adopts the same structure in solution. Hence 
for the Michael addition, the Re-face addition is more favoured than the Si-face addition. 
Thus, thiophenol undergoes a preferential Re-face addition, to give  sulfide 39b as a major 
diastereomer and to a small extent Si-face addition to yield the sulfide epi-39b as a minor 
diastereomer. 
  
After having obtained favorable results in the Michael addition with the d-
sulfoximine-substituted g,d-unsaturated a-amino acid derivatives, a similar reaction with 
d-sulfoximine substituted g,d-unsaturated homoallylic alcohols was studied. Former 
members of our research group disclosed a method for the regio- and stereoselective 
hydroxyalkylation of allylic sulfoximines 1 through successive treatment with nBuLi and 
2.1 equiv Cl(Ti(O iPr)3 followed by treatment with aldehydes, which leads to the 
formation of the anti-configured d-N-methylsulfonimidoyl substituted homoallylic 
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alcohols (eg. 40).11,97 Thus the sulfoximine-substituted homoallylic alcohol 4083 was 
synthesized from the allyl sulfoximine 1a with ³96% de in 81% yield (Scheme 4.7). 
 
S
Ph
NCH3O
1) 1.1 eq n-BuLi
2) 2.1 eq ClTi(O i-Pr)3
OH
401a
3) 1.1 eq (CH3)2CHCHO
S
Ph
O NCH3
81% yield; • 98: 2 ds  
Scheme 4.7: Asymmetric synthesis of the sulfoximine-substituted (Z)-homoallylic 
alcohol 40. 
 
The thus obtained (Z)-homoallylic alcohol 40 was silylated by treatment with TBDMSCl 
(2 equiv) in the presence of excess of imidazole (4 equiv) in CH2Cl2 , which furnished 
sulfoximine 41 in 95% yield (Figure 4.8). The silyl protected (Z)-configured vinyl 
sulfoximine 41 was treated with 2 equiv of thiophenol at room temperature under argon 
atmosphere. Interestingly, thiophenol caused a change in the double bond configuration 
of vinyl sulfoximine from Z-41  to E-41 but no Michael addition was observed. Hence, 
sulfoximine E-41 was isolated in 65% yield along with the unreacted sulfoximine Z-41  
in 20% yield (Scheme 4.8). 
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Scheme 4.8: Reaction of the silyl-protected Z-conf igured vinyl sulfoximine with 
thiphenol 
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After having observed a tendency of thiophenol to isomerize the Z-configured vinyl 
sulfoximine Z-41 to E-configured vinyl sulfoximine E-41, it seemed of interest to study 
the Michael addition of thiophenol to the E-configured vinyl sulfoximine E-41. Therefore 
Z-41  was first transformed into E-41 through a-lithiation followed by protonation. 82 The 
lithiation of the Z-alkenyl sulfoximine Z-41 with nBuLi at -78 °C occurred selectively at 
the a-position and gave the corresponding Z-alkenyllithium derivative which suffered at 
-20 °C a complete isomerization to the E-configured alkenyllithium derivative, the 
protonation of which gave E-41. The resulting E-41 was treated with 6 equiv of 
thiophenol at room temperature under argon atmosphere. The reaction was finished in 4 h 
and furnished sulfides 42 and epi-42 in 92% yield in a ratio of 2:1. Preparative HPLC 
(EtOAc/n-hexane; 1:9) afforded the pure sulfide 42 in 58% yield and sulfide epi-42 in 
33% yield. The stereochemistry of  both the diastereomers was not determined.  
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Scheme 4.9: Michael addition of thiophenol to silyl protected E-configured vinyl 
sulfoximine. 
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4.3 Conclusions 
 
In summary, we have achieved an efficient thia-Michael addition of thiophenol to a 
variety of 1-alkenyl sulfoximines, including simple vinyl sulfoximines 12b,d, d-
sulfoximine substituted g,d-unsaturated a-amino acid derivatives 4a,b, and silyl protected 
d-sulfoximine substituted g,d-unsaturated homoallylic alcohols 40. The Michael addition 
went well in all cases to give the sulfides in very good yields. It was interesting to 
observe a high diastereoslectivity in the case of d-sulfoximine-substituted g,d-unsaturated 
a-amino acid derivatives 4a,b. These results can serve as interesting starting point for the 
synthesis of biologically important molecules like highly substituted proline derivatives 
as explained in the following chapter. 
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CHAPTER 5 
 
Asymmetric synthesis of 3-substituted 4-phenylsulfenyl prolines 
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5   Asymmetric synthesis of 3-substituted 4-phenylsulfenyl 
prolines 
 
5.1 Introduction 
 
Having observed a diastereoselective thia-Michael addition of thiophenol to d-
sulfoximine-sulbstituted g,d-unsaturated a-amino acids 4a,b, a conversion of the 
corresponding sulfides into a 4-thia substituted proline derivative was envisioned. 
 
5.1.1 Sulfur-containing biologically active molecules 
 
Sulfur-containing compounds can be found in all living organisms and, therefore, play an 
important role in biochemistry.98 Biosynthetically, sulfur-containing functionalities are 
introduced by a variety of chemical processes, including the thia-Michael addition.99 
Coenzyme M is synthesized in methanogenic bacteria involving an initial addition of 
bisulfite to phosphoenolpyruvate to form the a-hydroxy acid,100, which is subsequently, 
transformed into the coenzyme M over 5 steps (Figure 5.1). 
 
HSO3
CO2H
OPO3
+ SMA
HO3S
CO2H
OH
5 steps
HO3S
SH
coenzyme M
 
 
Figure 5.1. Biosynthesis of coenzyme M following SMA 
 
Among the various important biosynthetic compounds proline derivatives have found 
considerable application.101 Peptide mimetics containing modified prolines are interesting 
probes for receptor studies and for the development of new drugs. Highly substituted 
prolines are being currently considered as conformationally restricted arginine, 
norleucine, phenylalanine, tyrosine, aspartic acid, and glutamic acid analogues102 for the 
development of small molecule drugs. Proline has been found to be an excellent catalyst 
of asymmetric Aldol and Mannich reactions and of the asymmetric a-amination of 
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carbonyl compounds.103 There are several methods known in the literature for the 
synthesis of 2-, 3-, and 5-substituted prolines. But not many promising me thods exist for 
4-substituted prolines.104 In particular 4-thia substituted proline derivatives have found a 
few important biological applications. The thiamethylene linkage for example, offered 
from a 4-mercapto proline, in peptides generates a maximum rigidity and provides the 
desired dihedral angle.105  
N
S
N
O
X
O
O
X = OCH3, OH,  NHCH3  
Figure 5.2. 4-Thia substituted prolines and thiamethylene linkage in peptides 
 
Natural products containing 4-thia-substituted prolines are known. For example 
meropenem is an important b-lactam antibiotic drug.106 
 
N
O
S NH
COOH
OH
H H
N(CH3)2
O
meropenem  
Figure  5.3. 4-Thia proline substituted natural products 
 
A widely used method for the synthesis of 4-thia substituted prolines107 involves a 
Finkelstein type reaction of the corresponding activated hydroxyproline derivative 
(Figure 5.4). 
 
N
H2
CO2
HO 1) MeOH, HCl, (MeO)2SO
2) Ac2O, H2O, NaHCO3
3) TsCl, Py N
CO2Me
TsO
Ac
4) MeOH, NaOH
5) PhCH2SNa N
CO2Me
PhCh2S
Ac  
Figure 5.4. Synthesis of 4-thia prolines 
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The 1,3-dipolar cycloaddition of azomethine ylides with alkenes is good method for the 
synthesis of substituted prolines.102 
 
MeO2C N R1
R2
SO2Ph
+
Cu(CH3CN)4ClO4
Taniaphos
Et3N, toluene, 0 °C N
H
MeO2C R1
R2
SO2Ph
(ee upto 85%)  
Figure 5.5. Synthesis of 4-thia prolines by 1,3-cycloaddition reaction 
 
5.2  Present Work 
 
5.2.1 Aim 
 
As illustrated in the previous section, substituted prolines are valuable compounds in 
organic synthesis. Having developed a diastereoselective thia-Michael addition of 
thiophenol to the d-sulfoximine-sulbstituted g,d-unsaturated a-amino acids 4a,b (Chapter 
4; Scheme 4.5, 4.6), we envisioned a synthesis of the 3-substituted 4-thia prolines 44a,b 
from sulfides 39a,b (Scheme 5.1). 
 
S
Ph
NMeO
EtO2C
NH
Bus
S
Ph
39a,b
R
N
Bus
EtO2C
R SPh
44a,ba: R = Ph; b: R = iPr  
 
Scheme 5.1: Synthesis of 3-substituted-4-thiophenyl prolines 
 
5.2.2 Results and Discussion 
 
5.2.2.1 Substitution of sulfoximine group by a Cl-atom 
 
The synthesis of sulfides 4a,b has been described in chapter 4. The successive synthesis 
of proline derivatives from 39a,b would involve a substitution of sulfoximine group by a 
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Cl-atom followed by intramolecular cyclization. The substitution of a sulfoximine group 
by a Cl-atom has been accomplished in the case of vinyl sulfoximines57 and b-amino 
substituted sulfoximine derivatives10,17d by a treatment with ClCO2Me or 
ClCO2CH(Cl)Me. Vinyl sulfoximines upon treatment with ClCO2CH(Cl)Me give the 
corresponding allyl chlorides.57 Where as the b-amino substituted sulfoximine derivatives 
can be transformed into b-amino chlorides upon treatment with ClCO2CH(Cl)Me, which 
presumably undergo a neighbouring group participation of b-substituted amino group 
(Figure 5.6).  
 
S
Ph
NMeO
EtO2C
NH
Bus
39a,b
R
1) ClCO2CH(Cl)Me
DCM
Cl
EtO2C
NH
Bus
R
EtO2C
NH
Bus
R
Cl
+
 
 
Figure 5.6: Substitution of sulfoximine by a Cl-atom 
 
Similarly, it was envisioned that b-thio sulfoximines could also be transformed into their 
corresponding b-thio chlorides. It was expected that a neighbouring group participation 
from S-atom may take place during the chloride substitution of sulfoximine group. 
Indeed, sulfides 39a,b were transformed into chlorides 43a,b in 78% and 75% yield, 
respectively, upon treatment with 2 equiv of ClCO2 CH(Cl)Me in CH2Cl2 at 0 °C for 2-3 
h (Scheme 5.2). Besides chlorides 43a,b sulfinamide 44 was isolated in 88% and 90% 
yield, respectively.  
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Scheme 5.2: Substitution of sulfoximine group by a Cl-atom 
 
However, we were still apprehensive as to the structure of the chlorides. The chloride 
substitution of sulfoximines 39a,b could proceed with a neighbouring group participation 
of S-atom with formation of episulfide 45. Attack of Cl- can occur both at g-position and 
also at the d-position (Scheme 5.3).  
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Scheme 5.3: Substitution of the sulfoximine group by a Cl-atom under neighbouring 
group participation. 
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However, the structure of the chlorides was confirmed by comparing their NMR data 
with the literature reports.108,109 In 1980 C. Walsh and R. A. Firestone reported the 
preparation of amino acids 48a,b and 49a,b (Scheme 5.4) for a study of mechanism-
based enzyme inactivation.108 
 
CO2CHR2
NHBOC
ArSCl CO2CHR2
NHBOC
ArS
Cl
CO2CHR2
NHBOC
Cl
SAr
+
47 48a,b 49a,b
a: Ar = p - Nitrophenyl
b: Ar = p - Tolyl  
Scheme 5.4: Addition of arylsulfenyl chloride to terminal olefine 
 
According to Walsh and Firestone addition of arylsulfenyl chlorides to the double bond 
of 47 was fast and quantitative to give the regio isomers 48a,b and 49a,b. The structures 
of 48a,b and 49a,b were confirmed by their NMR data. NMR of 48a showed a d-value of 
3.3-3.7 ppm for CH2S and 3.9-4.35 ppm for CHCl where as its regio isomer 49a gave a 
multiplet together for CH2Cl and CHS at 3.7 ppm. Similarly, the addition of p-
tolylsulfenyl chloride to 47 was studied, it was observed that the product was principally 
49b by NMR as it showed a multiplet, corresponding to CHS and CH2Cl together, at 
3.0-3.8 ppm. 
 
The factors influencing the nature of the episulfonium ion in sulfenyl chloride addition to 
terminal olefins has been studied. It was quoted that, in general, protons a or b to 
chlorine are considerably deshielded relative to those a or b to sulfur.109 The NMR 
parameters compiled109 show relative differences in chemical shift for the signals of such 
a-methylene or methane protons on the order of 0.7-1 ppm. When methane or 
benzenesulfenyl chloride was added to alkyl-substituted olefins, the initial adduct isomer 
mixture obtained was predominantly the anti-Markonikov product Scheme 5.5. With 
increasing size of the substituent on the double bond (e.g., going from methyl as in 
propylene to isopropyl and t-butyl as in 3-methylbutene) with 3,3-dimethylbutene higher 
selectivity for the anti-Markonikov-oriented product was observed according to NMR.109  
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R1 RSCl
R1
Cl SR
R1
RS Cl
+
> 82% <18%
R1 = Me, iPr, tBu; 
R Me, Ph  
 
Scheme 5.5: Addition of methane- and benzene sulfenyl chloride to terminal olefine109  
 
Thus, considering these results, the structure of chlorides obtained from the episulfonium 
ions 45a,b was assigned. According to the NMR 39b gave only one regio isomer after the 
chloride substitution and it showed a multiplet at 3.28 ppm for CHS and two doublet of 
doublets at 3.61 ppm and at 3.73 ppm for CH2Cl. Whose d-values are in the range of 
those reported in the literature. Hence, the structure of chloride can be assigned as 43b. 
Similarly, 39a gave only one regio isomer and whose structure can be assigned as 43a 
according to the NMR. 
 
5.2.2.2 Synthesis of 3-substituted-4-thiophenyl prolines 
 
The chlorides 43a,b upon treatment with Cs2CO3 in DMF at 40 °C underwent a 
cyclization to afford the proline derivatives 50a,b in 87% and 90% yield, respectively 
(Scheme 5.6). The structure of the prolines was determined by NoE measurements of the 
deprotected proline 50b (Figure 5.6). 
 
Cs2CO3/DMF
NBus
EtO2C R
SPh
50a; 87%, 50b; 90%
Cl
EtO2C
NH
Bus
S
Ph
43a,b
R
 
 
Scheme 5.6: Synthesis of N-Bus 3-substituted-4-thiophenyl proline derivatives 
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5.2.2.3 Deprotection of the Prolines 
 
The final step of the synthesis of the 4-thiophenyl substituted proline derivative is the 
deprotection of the N-atom of 50. Because of the deliberate selection of the Bus group, 
this transformation should be possible by applying a water-free acid. 110 Indeed, treatment 
of the proline derivative 50b with CF3SO3H in CH2Cl2 (0.05-0.1M) in the presence of an 
excess of anisole (8-10 equiv), afforded the proline ester 51 in 84% yield (Scheme 5.4). 
The excess anisole was used in order to trap the in situ generated tert-butyl carbo cation. 
Care had to be taken in the case of the isolation of 51 from the acidic reaction mixture. 
Workup was carried out by the addition of water and extraction with CH2Cl2 following 
the adjustment of the pH of the mixture to a value of 7.1 by the addition of 0.1 M NaOH. 
 
N
H
EtO2C S
Ph
50b
CF3SO3H
51
N
Bus
EtO2C S
Ph
CH2Cl2
 
 
Scheme 5.4: Deprotection of the N-Bus proline 50b 
 
 
 
5.3 NoE measurements of proline 51 
 
NOE measurements of 51 were carried out in order to prove its constitution. NOE’s 
between H4-H6, H4-H7, H4-H5a and H4-H8 were observed. No NOE’s were observed 
between H4 and H5b, H4-H3, H2-H3 , H4-H3, and H2-H3. 
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HH
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nOe: H4          H5a
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H4          H7
H4          H9
 
 
Figure 5.6. NOE measurements of proline 51 
 
5.3  Conclusions 
 
In summary, we have achieved an efficient asymmetric synthesis of highly substituted 
prolines. 3-Alkyl(aryl)-4-thiophenyl substituted proline derivatives were synthesized via  
the d-chloro-g-thiophenyl b-alkyl(aryl)- substituted a-amino acid derivatives obtained 
from the thia -Michael addition of the d-sulfonimidoyl substituted g,d-unsaturated b-
substituted a-amino acid derivatives. 
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CHAPTER 6 
 
Experimental Part 
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6  Experimental Part  
 
 6.1  General Information  
 
All reactions with water and oxygen sensitive compounds were carried out in dry 
solvents under argon with syringe and schlenk techniques in oven-dried glassware. THF 
and toluene were distilled under nitrogen from sodium-lead/benzophenone. CH2Cl2 was 
distilled from CaH2. Commercially available DMF (water free, 99.8%) was used. 
Commercial Me3OBF4 was washed with dry CH2Cl2 and dry Et2O before use. Vinyl 
sulfoximines 12a-d,11 allyl sulfoximines 1a-d,11 cyclic vinyl sulfoximines 42a-d,84 
sulfoximine-substituted homoallyl amines 4a-d,15 sulfoximine-substituted homoallyl 
alcohol 4083 and a-iminoester 354 were prepared according to the literature. All other 
chemicals were obtained from commercial sources and used without further purification. 
Thin layer chromatography (TLC) was performed on silica gel 60 (Merck F254) plates. 
Column chromatography and flash chromatography were performed on silica gel 60 
(Merck 0.040–0.063 mm). HPLC: Varian SD-1 pump, prostar 320, Knauer RI-detector, 
Kromasil Si 100 (diameter: 30 mm or 40 mm, length: 250 mm). Solutions of crude 
reaction mixtures were filtered through Celite (Fluka 535).  
 
6.2  Analytic 
 
1H NMR Spectroscopy: 
 Varian Mercury 300 (300 MHz) 
 Varian Inova 400 (400 MHz) 
 Varian Unity 500 (500 MHz) 
 Internal Standard: Tetramethylsilan 
 
The following abbreviations are used to designate the multiplicity of the peaks in the 1H 
NMR spectra: 
 s         =  Singlet 
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 d         =  Doublet 
 t          =  Triplet 
 q         =  Quartet 
 quin    =  Quintet 
 sext     =  Sextet 
 sept     =  Septet 
 m        =  Multiplet 
 br        =  broad 
 
13C NMR Spectroscopy:  
 Varian Mercury 300 (300 MHz) 
 Varian Inova 400 (400 MHz) 
 Varian Unity 500 (500 MHz) 
 Internal Standard: Tetramethylsilan 
 
Peaks in the 13C NMR spectra are designated with the abbreviations, ‘u’ for carbons with 
zero or two attached protons and ‘d’ for carbons with one or three attached protons, as 
determined from APT pulse sequence. 
 
Infrared Spectroscopy: 
 
IR spectra were taken with a Perkin-Elmer PE 1759 FT, Perkin Elmer FTIR 1760 S, and 
only peaks of ? >800 cm-1 are listed. 
 
 w     =  weak (Absorption 20-40%) 
 m     =  medium (Absorption 40-70%) 
 s      = strong  (Absorption > 70%) 
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Mass Spectroscopy: 
 
Varian Mat 212 S  
Finnigan MAT 312 
        Varian MAT 95  
 
Electron impact (EI) 70 eV; Chemical ionization (CI) 100 eV; Direct chemical ionization 
(DCI) 70 eV; High resolution mass spectroscopy (HRMS) 70 eV. 
 
Only peaks of m/z >70 and an intensity >20%, expect decisive ones, are listed.  
 
Elemental Analysis:  
 
Heraeus CHN-O-RAPID  
Elemental Vario EI 
 
Optical Rotation: 
 
Optical rotations were measured on a Perkin Elmer Model 241 polarimeter at ˜23° C 
 
6.3 General Procedures 
 
6.3.1  General Procedure for the Synthesis of Alkenyl Aziridine Carboxylates 6 from 
the Sulfoximine Substituted a-Amino Acids 4 (GP1):  
 
To a solution of the vinyl sulfoximine 4 (1.0 mmol) in dry CH2Cl2 (5 mL) was added 
Me3OBF4 (1.2 mmol) at room temperature. Me 3OBF4 is not soluble in CH2Cl2 but the 
vinyl sulfoxonium salt is freely soluble in CH2Cl2. After stirring the mixture for 2-3 h, 
DBU (1.2 mmol) was added. Aziridine formation was completed in <5 min. Then the 
mixture was quenched with distilled water and extracted with CH2Cl2. The combined 
organic phases were dried (MgSO4), and the solvent was removed in vacuo. Purification 
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of the residue by chromatography (EtOAc/hexane, 15:85) gave a mixture of cis-6 and 
trans-6 as a colour less liquid and sulfinamide 7. 
 
6.3.2  General Procedure for the Synthesis of Alkenyl Aziridine Carboxylates 6 from 
the Vinyl Sulfoximines 12 and a-imino ester 3 (GP2):  
 
To a suspension of Me3OBF4 (1.2 mmol) in dry CH2Cl2 (5 mL) was adde d a solution of 
the vinyl sulfoximine 12 (1.0 mmol) in dry CH2Cl2 (10 mL) under stirring at 0 °C. After 
15 min the mixture was allowed to stir for 1.5 h at room temperature. Then the iminoester 
3 (1.2 mmol) and DBU (1.3 mmol) were successively added. The aziridine formation was 
completed in 20-30 min. Then the mixture was quenched with distilled water and 
extracted with CH2Cl2. The combined organic phases were dried (MgSO4), and the 
solvent was removed in vacuo. Purification of the residue by chromatography 
(EtOAc/hexane, 10:90) gave a mixture of cis-6 and trans-6 as a colour less liquid along 
with sulfinamide 7. 
 
6.3.3  General Procedure for the Synthesis of Cycloalkenyl Aziridine Carboxylates 
45 from the Vinyl Sulfoximines 42 (GP3):  
 
To a suspension of Me3OBF4 (1.2 mmol) in dry CH2Cl2 (5 mL) was added a solution of 
vinyl sulfoximine 42 (1.0 mmol) in dry CH2Cl2 (10 mL) under stirring at 0 °C. After 30 
min Me3OBF4 (0.5 mmol) was added and the mixture was allowed to stir for 30 min at 
room temperature. Then the iminoester 3 (1.4 mmol) and DBU (1.8 mmol) were 
successively added. The aziridine formation was completed in 20-30 min. Then the 
mixture was quenched with distilled water and extracted with CH2Cl2. The combined 
organic phases were dried (MgSO4) and the solvent was removed in vacuo. Purification 
of the residue by chromatography (EtOAc/hexane, 10:90) gave a mixture of cis-45 and 
trans-45 as a colour less liquid along with sulfinamide 7. 
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 6.3.4  General Procedure for Thiophenol Addition to Vinyl Sulfoximines (GP 4): 
 
To the vinyl sulfoximine (1 mmol) in a conical bottom flask at 0 °C was added neat 
thiophenol (6 mmol) under an argon atmosphere. After the mixture was allowed to warm 
to room temperature, it was stirred until TLC indicated the consumption of the 
sulfoximine (1-2 h). The mixture was directly subjected to flash column purification 
(EtOAc:n-hexane, 1:4), which gave the excess thiophenol and the sulfides. 
6.4  Synthesis of aziridines 
 
6.4.1  (2R,3R)- and (2R,3S)-Ethyl 3-styryl-1-(2-methylpropane-2-sulfonyl)aziridine -
2-carboxylate (cis-6a and trans -6a): 
 
N
EtO2C
H H
Ph
Bus
N
EtO2C
H H
Ph
Bus
 
 
Following GP1 , the aziridines cis-6a and trans-6a were synthesized from the vinyl 
sulfoximine 4a (500 mg, 1.02 mmol) by activating with Me 3OBF4 (180 mg, 1.22 mmol) 
followed by the treatment with DBU (186 mg, 1.22 mmol). A mixture of cis-6a and 
trans-6a (320 mg, 94%) was obtained in a ratio of 93:7. Preparative HPLC afforded cis-
6a (279 mg, 82%) and trans-6a (17 mg, 5%) as colorless syrupy liquids with ee-values of 
³98% (Chiralpack-AD, n-heptane/EtOH, 97:3, Rf = 18.0) and 30% (Chiralpack-AD, n-
heptane/EtOH, 97:3, Rf = 15.3, ent–Rf = 17.9) respectively. The sulfinamide 7 (160 mg, 
93%) was collected as a biproduct. 
 
cis-6a: 
 
1H NMR (300 MHz, C6D6): d = 0.78 (t, J = 7.17 Hz, 3 H, CH2CH3), 1.32 (s, 9 H, 
C(CH3)3), 3.54 (dd, J = 15.58, J = 7.17 Hz, 1 H, CH=CHCH), 3.68  (d, J = 7.17 Hz, 1 H, 
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COCH), 3.79 (dq, J = 7.17, J = 2.23 Hz, 2 H, CH2CH3), 6.32 (dd, J = 16.2, J = 8.29 Hz, 1 
H, CHCH=CH), 6.47 (d, J = 16.08 Hz, 1 H, CHCH=CH), 6.98–7.16 (m, 5 H, Ph). 
 
13C NMR (75 MHz, C6D6): d 13.5 (d), 23.5 (d), 41.5 (d), 45.2 (d), 59.2 (u), 61.2 (u), 
120.3 (d), 126.6 (d), 128.0 (d), 128.4 (d), 135.7 (u), 137.4 (d), 165.5 (u).  
 
IR (CHCl3) ? 3276 (s), 2936 (s), 1740 (s), 1623 (w), 1451 (m), 1368 (w), 1318 (s), 1235 
(w), 1128 (s), 1022 (m), 972 (m) cm-1. 
 
MS (CI, CH4) m/z (relative intensity, %) 338 (M+ + H, 3), 274 (5), 264 (6), 246 (8), 218 
(100), 172 (4), 144 (4), 115 (4).  
 
Optical rotation: [a]D –14.1 (c 1.75, CHCl3 ). 
 
Elemental Analysis: 
 
C17H23NO4S C H N 
calcd 60.51 6.87 4.15 
found 60.19 6.57 3.90 
 
trans-6a: 
 
1H NMR (300 MHz, CDCl3): d = 1.32 (t, J = 7.17 Hz, 3 H, CH2CH3), 1.49 (s, 9 H, 
C(CH3)3), 3.54 (d, J = 3.71 Hz, 1 H, COCH), 3.68 (dd, J = 9.64, J = 3.71 Hz, 1 H, 
CH=CHCH), 4.27 (q, J = 7.18 Hz, 2 H, CH2CH3), 6.27 (dd, J = 15.83, J = 9.65 Hz, 1 H, 
CHCH=CH), 6.89 (d, J = 15.83 Hz, 1 H, CHCH=CH), 7.27–7.42 (m, 5 H, Ph).  
 
13C NMR (75 MHz, CDCl3): d 14.1 (d), 23.9 (d), 45.0 (d), 48.8 (d), 61.0 (u). 62.0 (u), 
121.1 (d), 126.7 (d ), 128.5 (d), 128.6 (d), 135.6 (u), 137.9 (d), 166.8 (u).  
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IR (KBr) ? 3483 (w), 2989(s), 1750 (s), 1453 (m), 1403 (m), 1308 (s), 1199 (s), 1128 (s), 
1031 (s), 986 (m), 938 (s) cm-1.  
 
MS (CI, CH4) m/z (relative intensity, %) 337 (58) (M+), 282 (6), 217 (100), 200 (9), 188 
(75), 170 (17), 144 (70), 133 (32), 115 (40), 102 (26), 69 (8), 57 (100).  
 
Optical rotation: [a]D +6.4 (c 1.5, CHCl3 ). 
 
HRMS (EI, 70 eV): 
 
C17H23NO4S calcd found 
 337.134832 337.134781 
 
6.4.2  (2R,3R)- and (2R,3S)-Ethyl 3-((E)-3-methylbut-1-enyl)-1-(2-methylpropane-2-
sulfonyl)aziridine-2-carboxylate (cis-6b and trans-6b):  
 
N
EtO2C
H H
Bus
N
EtO2C
H H
Bus
 
 
Following GP1 , the aziridines 6b and 6b were synthesized from the vinyl sulfoximine 4b 
(450 mg, 0.98 mmol) by activating with Me 3OBF4 (174 mg, 1.17 mmol) followed by the 
treatment with DBU (179 mg, 1.17 mmol). A mixture of cis-6b and trans-6b (270 mg, 91 
%) was obtained in a ratio of 91:9 along with sulfinamide 7 (154 mg, 93 %). Preparative 
HPLC afforded cis-6b (227 mg, 76%) and trans-6b (16 mg, 6%) as colorless syrupy 
liquids with ee-values of 92% (Chiralcel OD-H, n-heptane/isopropanol, 98:2, Rf = 15.8, 
ent–Rf = 19.3) and 26% (Chiralcel OD-H, n-heptane/isopropanol, 98:2, Rf = 16.0, ent–Rf 
= 17.3) respectively. 
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Following GP2 , the  vinyl sulfoximine 12b (400 mg, 1.68 mmol) was activated with 
Me3OBF4 (298 mg, 2.01 mmol) followed by successive treatment with the imino ester 3 
(447 mg, 2.02 mmol) and DBU (334mg, 2.19 mmol), which afforded the aziridines cis-
6b and trans-6b (356 mg, 70%) in a ratio of 64:36 and with ee values of 76% 
(Chiralpack-IA, n-heptane/isopropanol, 97:3, Rf = 11.8, ent–Rf = 12.5) and 49% 
(Chiralpack-IA, n-heptane/isopropanol, 97:3, Rf = 34.3, ent–Rf = 37.3), respectively, 
along with the biproduct 7 (262 mg, 92%). cis-6b (197 mg, 39%) and trans-6b (106 mg, 
21%) were separated by preparative HPLC. 
 
cis-6b: 
 
1H NMR (400 MHz, CDCl3): d = 0.98 (d, J = 6.59 Hz, 3 H, CH(CH3)(CH3)), 1.0 (d, J = 
6.59 Hz, 3 H, CH(CH3)(CH3)), 1.29 (t, J = 7.14 Hz, 3 H, CH2CH3), 1.49 (s, 9 H, 
C(CH3)3), 2.33 (m, 1 H, CH(CH3)2), 3.41 (dd, J = 15.65, J = 7.41 Hz, 1 H, COCHCH), 
3.47 (d, J = 7.14 Hz, 1 H, COCH), 4.24 (q, J = 7.14 Hz, 2 H, CH2CH3), 5.31 (ddd, J = 
15.66, J = 7.71, J = 1.37 Hz, 1 H, CHNCH=CH), 5.99 (dd, J = 15.66, J = 6.59 Hz, 1 H, 
CHNCH=CH).  
 
13C NMR (100 MHz, CDCl3): d 14.3 (d), 21.9 (d), 22.0 (d), 24.0 (d), 31.2 (d), 41.4 (d), 
45.1 (d), 59.8 (u), 61.7 (u), 118.0 (d), 147.0 (d), 165.6 (u).  
 
IR (CHCl3): ? 2964 (s), 1750 (s), 1465 (m), 1377 (m), 1316 (s), 1197 (s), 1130 (s), 1036 
(s), 975 (m), 937 (m), 873 (m), 835 (m) cm-1.  
 
MS (CI, CH4) m/z (relative intensity, %): 304 (M+ + H, 2), 276 (3), 240 (5), 230 (9), 224 
(4), 212 (9), 184 (100), 167 (58), 154 (3), 138 (5), 121 (4), 108 (7), 93 (4).  
 
Optical rotation: [a]D –10.8 (c 2.3, CHCl3). 
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Elemental Analysis: 
 
C14H25NO4S C H N 
calcd 55.42 8.30 4.62 
found 55.19 8.26 4.72 
 
 
trans-6b: 
 
1H NMR (400 MHz, CDCl3): d = 1.0 (d, J = 6.6 Hz, 3 H, CH(CH3)(CH3)), 1.02 (d, J = 
6.6 Hz, 3 H, CH(CH3)(CH3)), 1.30 (t, J = 7.14 Hz, 3 H, CH2CH3), 1.46 (s, 9 H, 
C(CH3)3), 2.38 (m, 1 H, CH(CH3)2), 3.41 (d, J = 3.84 Hz, 1 H, COCH), 3.48 (dd, J = 
9.34, J = 3.85 Hz, 1 H, COCHCH), 4.24 (q, J = 7.14 Hz, 2 H, CH2CH3), 5.51 (dd, J = 
15.38, J = 9.56 Hz, 1 H, CHNCH=CH), 6.02 (dd, J = 15.38, J = 6.86 Hz, 1 H, 
CHNCH=CH).  
 
13C NMR (100 MHz, CDCl3): d 14.2 (d), 21.8 (d), 22.0 (d), 24.0 (d), 31.2 (d), 44.9 (d), 
48.8 (d), 60.9 (u), 61.9 (u), 119.2 (d), 147.2 (d), 166.9 (u).  
 
IR (CHCl3 ): ? 2964 (s), 1745 (s), 1514 (w), 1466 (m), 1369 (w), 1317 (s), 1232 (s), 1134 
(s), 1028 (m), 970 (m), 914 (s), 852 (m), 822 (m) cm–1.  
 
MS (CI, CH4) m/z (relative intensity, %): 304 (M+ + H, 28), 262 (4), 240 (5), 230 (11), 
216 (7), 184 (100), 167 (90), 113 (32).  
 
Optical rotation: [a]D +5.9 (c 3.2, CHCl3 ). 
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HRMS (EI, 70 eV): 
 
C14H25NO4S–C4H9O2S calcd. found. 
 182.118179 182.118104 
 
 
6.4.3  (2R,3R)- and (2R,3S)-Ethyl 3-((E)-2-cyclohexylvinyl)-1-(2-methylpropane-2-
sulfonyl)aziridine-2-carboxylate (cis-6c and trans-6c):  
 
N
EtO2C
H H
Bus
N
EtO2C
H H
Bus
 
 
Following GP1 , the aziridines cis-6c  and trans-6c were synthesized from the vinyl 
sulfoximine 4c (520 mg, 1.04 mmol) by activating with Me3OBF4 (185 mg, 1.25 mmol) 
followed by the treatment of DBU (190 mg, 1.25 mmol). A mixture of cis-6c and trans-
6c (332 mg, 93 %) was obtained in a ratio of 90:10 along with the byproduct N-methyl-S-
phenyl sulfinamide 7  (165 mg, 94%). Preparative HPLC afforded cis-6c (266 mg, 75%) 
and trans-6c (29 mg, 9 %) as colorless syrupy liquids with ee-values of 71% (Chiralpack-
IA, n-heptane/isopropanol, 98:2, Rf = 7.6, ent–Rf = 9.6) and 48% (Chiralpack-IA, n-
heptane/isopropanol, 98:2, Rf = 7.5, ent–Rf = 8.8) respectively. 
 
Following GP2 , the vinyl sulfoximine 12c  (380 mg, 1.37 mmol) was activated with 
Me3OBF4 (243 mg, 1.64 mmol) followed by successive treatment with the imino ester 3 
(363 mg, 1.64 mmol) and DBU (271 mg, 1.78 mmol), which afforded the aziridines cis-
6c and trans-6c (320 mg, 68%) in a ratio of 70:30 and with ee values of 47% 
(Chiralpack-IA, n-heptane/isopropanol, 98:2, Rf = 11.2, ent–Rf = 14.0) and 45% 
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(Chiralpack-IA, n-heptane/isopropanol, 98:2, Rf = 14.6, ent–Rf = 15.6), respectively, 
along with the biproduct 7 (217 mg, 94%). cis-6c  (205 mg, 43%) and trans-6c (75 mg, 
16%) were by preparative HPLC. 
 
cis-6c: 
 
1H NMR (300 MHz, CDCl3) : d = 1.04–1.28 (m, 5H, CH2CH2CH2), 1.29 (t, J = 7.17 Hz, 
3 H, CH2CH3), 1.5 (s, 9 H, C(CH3)3), 1.7 (m, 5 H, CH2CH2CH2), 2.00 (m, 1 H, 
CH2CHCH2), 3.40 (dd, J = 15.58, J = 7.42 Hz, 1 H, COCHCH), 3.46 (d, J = 7.66 Hz, 1 
H, COCH), 4.22 (q, J =  7.17 Hz, 2 H, CH2CH3), 5.32 (ddd, J =  15.58 Hz, J = 6.68 Hz, J 
= 1.24 Hz, 1 H, CHNCH=CH), 5.95 (dd, J = 15.58 Hz, J = 6.68 Hz, 1 H, CHNCH=CH).  
 
13C NMR (75 MHz, CDCl3): d 14.1 (d), 23.9 (d), 25.8 (u), 26.0 (u), 32.9 (u), 40.5 (d), 
41.2 (d), 45.3 (d), 59.7 (u), 61.6 (u), 118.4 (d), 145.9 (d), 165.7 (u).  
 
IR (CHCl3): ? 2927 (s), 1749 (s), 1662 (w), 1450 (m), 1378 (m), 1315 (s), 1197 (s), 1130 
(s), 1036 (s), 972 (m), 939 (m), 870 (w), 836 (m) cm–1.  
 
MS (CI, CH4) m/z (relative intensity, %): 344 (M+ + H, 1), 316 (4), 280 (5), 270 (7), 252 
(10), 224 (100), 207 (50), 178 (4), 161 (6), 148 (7), 133 (17), 121 (7), 102 (3).  
 
Optical rotation: [a]D –7.8 (c 1.25, CHCl3). 
 
Elemental Analysis: 
 
C17H29NO4S C H N 
calcd 59.44 8.51 4.08 
found 59.19 8.42 3.93 
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trans-6c: 
 
1H NMR (300 MHz, CDCl3): d = 1.06–1.28 (m, 5 H, CH2CH2CH2), 1.3 (t, J = 7.17 Hz, 
3 H, CH2CH3), 1.46 (s, 9 H, C(CH3)3), 1.63-1.76 (m, 5 H, CH2CH2CH2), 2.05 (m, 1 H, 
CH2CHCH2), 3.42 (d, J = 3.71 Hz, 1 H, COCH), 3.48 (dd, J = 9.40, J = 3.71 Hz, 1 H, 
COCHCH), 4.24 (q, J = 7.17 Hz, 2 H, CH2CH3), 5.50 (ddd, J = 15.58, J = 6.68, J = 1.24 
Hz, 1 H, CHNCH=CH), 6.0 (dd, J = 15.58, 6.68 Hz, 1 H, CHNCH=CH).  
 
13C NMR (75 MHz, CDCl3): d 14.1 (d), 23.9 (d), 25.8 (u), 26.0 (u), 32.3 (u), 40.5 (d), 
44.9 (d), 48.8 (d), 60.8 (u), 61.9 (u), 119.6 (d), 146.1 (d), 167.0 (u).  
 
IR (CHCl3): ? 2927 (s), 1744 (s), 1450 (m), 1370 (w), 1316 (s), 1227 (s), 1194 (s), 1132 
(s), 1028 (m), 968 (m), 915 (s), 847 (w), 816 (s) cm–1.  
 
MS (CI, CH4) m/z (relative intensity, %): 384 (M + C3H5+, 1), 344 (M+ + H, 4), 316 (3), 
280 (5), 270 (7), 252 (10), 222 (100), 207 (48), 194 (3), 178 (4), 161 (5), 148 (9), 133 
(17), 121 (6), 102 (3).  
 
Optical rotation: [a]D +5.7 (c 1.5, CHCl3 ). 
 
 
HRMS (EI, 70 eV): 
 
C17H29NO4S – C4H9O2S calcd found 
 347.137816 347.137760 
 
6.4.4 (2R,3R)- and (2R,3S)-Ethyl 3-((E)-3,3-dimethylbut-1-enyl)-1-(2-
methylpropane-2-sulfonyl)aziridine-2-carboxylate (cis-6d and trans -6d):  
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N
EtO2C
H H
Bus
N
EtO2C
H H
Bus
 
 
Following GP1 , the aziridines cis-6d and trans-6d were synthesized from the vinyl 
sulfoximine 4d (550 mg, 1.16 mmol) by activating with Me 3OBF4 (207 mg, 1.39 mmol) 
followed by the treatment with DBU (213 mg, 1.39 mmol). The inseparable mixture of 
cis-6d and trans-6d (347 mg, 94 %) was obtained in a ratio of 91:9 and with ee–values of 
50% (Chiralcel OD-H, n-heptane/isopropanol, 98:2, Rf = 13.4, ent–Rf = 18.8) and 5% 
(Chiralcel OD-H, n-heptane/isopropanol, 98:2, Rf = 19.8, ent–Rf = 24.1) respectively. The 
biproduct 7 (184 mg, 93 %) was collected. 
 
cis-8d: 
 
1H NMR (400 MHz, CDCl3): d  1.01 (s, 9 H, CHC(CH3)3), 1.3 (t, J = 7.14 Hz, 3 H, 
CH2CH3), 1.46 (s, 9 H, SO2C(CH3)3), 3.41 (dd, J = 15.38, J = 7.69 Hz, 1 H, COCHCH), 
3.47 (d, J = 714, COCH), 4.23 (q, J = 7.14 Hz, 2 H, CH2CH3), 5.26 (dd, J = 15.93, J = 
8.24 Hz, 1 H, CHNCH=CH), 6.04 (dd, J = 15.93, J = 10.98 Hz, 1 H, CHNCH=CH).  
 
13C NMR (100 MHz, CDCl3): d 14.2 (d), 23.9 (d), 29.1 (d), 33.5 (d), 41.3 (d), 45.2 (d), 
59.7 (u), 61.5 (u), 115.8 (d), 150.7 (d), 165.5 (u). 
 
trans-5d: 
 
1H NMR (400 MHz, CDCl3): d 1.04 (s, 9 H, CHC(CH3)3), 1.3 (t, J = 7.14 Hz, 3 H, 
CH2CH3), 1.50 (s, 9 H, SC(CH3)3), 3.41 (d, J = 4.12 Hz, 1 H, COCH), 3.48 (dd, J =  
9.34Hz, J = 3.84 Hz, 1 H, COCHCH), 4.24 (q, J = 7.14 Hz, 2 H, CH2CH3), 5.46 (dd, J = 
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15.66, J = 9.34 Hz, 1 H, CHNCH=CH), 6.04 (dd, J = 15.93, J = 10.98 Hz, 1 H, 
CHNCH=CH).  
 
13C NMR (100 MHz, CDCl3): d 14.0 (d), 23.9 (d), 29.0 (d), 30.8 (d), 44.8 (d), 48.8 (d),  
60.7 (u), 61.8 (u), 117.1 (d), 150.8 (d), 166.8 (u). 
 
6.4.5 (2R,3R)- and (2R,3S)-Ethyl 3-((E)-prop-1-enyl)-1-(2-methylpropane-2-
sulfonyl)aziridine-2-carboxylate (cis-6e and trans-6e):  
 
N
EtO2C
H H
Bus
N
EtO2C
H H
Bus
 
 
Following GP2 , the vinyl sulfoximine 12e  (520 mg, 2.49 mmol) was activated with 
Me3OBF4 (442 mg, 2.98 mmol) followed by the successive treatment with the imino ester 
3 (660 mg, 2.98 mmol) and DBU (490 mg, 3.23 mmol), which afforded aziridines cis-6e  
and trans -6e (445 mg, 65%), with cis-6e  having an ee-value of 65% (Chiralpack-IA, n-
heptane/isopropanol, 97:3, Rf = 11.3, ent–Rf = 11.8). The ee value of the trans isomer 
could not be determined. The biproduct 7  (378 mg, 90%) was collected. Pure cis-6e  (106 
mg, 24%) could be separated from the mixture by preparative HPLC but the pure trans-
6e  could not be separated from the mixture. 
 
cis-5e: 
 
1H NMR (400 MHz, CDCl3): d = 1.29 (t, J = 7.14 Hz, 3 H, CH2CH3), 1.50 (s, 9 H, 
C(CH3)3), 1.82 (dd, J = 7.14, J = 1.92 Hz, 3 H, CH=CHCH3), 3.54 (d, J = 7.42 Hz, 1 H, 
COCH), 3.69 (m, 1 H, COCHCH) 4.23 (dq, J = 7.15 Hz, J = 1.64 Hz, 2 H, CH2CH3), 
5.32 (m, 1 H, CH3CH=CH), 5.91 (m, 1 H, CH3CH=CH).   
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13C NMR (100 MHz, CDCl3): d 13.4 (d), 14.1 (d), 23.8 (d), 40.5 (d), 41.0 (d), 59.8 (u), 
61.6 (u), 121.0 (u), 133.4 (u), 165.5 (u).  
 
IR (CHCl3): ? 2984 (s), 1751 (s), 1478 (m), 1382 (m), 1316 (s), 1195 (s), 1130 (s), 1060 
(w), 1028 (m), 942 (s), 869 (m), 835 (m) cm–1.  
 
MS (CI, CH4) m/z (relative intensity, %): 276 (M+ + H, 1), 248 (1), 220 (7), 202 (9), 184 
(5), 156 (100), 129 (1), 110 (5), 80 (6).  
 
Optical rotation: [a]D –23.1 (c 1.25, CHCl3 ). 
 
HRMS (EI, 70 eV): 
 
C12H21NO4S–C4H9O2S calcd found 
 154.086771 154.086804 
 
trans-5e: 
 
1H NMR (400 MHz, CDCl3): d = 1.31 (t, J = 7.15 Hz, 3 H, CH2CH3), 1.46 (s, 9 H, 
C(CH3)3), 1.84 (dd, J = 7.14, J = 1.65 Hz, 3 H, CH=CHCH3), 3.40 (d, J = 3.84 Hz, 1 H, 
COCH), 3.76 (dd, J = 9.89, J = 3.84 Hz, 1 H, COCHCH), 4.26 (q, J = 7.14 Hz, 2 H, 
CH2CH3), 5.54 (m, 1 H, CH3CH=CH), 5.98 (m, 1 H, CH3CH=CH).  
 
13C NMR (100 MHz, CDCl3): d = 13.3 (d), 14.0 (d), 23.9 (d), 43.4 (d), 45.0 (d), 60.9 
(u), 61.9 (u), 121.6 (d), 134.0 (d), 166.3 (u). 
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6.4.6 (+)-(E,S)-N-Methyl-S-(4-methyl-1-methyl-1-pentenyl)-S-phenyl sulfoximine 
(39) 
 
S
Ph
NMeO
 
 
To a solution of sulfoximine 12b (830 mg, 3.50 mmol) in THF (10 mL) was added at -78 
°C BuLi (4.2 mmol, 2.7 ml of 1.6 M in hexane) and the reaction mixture was stirred at 0 
°C for 1 h. Then a solution of MeI (2.2 mL, 35 mmol) in THF (3 mL) was added at -78 
°C and the resulting mixture was stirred first at -78 °C for 30 min and then warmed upto 
room temperature over a period of 2 h. Subsequently saturated aqueous NH4Cl (10 mL) 
was added and the resulting mixture was extracted with EtOAc. The combined organic 
phases were dried (MgSO4) and concentrated in vacuo. Purification by column 
chromatography (EtOAc/cyclohexane, 1:3) gave sulfoximine 39 in 95% yield. 
 
1H NMR (400 MHz, CDCl3): d = 0.89 (d, J = 6.6 Hz, 3 H, CH(CH3)(CH3)), 0.91 (d, J = 
6.59 Hz, 3 H, CH(CH3)(CH3)), 1.77 (m, 1 H, CH(CH3)2), 1.81 (s, 3 H, CH=CCH3), 2.05 
(m, 2 H, CH2), 2.77 (s, 3 H, NCH3), 6.86 (tm, J = 7.69 Hz, 1 H, C=CH), 7.51 (m, 3 H, 
Ph), 7.87 (m, 2 H, Ph). 
 
13C NMR (100 MHz, CDCl3): d = 12.4 (d), 22.5 (d), 28.3 (d), 29.6 (d), 37.8 (u), 128.8 
(d), 128.9 (d), 132.3 (d), 136.1 (u), 138.4 (u), 140.3 (d). 
 
 IR (neat): ? 2956 (s), 2872 (s), 1447 (s), 1381 (m), 1245 (s), 1141 (s), 1109 (s), 1076 (s), 
925 (m), 859 (s) cm–1. 
 
MS (EI, 70 eV): m/z (%): 251 (M+, 10), 208 (4), 155 (28), 139 (6), 126 (55), 107 (100), 
95 (10), 78 (35), 55 (41). 
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HRMS (EI, 70 eV): 
 
C14H21NOS calcd found 
 251.134465 251.134387 
 
6.4.7 (2R,3R)- and (2R,3S)-Ethyl-3-methyl-3-((E)-3-methylbut-1-enyl)-1-(2-
methylpropane-2-sulfonyl)aziridine-2-carboxylate (cis-41 and trans-41): 
 
N
EtO2C
H Me
Bus
iPr
N
EtO2C
H Me
Bus
iPr 
 
Following GP2 , the vinyl sulfoximine 39 (547 mg, 2.18 mmol) was methylated with 
Me3OBF4 (419 mg, 2.83 mmol) followed by the successive treatment with the imino ester 
3 (626 mg, 2.83 mmol) and DBU (464 mg, 3.05 mmol), which afforded aziridines cis-41  
and trans -41 (558 mg, 81%) in a ratio of 60:40, with cis-41  having an ee-value of 28% 
(Chiralpack-IA, n-heptane/isopropanol, 98:2, Rf = 25.1, ent–Rf = 37.1). The ee value of 
the trans isomer could not be determined. The biproduct 7 (338 mg, 92%) was collected. 
Pure cis-41 (317 mg, 43%) was isolated by preparative HPLC but the pure trans-41 could 
not be separated from the mixture. 
 
cis-41: 
 
1H NMR (300 MHz, CDCl3): d = 0.89 (d, J = 6.68 Hz, 3 H, CH(CH3)(CH3)), 0.90 (d, J 
= 6.68 Hz, 3 H, CH(CH3)(CH3)), 1.20 (t, J = 7.17 Hz, 3 H, CH2CH3), 1.44 (s, 9 H, 
C(CH3)3), 1.76 (s, 3 H, CCH3), 2.21 (dsext, J = 1.48 Hz, J = 6.92 Hz, 1 H, CH(CH3)2), 
3.44 (s, 1 H, COCH), 4.12 (m, 2 H, CH2CH3), 5.21 (dd, J = 1.48 Hz, J = 15.83 Hz, 1 H, 
iPrCH=CH), 5.76 (dd, J = 6.93 Hz, J = 15.83 Hz, 1 H, iPrCH=CH). 
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13C NMR (75 MHz, CDCl3): d = 14.2 (d), 18.8 (d), 22.1 (d), 23.8 (d), 30.8 (d), 50.7 (d), 
51. 9 (u), 61.2 (u), 61.4 (u), 123.6 (d), 142.7 (d), 165.9 (u).  
 
IR (CHCl3): ? 2966 (s), 1746 (s), 1464 (m), 1388 (m), 1313 (s), 1196 (s), 1130 (s), 1035 
(m), 967 (m), 884 (m), 838 (m) cm–1. 
 
MS (CI, isobutane) m/z (relative intensity, %): 317 (40), 290 (7), 270 (7), 238 (10), 214 
(87), 196 (77), 181 (100), 170 (6), 154 ( 7), 138 (8), 113 (7), 81 (8), 71 (12). 
 
HRMS (EI, 70 eV): 
 
C15H27NO4S–C4H9O2S calcd found 
 196.133947 196.133754 
 
trans-41: 
 
1H NMR (300 MHz, CDCl3): d = 0.97 (d, J = 6.87 Hz, 6 H, CH(CH3)2), 1.23 (t, J = 7.16 
Hz, 3 H, CH2CH3), 1.50 (s, 9 H, C(CH3)3), 1.48 (s, 3 H, CCH3), 2.30 (m, 1 H, 
CH(CH3)2), 3.52 (s, 1 H, COCH), 4.18 (q, J = 7.17 Hz, 2 H, CH2CH3), 5.57 (dd, J = 1.24 
Hz, J = 15.58 Hz, iPrCH=CH), 5.83 (dd, J = 6.92 Hz, J = 15.83 Hz, 1 H, iPrCH=CH). 
 
6.4.8 (2R,3R)- and (2R,3S)-Ethyl 3-(E)-cyclopentenyl-1-(2-methylpropane-2-
sulfonyl) aziridine -2-carboxylate (cis-45a and trans -45a):  
 
N
EtO2C
H H
Bus
N
EtO2C
H H
Bus
 
 
 
EXPERIMENTAL PART 
 101 
 
Treatment of 42a (770 mg, 3.27 mmol) with Me3OBF4 (727 mg, 4.91 mmol) followed by 
successive treatment with the imino ester 3 (869 mg, 3.93 mmol) and DBU (698 mg, 4.58 
mmol) according to GP3  gave an inseparable mixture of cis-45a and trans-45a (690 mg, 
70%) in a ratio of 3:2 and with ee-values of 79% (Chiralpack-IA, n-heptane/isopropanol, 
97:3, Rf = 9.9, ent–Rf = 11.0) and 90% (Chiralpack-IA, n-heptane/isopropanol, 97:3, Rf = 
12.0, ent Rf = 12.7) respectively, along with the sulfinamide 7 (443 mg, 80%) and 
unreacted starting vinylsulfoximine 42a (69 mg, 9%) was recovered.  
 
cis-45a: 
 
1H NMR (400 MHz, CDCl3): d 1.26 (t, J = 7.14 Hz, 3 H, CH2CH3), 1.45 (s, 9 H, 
C(CH3)3), 1.89 (m, 2 H, CH2CH2CH2), 2.34 (m, 4 H, CH2CH2CH2), 3.51 (d, J = 7.41 Hz, 
1 H, CH=CCH), 3.55 (d, J = 7.97 Hz, 1 H, COCH), 4.19 (m, 2 H, CH3CH2), 5.85 (m, 1 
H, C=CH). 
 
13C NMR (100 MHz, CDCl3): d 14.1 (d), 23.3 (u), 23.9 (d), 32.4 (u), 32.8 (u), 41.5 (d), 
43.2 (d), 59.9 (u), 61.4 (u), 131.8 (d), 134.6 (u), 165.1 (u). 
 
trans-45a: 
 
1H NMR (400 MHz, CDCl3): d 1.31 (t, J = 7.14 Hz, 3 H, CH2CH3), 1.53 (s, 9 H, 
C(CH3)3), 1.89 (m, 2 H, CH2CH2CH2), 2.34 (m, 4 H, CH2CH2CH2), 3.43 (m, 1 H, 
COCH), 3.89 (m, 1 H, CH=CCH), 4.26 (m, 2 H, CH3CH2), 6.01 (m, 1 H, C=CH). 
 
13C NMR (100 MHz, CDCl3): d 14.0 (d), 23.2 (u), 23.8 (d), 31.8 (u), 32.7 (u), 43.4 (d), 
46.0 (d), 60.8 (u), 62.0 (u), 134.6 (d), 136.0 (u), 166.2 (u).  
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6.4.9  (2R,3R)- and (2R,3S)-Ethyl 3-(E)-cyclohexenyl-1-(2-methylpropane-2-sulfonyl) 
aziridine -2-carboxylate (cis-45b and trans-45b):  
 
N
EtO2C
H H
Bus
N
EtO2C
H H
Bus
 
 
Treatment of 42b (456 mg, 1.83 mmol) with Me3OBF4 (460 mg, 3.11 mmol) followed by 
the successive treatment with the imino ester 3 (567 mg, 2.56 mmol) and DBU (500 mg, 
3.29 mmol) according to GP3  gave a mixture of cis-45b and trans-45b (419 mg, 73%) in 
a ratio of 3:2 and with ee-values of 76% (Chiralpack-IA, n-heptane/isopropanol, 97:3, Rf 
= 43.5, ent–Rf = 46.5) and 56% (Chiralpack-IA, n-heptane/isopropanol, 97:3, Rf = 44.0, 
ent–Rf = 46.3) respectively, along with the sulfinamide 7 (250 mg, 73%) and unreacted 
starting vinyl sulfoximine 42b (41 mg, 9%). Preparative HPLC afforded cis-45b (242 
mg, 42%) and trans-45b (82 mg, 28%) as colorless syrupy liquids. 
 
cis-45b: 
 
1H NMR (300 MHz, CDCl3): d 1.18 (t, J = 7.17 Hz, 3 H, CH2CH3), 1.45-1.52 (m, 4 H, 
CH2CH2CH2), 1.47 (s, 9 H, C(CH3)3), 1.87-1.96 (m, 4 H, CH2CH2CH2), 3.31 (d, J = 7.42 
Hz, 1 H, COCHCH), 3.41 (d, J = 7.66 Hz, 1 H, COCH), 4.11 (m, 2 H, CH2CH3), 5.81 (m, 
1 H, C=CH).  
 
13C NMR (75 MHz, CDCl3) : d 14.2 (d), 22.0 (u), 22.2 (u), 23.9 (d), 24.7 (u), 26.0 (u), 
44.0 (d), 44.5 (d), 60.0 (u), 61.4 (u), 127.1 (d), 128.4 (u), 165.2 (u). 
 
IR (neat): ? 2932 (s), 2354 (s), 1743 (s), 1461 (m), 1382 (w), 1313 (m), 1203 (s), 1129 
(s), 1043 (s), 949 (s ), 896 (m) cm–1.  
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MS (CI, CH4) m/z (relative intensity, %): 316 (M+ + H, 7), 288 (4), 252 (3), 242 (10), 
196 (100), 179 (25), 150 (3), 122 (5).  
 
Optical rotation: [a]D –21.5 (c 2.3 , CHCl3). 
HRMS (EI, 70 eV): 
 
C15H25NO4S–C3H5O2 calcd found 
 242.121492 242.121477 
 
trans-45b: 
 
1H NMR (300 MHz, CDCl3): d 1.24 (t, J = 7.17 Hz, 3 H, CH2CH3), 1.37 (s, 9 H, 
C(CH3)3, 1.48-1.56 (m, 4 H, CH2CH2CH2), 1.78-1.85 (m, 2 H, CH2CH2CH2), 2.00 (m, 2 
H, CH2CH2CH2), 3.28 (d, J = 3.95 Hz, 1 H, COCH), 3.69 (d, J = 3.95 Hz, 1 H, 
COCHCH), 4.19 (m, 2 H, CH2CH3), 5.93 (s, 1 H, C=CH).  
 
13C NMR (75 MHz, CDCl3) : d 13.9 (d), 22.0 (u), 22.1 (u), 23.9 (d), 25.3 (u), 42.6 (d), 
50.9 (d), 60.8 (u), 62.1 (u), 129.9 (u), 130.7 (d), 166.7 (u).  
 
IR (CHCl3): ? 3284 (m), 2936 (s), 2361 (s), 1737 (s), 1456 (s), 1369 (s), 1213 (s), 1129 
(s), 1023 (s), 934 (m), 856 (w) cm–1. 
 
MS (CI, CH4) m/z (relative intensity, %): 316 (M+ + H, 6), 252 (3), 242 (13), 224 (4), 
196 (100), 179 (36), 149 (4), 122 (7), 101 (3).  
 
Optical rotation: [a]D –8.7 (c 1.3 , CHCl3 ). 
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HRMS (EI, 70 eV): 
 
C15H25NO4S–C3H5O2 calcd found 
 242.121492 242.121477 
 
6.4.10 (2R,3R)- and (2R,3S)-Ethyl 3-(E)-cycloheptenyl-1-(2-methylpropane-2-
sulfonyl) aziridine -2-carboxylate (cis-45c and trans-45c):  
 
N
EtO2C
H H
Bus
N
EtO2C
H H
Bus
 
 
Treatment of 42c (540mg, 2. 05 mmol) with Me3OBF4 (516 mg, 3.49 mmol) followed by 
the successive treatment with the imino ester 3 (635 mg, 2.87 mmol) and DBU (561 mg, 
3.69 mmol) according to GP3  gave a mixture of cis-45c and trans-45c (479 mg, 71%) in 
a ratio of 3:2 and with ee-values of 78% (Chiralpack-IA, n-heptane/isopropanol, 98:2, Rf 
= 44.4, ent–Rf = 47.5) and 57% (Chiralpack-IA, n-heptane/isopropanol, 98:2, Rf = 43.7, 
ent–Rf =46.6) respectively, along with the sulfinamide 7 (260 mg, 75%) and unreacted 
starting vinyl sulfoximine 45c (60 mg, 11%). Preparative HPLC afforded cis-45c (277 
mg, 41%) and trans-45c (134 mg, 26%) as colorless syrupy liquids. 
 
cis-45c: 
 
1H NMR (400 MHz, CDCl3) : d 1.27 (t, J = 7.14 Hz, 3 H, CH2CH3), 1.39 (m, 2 H, 
CH2CH2CH2), 1.47-1.53 (m, 2 H, CH2CH2CH2), 1.53 (s, 9 H, C(CH3)3), 1.71 (m, 2 H, 
CH2CH2CH2), 2.14 (m, 4 H, CH2CH2CH2), 3.43 (d, J = 7.42 Hz, 1 H, COCHCH), 3.49 
(d, J = 7.69 Hz, 1 H, COCH), 4.18 (q, J = 7.14 Hz, 2 H, CH2CH3), 6.04 (t, J =  6.31 Hz, 1 
H, C=CH).  
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13C NMR (100 MHz, CDCl3): d 14.1 (d), 23.9 (d), 26.3 (u), 26.6 (u), 28.17 (u), 30.1 (u), 
32.0 (u), 44.0 (d), 45.9 (d), 59.9 (u), 61.4 (u), 132.2 (d), 133.9 (u), 165.0 (u).  
 
IR (CHCl3 ): ? 3553 (w), 2926 (s), 1743 (s), 1471 (m), 1368 (w), 1321 (s), 1200 (s), 1160 
(s), 1097 (m), 1066 (w), 1028 (m), 946 (m), 919 (s), 811 (m) cm–1.  
 
MS (CI, CH4) m/z (relative intensity, %): 330 (M+ + H, 2), 302 (3), 256 (9), 210 (100), 
193 (20), 164 (2), 136 (2).  
Optical rotation: [a]D –29.5 (c 1.4 , CHCl3). 
 
HRMS (EI, 70 eV): 
 
C16H27NO4S–C3H5O2 calcd found 
 256.137246 256.137127 
 
trans-45c: 
 
1H NMR (400 MHz, CDCl3) : d 1.32 (t, J = 7.14 Hz, 3 H, CH2CH3), 1.44 (s, 9 H, 
C(CH3)3), 1.45-1.52 (m, 4 H, CH2CH2CH2), 1.75 (m, 2 H, CH2CH2CH2), 1.99 (m, 2 H, 
CH2CH2CH2), 2.18 (m, 2 H, CH2CH2CH2), 3.20 (d, J = 3.84 Hz, 1 H, COCH), 3.79 (d, J 
= 3.57 Hz, 1 H, COCHCH), 4.26 (m, 2 H, CH2CH3), 6.14 (t, J = 6.59 Hz, 1 H, C=CH).  
 
13C NMR (100 MHz, CDCl3): d 13.9 (d), 23.9 (d), 26.3 (u), 26.4 (u), 27.1 (u), 28.5 (u), 
32.0 (u), 42.8 (d), 51.3 (d), 60.7 (u), 62.0 (u), 135.2 (d), 136.0 (u), 166.3 (u).  
 
IR (CHCl3): ? 2927 (s), 1743 (s), 1471 (m), 1368 (w), 1321 (s), 1200 (s), 1160 (s), 1132 
(w), 1096 (w), 1027 (m), 919 (s), 810 (m) cm–1.  
 
MS (CI, CH4) m/z (relative intensity, %): 330 (M+ + H, 3), 302 (2), 256 (7), 210 (100), 
193 (23), 164 (2), 136 (2), 102 (2).  
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Optical rotation: [a]D –10.4 (c 1.5 , CHCl3). 
 
HRMS (EI, 70 eV): 
 
C16H27NO4S–C3H5O2 calcd found 
 256.137246 256.137127 
 
 
 6.4.11 (2R,3R)- and (2R,3S)-Ethyl 3-(E)-cyclooctenyl-1-(2-methylpropane-2-
sulfonyl) aziridine -2-carboxylate (cis-45d and trans -45d):  
 
N
EtO2C
H H
Bus
N
EtO2C
H H
Bus
 
 
Treatment of 42d (660mg, 2.38 mmol) with Me3OBF4 (600 mg, 4.05 mmol) followed by 
the successive treatment with the imino ester 3 (737 mg, 3.33 mmol) and DBU (652 mg, 
4.28 mmol) according to GP3  gave a mixture of cis-45d and trans-45d (540 mg, 66%) in 
a ratio of 1:1 and with ee-values of 70% (Chiralpack-IA, n-heptane/isopropanol, 95:5, Rf 
= 27.4, ent–Rf = 31.3) and 25% (Chiralpack-IA, n-heptane/isopropanol, 95:5, Rf = 27.2, 
ent–Rf = 31.0) respectively, along with the sulfinamide 7 (282 mg, 70%) and unreacted 
starting vinyl sulfoximine 42d (86 mg, 13%). Preparative HPLC afforded cis-45d (236 
mg, 29%) and trans-45d (245 mg, 30%) as colorless syrupy liquids.  
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cis-45d: 
 
1H NMR (300 MHz, CDCl3) : d 1.25 (t, J = 7.17 Hz, 3 H, CH2CH3), 1.41-1.58 (m, 8 H, 
CH2CH2CH2), 1.54 (s, 9 H, C(CH3)3), 2.12 (m, 2 H, CH2CH2CH2), 2.22 (m, 2 H, 
CH2CH2CH2), 3. 42 (d, J = 7.42 Hz, 1 H, COCHCH), 3.50 (d, J = 7.66 Hz, 1 H, COCH), 
4.15 (q, J = 7.17 Hz, 2 H, CH2CH3), 5.83 (t, J = 8.16 Hz, 1 H, C=CH).  
 
13C NMR (100 MHz, CDCl3): d 14.0 (d), 23.9 (d), 25.9 (u), 27.6 (u), 28.5 (u), 29.2 (u), 
44.3 (d), 44.9 (d), 59.8 (u), 61.4 (u), 129.6 (d), 130.6 (u), 164.9 (u).  
 
IR (CHCl3 ): ?  2925 (s), 1747 (s), 1465 (m), 1380 (w), 1314 (s), 1202 (s), 1130 (s), 1042 
(m), 951 (m), 873 (w) cm–1.  
 
MS (CI, isobutane) m/z (relative intensity, %): 344 (M+ + H, 5), 280 (3), 262 (3), 224 
(100), 207 (4). 
 
Optical rotation: [a]D –30.9 (c 1.8 , CHCl3). 
 
HRMS (EI, 70 eV): 
 
C17H29NO4S–C4H9O2S calcd found 
 222.149604 222.149404 
 
trans-45d: 
 
1H NMR (400 MHz, CDCl3) : d 1.32 (t, J = 7.14 Hz, 3 H, CH2CH3), 1.42-1.60 (m, 8 H, 
CH2CH2CH2), 1.45 (s, 9 H, C(CH3)3), 2.11-2.19 (m, 4 H, CH2CH2CH2), 3.23 (d, J = 3.85 
Hz, 1 H, COCH), 3.83 (d, J = 3.85 Hz, 1 H, COCHCH), 4.27 (m, 2 H, CH2CH3), 5.91 (t, 
J = 8.24 Hz, 1 H, C=CH).  
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13C NMR (100 MHz, CDCl3) : d 13.9 (d), 23.9 (d), 24.9 (u), 26.10 (u), 26.16 (u), 26.2 
(u), 29.0 (u), 29.3 (u), 44.1 (d), 50.0 (d), 60.7 (u), 62.1 (u), 132.5 (d), 132.8 (u), 166.2 (u).  
 
IR (CHCl3): ? 2927 (s), 1741 (s), 1460 (m), 1319 (s), 1210 (s), 1130 (m), 1026 (m), 920 
(m), 808 (m) cm–1.  
 
MS (CI, isobutane) m/z (relative intensity, %): 344 (M+ + H, 6), 280 (2), 262 (3), 224 
(100), 207 (5).  
 
Optical rotation: [a]D –11.3 (c 1.4 , CHCl3). 
 
HRMS (EI, 70 eV): 
 
C17H29NO4S–C4H9O2S calcd found 
 222.149604 222.149404 
 
6.5 Synthesis of a-amino acid 
 
6.5.1  (R)-Ethyl-5-phenyl-2-(2-methylpropane-2-sulfonylamino) pentanoate (24).  
 
O
O
NH
Bus
 
 
After two vacuum/H2 cycles to remove air from the reaction flask, a mixture of aziridine 
cis-6a (230 mg, 0.68 mmol) and 10 % Pd/C (22 mg, 10% of the weight of the substrate) 
in ethanol (5 mL) was stirred under a hydrogen atmosphere (balloon) at 0 °C for 3 h. The 
mixture was filtered through celite and the filtrate was concentrated under vacuo. 
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Purification by chromatography (hexane/EtOAc, 1:1) gave amino ester 24 (210 mg, 
91%).  
 
Under the same Pd/C hydrogenation conditions trans-6a also gave the amino ester 24. 
The two samples of 24 showed the same NMR, MS and IR data.  
 
1H NMR (300 MHz, C6D6): d 0.86 (t, J = 7.17 Hz, 3 H, CH3CH2), 1.18 (s, 9 H, 
C(CH3)3), 1.43 (m, 1 H, COCHCHH, 1.61 (m, 3 H, COCHCHHCH2), 2.42 (m, 3 H, 
PhCH2), 3.84 (q, J = 7.18 Hz, 2 H, CH3CH2), 4.16 (m, 1 H, COCH), 4.43 (m, 1 H, NH).  
 
13C NMR (75 MHz, CDCl3): d 14.0 (d), 24.1 (d), 27.2 (u), 33.6 (u), 35.3 (u), 57.2 (d), 
59.5 (u), 61.2 (u), 126.2 (d), 128.3 (d), 128.7 (d), 141.9 (u), 172.6 (u).  
 
IR (neat): ? 3292 (s), 2979 (s), 1739 (s), 1602 (w), 1455 (s), 1370 (w), 1313 (s), 1199 
(m), 1127 (s), 1023 (m), 917 (m), 857 (w), 811 (w) cm–1.  
 
MS (EI, 70 eV) m/z (relative intensity, %): 268 (M+, 6), 220 (46), 204 (7), 163 (25), 148 
(100), 131 (37), 117 (24), 91 (25), 57 (53). 
 
Optical rotation: [a]D23 +5.1 (c 1.2 , CHCl3) (24 obtained from cis-6a). 
                              [a]D23 +4.7 (c 1.2 , CHCl3) (24 obtained from trans-6a). 
 
HRMS (EI, 70 eV): 
 
C13H27NO4S-C3H5O2 calcd found 
 220.137131 220.137127 
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6.5.2  (R)-Ethyl 2-amino-5-phenylpentanoate (23).  
 
O
O
NH2
 
 
To a solution of the N-Bus amino acid 24 (130 mg, 0.38 mmol) and anisole (329 mg, 3.05 
mmol) in CH2Cl2 (9 mL) was slowly added CF3SO3H (229 mg, 1.52 mmol, 0.2 N in 
CH2Cl2 , 9 mL) at 0 °C. After 1 h 0.1 N aqueous NaOH was added until a pH of 8 was 
readed. The aqueous layer was extracted with CH2Cl2. The combined organic extracts 
were dried (MgSO4) and concentrated under reduced pressure. The residue was purified 
by flash chromatography (hexane/EtOAc, 1:3) to afford amino ester 23 (79 mg, 94 %) as 
a colorless liquid.  
 
1H NMR (300 MHz, CDCl3): d 1.26 (t, J = 7.14 Hz, 3 H, CH3CH2), 1.55~1.78 (m, 4 H, 
PhCH2CH2CH2), 2.65 (m, 2 H, PhCH2), 3.43 (m, 1 H, COCH), 4.16 (q, J = 7.14 Hz, 2 H, 
CH3CH2), 7.17~7.40 (m, 5 H, Ph).  
 
13C NMR (75 MHz, CDCl3): d 14.2 (d), 27.4 (u), 34.5 (u), 35.5 (u), 54.3 (d), 60.7 (u), 
125.8 (d), 128.31 (d), 128.38 (d), 141.9 (u), 176.1 (u).  
 
IR (neat): ? 3382 (w), 2979 (s), 1732 (s), 1602 (w), 1495 (w), 1453 (m), 1377 (w), 1182 
(s), 1027 (m), 856 (w) cm–1.  
 
MS (EI, 70 eV) m/z (relative intensity, %): 221 (M+, 10), 148 (100), 131 (64), 105 (10), 
91 (16), 56 (9).  
 
Optical rotation: [a]D –13.9° (c 2.0, CHCl3). 
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HRMS (EI, 70 eV): 
 
C13H19NO2 calcd found 
 221.141790 221.141579 
 
6.6  Pd(0)-catalyzed isomerization 
 
6.6.1  ((2R,3R)-3-((E)-3-methylbut-1-enyl)-1-(2-methylpropane-2-sulfonyl) aziridin-
2-yl) methanol (cis-32):  
 
N
H H
HO
Bus
 
 
To a solution of ester 6b (185 mg, 0.61 mmol) in CH2Cl2 (3 mL) at 0 °C was added 
DIBALH (3.3 mL, 1.83 mmol, 0.56 M solution in THF). After stirring the mixture for 3 h 
at 0 °C, ice pieces were slowly added and the solution was filtered and the residue was 
washed with hot ethyl acetate (20 mL). The filtrate was dried (MgSO4) and concentrated 
in vacuo. The residue was purified by flash chromatography (hexane/ EtOAc, 2:1) to 
afford alcohol cis-32 (144 mg, 91%).  
 
1H NMR (400 MHz, CDCl3): d 1.01 (d, J = 6.87 Hz, 6 H, CH(CH3)2), 1.25 (s, 9 H, 
C(CH3)3), 1.83 (b, 1 H, OH), 2.35 (m, 1 H, CH(CH3)2), 3.10 (m, 1 H, CH2CH), 3.28 (dd, 
J = 15.1, J = 7.4 Hz, 1 H, CH=CHCH), 3.73 (m, 1 H, OCHH), 3.81 (m, 1 H, OCHH), 
5.25 (dd, J = 15.38 Hz, J = 7.96 Hz, 1 H, CH=CHCH(CH3)2), 5.92 (dd, J = 15.39 Hz, J = 
6.86 Hz, 1 H, CH=CHCH(CH3)2).  
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13C NMR (100 MHz, CDCl3): d 21.9 (d), 22.0 (d), 24.1 (d), 31.1 (d), 42.8 (d), 46.4 (d), 
59.1 (u), 59.6 (u), 118.0 (d), 146.0 (d).  
 
IR (CHCl3): ? 3519 (s), 2962 (s), 2412 (w), 1664 (w), 1465 (m), 1367 (w), 1304 (s), 1214 
(w), 1125 (s), 1048 (s), 968 (s), 886 (m), 812 (m) cm–1.   
 
MS (CI, CH4) m/z (relative intensity, %): 262 (M+ + H, 29), 232 (18), 206 (7), 198 (9), 
180 (33), 142 (49), 125 (100), 107 (10),  
 
Optical rotation: [a]D –20.4 (c 1.5, CHCl3). 
 
HRMS (EI, 70 eV): 
 
C12H23NO3S-C4H9 SO2 calcd found 
 140.107631 140.107539 
 
6.6.2 ((2R,3S)-3-((E)-3-methylbut-1-enyl)-1-(2-methylpropane-2-sulfonyl) aziridin-2-
yl) methanol (trans-32):  
 
N
H H
HO
Bus
 
 
Following the same procedure that had been used for the synthesis of alcohol cis-32 , 
trans-32 (93 mg, 90 %) was synthesized from ester trans-6a (120 mg, 0.40 mmol) by 
reduction with DIBALH (2.1 mL, 1.19 mmol, 0.56 M solution in THF) in 90% yield (93 
mg). 
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1H NMR (300 MHz, CDCl3): d 1.01 (d, J = 6.67 Hz, 6 H, CH(CH3)2), 1.48 (s, 9 H, 
C(CH3)3), 2.33 (m, 1 H, CH(CH3)2), 2.98 (m, 2 H, HOCH2CH), 3.26 (dd, J = 8.65 Hz, J = 
4.45 Hz, 1 H, CH=CHCH), 3.85 (m, 1 H, OCHH), 4.12 (m, 1 H, OCHH), 5.16 (m, 1 H, 
CH=CHCH(CH3)2), 5.90 (dd, J = 15.58 Hz, J = 6.68 Hz, 1 H, CH=CHCH(CH3)2).  
 
13C NMR (75 MHz, CDCl3): d 21.9 (d), 22.0 (d), 23.9 (d), 30.9 (d), 46.8 (d), 50.7 (d), 
60.0 (u), 61.0 (u), 121.5 (d), 145.3 (d).  
 
IR (CHCl3): ? 3511 (s), 2961 (s), 2409 (w), 1664 (w), 1464 (m), 1366 (w), 1304 (s), 1218 
(w), 1125 (s), 1046 (s), 967 (s), 886 (m), 814 (m) cm–1. 
 
MS (EI, 70 eV) m/z (relative intensity, %): 262 (M++ H, 2), 234 (5), 206 (4), 198 (5), 188 
(10), 180 (8), 170 (9), 158 (3), 142 (100), 125 (32), 107 (15), 97 (9), 81 (4), 68 (4).  
 
Optical rotation: [a]D +6.2 (c 0.85, CHCl3). 
 
HRMS (EI, 70 eV): 
 
C12H23NO3S–C4H9SO2 calcd found 
 140.107619 140.107539 
 
 
6.6.3  (2R,3R)-2-((tert-Butyldimethylsilyloxy)methyl-3-((E)-3-methylbut-1-enyl)-1-
(2-methylpropane -2-sulfonyl)aziridine (cis-33):  
 
N
H H
TBSO
Bus
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To a solution of alcohol cis-32 (85 mg, 0.33 mmol) and imidazole (88 mg, 1.30 mmol) 
mixture in CH2Cl2 (3 mL) was added TBSCl (196 mg, 1.30 mmol) and the reaction was 
stirred under argon for 2 h. The mixture was then quenched by addition of water (5 mL) 
and the mixture was extracted with CH2Cl2. The combined organic extracts were dried 
(MgSO4). The residue was purified by flash chromatography (hexane/EtOAc, 4:1) to 
afford cis-33 (110 mg, 91%).  
 
 
1H NMR (400 MHz, CDCl3): d 0.06 (s, 1 H, SiCH3), 0.07 (s, 1 H, SiCH3), 0.89 (s, 9 H, 
SiC(CH3)3), 1.00 (d, J = 6.87 Hz, 6 H, CH(CH3)3), 1.48 (s, 9 H, SC(CH3)3), 2.33 (m, 1 H, 
CH(CH3)3), 3.02 (m, 1 H, CH2CH), 3.27 (dd, J = 11.27, J = 5.77 Hz, 1 H, CH=CHCH), 
3.66 (m, 1 H, OCHH), 3.81 (m, 1 H, OCHH), 5.22 (ddd, J = 15.66 Hz, J = 7.41 Hz, J = 
1.38 Hz, 1 H, CH=CHCH(CH3)2), 5.89 (dd, J = 15.66 Hz, J = 6.59 Hz, 1 H, 
CH=CHCH(CH3)2).  
 
13C NMR (100 MHz, CDCl3): d -5.38 (d), -5.31 (d), 18.2 (u), 21.93 (d), 21.99 (d), 24.1 
(d), 25.7 (d), 31.0 (d), 44.2 (d), 44.4 (d), 59.1 (u), 60.3 (u), 118.4 (d), 145.0 (d).  
 
IR (CHCl3): ? 2957 (s), 2861 (s), 1662 (w), 1596 (w), 1468 (m), 1387 (w), 1364 (w), 
1313 (s), 1255 (s), 1128 (s), 1101 (s), 969 (s), 944 (s), 889 (w), 836 (s) cm–1.  
 
MS (CI, CH4) m/z (relative intensity, %): 376 (M+ + H, 16), 360 (9), 346 (21), 318 (15), 
302 (8), 256 (100), 239 (94), 198 (48), 145 (4), 124 (11), 107 (9), 89 (7), 73 (5).  
 
Optical rotation: [a]D –34.5 (c 0.65, CHCl3 ). 
 
HRMS (EI, 70 eV): 
 
C18H37NO3SSi–C4H9 calcd found 
 318.156052 318.155920 
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6.6.4  (2R,3S)-2-((tert-Butyldimethylsilyloxy)methyl-3-((E)-3-methylbut-1-enyl)-1-(2-
methylpropane-2-sulfonyl)aziridine (trans-33):  
 
N
H H
TBSO
Bus
 
 
Following the above procedure, trans-33 (77 mg, 89%) was synthesized from trans-27  
(60 mg, 0.23 mmol), imidazole (63 mg, 0.92 mmol) and TBSCl (139 mg, 0.92 mmol) in 
89% yield (77 mg). 
 
1H NMR (300 MHz, CDCl3): d 0.07 (s, 2 × 3 H, 2 × SiCH3), 0.89 (s, 9 H, SiC(CH3)3), 
0.99 (d, J = 6.59 Hz, 3 H, CH(CH3)(CH3)), 1.01 (d, J = 6.59 Hz, 3 H, CH(CH3)(CH3)), 
1.46 (s, 9 H, SC(CH3)3), 2.35 (m, 1 H, CH(CH3)3), 2.98 (m, 1 H, CH2CH), 3.13 (m, 1 H, 
CH=CHCH), 3.85 (m, 2 H, CH2), 5.50 (m, 1 H, CH=CHCH(CH3)2), 5.90 (dd, J = 15.34 
Hz, J = 6.68 Hz, 1 H, CH=CHCH(CH3)2).  
 
13C NMR (75 MHz, CDCl3): d -5.36 (d), -5.35 (d), 18.2 (u), 21.9 (d), 22.0 (d), 24.1 (d), 
25.8 (d), 31.1 (d), 47.8 (d), 48.7 (d), 60.1 (u), 62.0 (u), 121.1 (d), 145.3 (d).  
 
IR (CHCl3): ? 2960 (s), 2860 (s), 1664 (w), 1633 (w), 1467 (m), 1383 (w), 1311 (s), 1255 
(m), 1127 (s), 1101 (s), 950 (s), 890 (w), 837 (s) cm–1.  
 
MS (CI, CH4) m/z (relative intensity, %): 376 (M+ + H, 12), 360 (8), 346 (17), 318 (12), 
312 (11), 296 (6), 284 (3), 256 (100), 239 (83), 198 (42), 174 (3), 145 (4), 124 (10), 107 
(8), 89 (6), 73 (4).  
 
Optical rotat ion: [a]D +14.8 (c 0.75, CHCl3 ). 
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HRMS (EI, 70 eV): 
 
C18H37NO3SSi–C4H9 calcd found 
 318.155897 318.155920 
 
6.6.5  ((2R,3R) and (2R,3S)-3-((E)-3-methylbut-1-enyl)-1-(2-methylpropane-2-
sulfonyl) aziridin-2-yl) methanol (cis-32 + trans-32):  
 
Following the same procedure that had been used to synthesize cis-32, a diasreomeric 
mixture of cis-32 and trans-32 (190 mg, 92 %) was synthesized from the mixture of cis-
6b and trans-6b (240 mg, 0.79 mmol) by reducing with DIBALH (4.2 mL, 2.38 mmol, 
0.56 M solution in THF) in a combined yield of 92% (190 mg). 
 
6.6.6  (2R,3R) and (2R,3S)-2-((tert-Butyldimethylsilyloxy)methyl-3-((E)-3-methylbut-
1-enyl)-1-(2-methylpropane -2-sulfonyl)aziridine (cis-33 + trans-33):  
 
Following the same procedure that used to synthesize cis-33 , a mixture of cis-33and 
trans-33 was synthesized from the mixture of cis-32 and trans-32(190 mg, 0.73 mmol), 
imidazole (198 mg, 2.91 mmol) and TBSCl (439 mg, 2.91 mmol) in a combined yield of 
94% (258 mg). 
 
6.6.7  Pd(0)-catalyzed isomerization reaction of  (2R,3S)-2-((tert-butyldimethyl 
silyloxy)methyl-3-((E)-3-methylbut-1-enyl)-1-(2-methylpropane-2-sulfonyl)aziridine 
(trans-33).  
 
To a stirred solution of the trans-vinyl aziridine trans-33 (64 mg, 0.17 mmol) in dry THF 
(3 mL) at 0 °C under argon was added by syringe a solution of Pd(PPh3)4 (12 mg, 0.01 
mmol, 6 mol %) in dry THF (2 mL) and the mixture was stirred at 0 °C for 18 h. 
Concentration under reduced pressure at 0 °C followed by flash chromatography 
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(hexane:EtOAc, 4:1) gave cis-33 (54mg, 84%). According to the NMR cis-33 was the 
only product after the Pd(0)-catalyzed isomerization. 
 
6.6.8  Pd(0)-catalyzed isomerization of 1:2 mixture of (2R,3S)-2-((tert-
butyldimethylsilyloxy)methyl-3-((E)-3-methylbut-1-enyl)-1-(2-methylpropane-2-
sulfonyl)aziridine (trans-33) and its (2R,3R)-isomer (cis-33).  
 
To a stirred solution of 1:2 mixture of the trans-33 and cis-33 (258 mg, 0.69 mmol) in 
dry THF (5 mL) at 0 °C was added by syringe a solution of Pd(Ph3)4 (24 mg, 0.02mmol, 
3 mol%) in dry THF (5 mL) and the mixture was stirred at 0 °C for 18 h. Concentration 
under reduced pressure at 0 °C followed by flash chromatography (hexane:EtOAc, 4:1) 
gave cis-33 (242 mg, 94 %). According to the NMR cis-33 was the only product after the 
Pd(0)-catalyzed isomerization. 
 
6.7  Thiophenol addition to vinyl sulfoximines 
 
6.7.1  (4-Methyl -1-(N-methyl-S-phenylsulfonimidoyl)pentan-2-yl) phenyl sulfane 
(38b and epi-38b) 
 
S
Ph
NMeOS
Ph
38b, epi-38b  
 
 
Following GP 1, the vinyl sulfoximine 12b (184 mg, 0.78 mmol) was treated with neat 
thiophenol (0.48 ml, 4.66 mmol). After the mixture was stirred at room temperature for 
1.5 h, TLC showed the consumption of the sulfoximine 12b. The excess thiophenol and 
the sulfides 38b and epi-38b were separated by flash column chromatography (EtOAc/n-
hexane, 1:5) in a ratio of 2:1. Sulfide 38b (EtOAc/n-hexane, 1:5, Rf  = 0.46) (167 mg, 
61%) and sulfide epi-38b (EtOAc/n-hexane, 1:5, Rf  = 0.27) (88 mg, 33%) were isolated 
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as colourless oils. The absolute configuration of sulfides 38b and epi-38b was not 
determined.  
 
sulfide 38b: 
 
1H-NMR (300 MHz, CDCl3): d = 0.86 (d, J = 6.68 Hz, 3 H, CHCH3), 0.92 (d, J = 6.43 
Hz, 3 H, CHCH3), 1.35 (m, 1 H, CH3CHCHH), 1.73 (m, 1 H, CH3CHCHH), 1.95 (m, 1 
H, CH3CH), 2.65 (s, 3 H, NCH3), 3.21 (dd, J = 9.65, J = 14.34 Hz, 1 H, SOCHH), 3.49 
(dd, J = 2.96, J = 14.34 Hz, 1 H, SOCHH), 3.67 (m, 1 H, SCH), 7.25 (m, 5 H, SPh), 7.55 
(m, 3 H, SOPh), 7.57 (m, 2 H, SOPh). 
 
13C-NMR (75 MHz, CDCl3): d  = 21.1 (d), 23.4 (d), 25.5 (d), 29.4 (d), 40.9 (d), 42.3 (u), 
61.7 (u), 127.3 (d’), 129.1 (d), 129.3 (d), 129.4 (d), 131.9 (d), 132.9 (d), 133.3 (u), 138.3 
(u). 
 
IR (CHCl3 ): ? 3062 (s), 2955 (s), 2872 (w), 1581 (m), 1472 (s), 1445 (s), 1396 (w), 1248 
(s), 1144 (s), 1103 (s), 1080 (s), 1024 (w), 1000 (w), 896 (m), 871 (m) cm-1. 
 
MS (EI, 70 eV)  m/z (relative intensity, %): 347 [M+] (2), 238 (5), 193 (100), 150 (50), 
123 (45), 83 (85), 55 (37). 
 
Optical rotation: [a]D = +58.3 (c 0.84, CH2Cl2) 
 
HRMS (EI, 70 eV): 
 
C19H25NOS2 calcd found 
 347.137816 347.137760 
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sulfide epi-38b: 
 
1H-NMR (400 MHz, CDCl3): d 0.92 (d, J = 5.77 Hz, 3 H, CHCH3), 0.94 (d, J = 6.32 Hz, 
3 H, CHCH3), 1.46 (m, 1 H, CH3CHCHH), 1.98 (m, 1 H, CH3CH), 2.04 (m, 1 H, 
CH3CHCHH), 2.60 (s, 3 H, NCH3), 3.34 (m, 3 H, SCH, SOCHH), 7.05 (m, 2 H, SPh), 
7.15 (m, 3 H, SPh), 7.48 (m, 2 H, SOPh), 7.59 (m, 1 H, SOPh), 7.68 (m, 2 H, SOPh). 
 
13C-NMR (100 MHz, CDCl3): d = 21.0 (d), 23.4 (d), 25.5 (d), 29.4 (d), 41.0 (d), 42.7 
(u), 60.7 (u), 127.2 (d), 128.9 (d), 129.1 (d), 129.2 (d), 132.2 (d), 132.6 (d), 132.8 (u), 
137.1 (u). 
 
IR (CHCl3): ? 3061 (s), 3025 (m), 1582 (w), 1475 (m), 1444 (m), 1249 (s), 1146 (m), 
1094 (w), 998 (w), 862 (m) cm-1. 
 
MS (EI, 70 eV)  m/z (relative intensity, %): 347 [M+] (1), 238 (15), 193 (82), 150 (46), 
123 (48), 83 (100), 55 (47). 
 
Optical rotation: [a]D = -4.4 (c 0.36, CH2Cl2) 
 
HRMS (EI, 70 eV): 
 
C19H25NOS2 calcd found 
 347.137681 347.137760 
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6.7.2  (4,4-Dimethyl-1-(N-methyl-S-phenylsulfonimidoyl)pentan-2-yl)(phenyl)sulfane 
(38d and epi-38d) 
 
S
Ph
NMeOS
Ph
38d, epi-38d  
  
Following GP 4, the vinyl sulfoximine 12d (220 mg, 0.88 mmol) was treated with neat 
thiophenol (0.54 mL, 5.26 mmol). After the mixture was stirred at room temperature for 2 
h, TLC showed the consumption of the sulfoximine 12d. The excess thiophenol and the 
sulfides 38d and epi-38d were separated by flash column chromatography (EtOAc:n-
hexane, 1:5). Sulfide 38d (EtOAc/n-hexane, 1:5, Rf  = 0.47) (190 mg, 60%) and sulfide 
epi-38d (EtOAc/n-hexane, 1:5, Rf  = 0.29) (104 mg, 33 %) were isolated as colourless 
oils. The absolute configurations of the sulfides 38d and epi-38d were not determined. 
 
sulfide 38d: 
 
1H-NMR (400 MHz, CDCl3): d = 0.99 (s, 9 H, C(CH3)3), 1.40 (dd, J = 9.61, J = 14.83 
Hz, 1 H, (CH3)3CCHH), 2.04 (dd, J = 2.19, J = 14.84 Hz, 1 H, (CH3)3CCHH), 2.64 (s, 3 
H, NCH3), 3.23 (dd, J = 9.89, J = 14.29 Hz, 1 H, SOCHH), 3.39 (dd, J = 2.48, J = 14.29 
Hz, 1 H, SOCHH), 3.79 (tt, J = 2.47, J = 9.61 Hz, 1 H, SCH), 7.22 (m, 5 H, SPh), 7.50 
(m, 2 H, SOPh), 7.57 (m, 1 H, SOPh), 7.75 (m, 2 H, SOPh). 
 
13C-NMR (100 MHz, CDCl3): d = 29.4 (d), 30.4 (d), 31.2 (u), 38.5 (d), 46.4 (u), 62.1 
(u), 126.8 (d), 129.1 (d), 129.2 (d), 129.4 (d), 130.6 (d), 132.7 (d), 134.4 (u), 138.6 (u). 
 
IR (CHCl3): ? 2949 (w), 1712 (w), 1598 (w), 1215 (m), 1042 (w), 991 (w), 850 (w) cm-1. 
 
Optical rotation: [a]D = +76.4 (c 1.01, CH2Cl2) 
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MS (EI, 70 eV)  m/z (relative intensity, %): 361 [M+] (1), 252 (5), 207 (100), 149 (46), 
123 (49), 97 (58), 77 (15), 57 (34). 
 
HRMS (EI, 70 eV): 
 
C20H27NOS2 calcd found 
 361.153514 361.153410 
 
 
sulfide epi-38d: 
 
1H-NMR (400 MHz, CDCl3): d = 1.02 (s, 9 H, C(CH3)3), 1.48 (m, 1 H, (CH3)3CCHH), 
2.30 (m, 1 H, (CH3)3CCHH), 2.57 (s, 3 H, NCH3), 3.37 (m, 3 H, SCH,SOCHH), 7.02 (m, 
2 H, SPh), 7.08-7.13 (m, 3 H, SPh), 7.43 (m, 2 H, SOPh), 7.57-7.62 (m, 3 H, SOPh). 
 
13C-NMR (100 MHz, CDCl3): d = 29.5 (d), 30.4 (d), 31.2 (u), 38.9 (d), 47.0 (u), 61.2 
(u), 127.1 (d), 129.0 (d), 129.2 (d), 129.4 (d), 131.5 (d), 132.7 (d), 133.9 (u), 137.2 (u). 
 
IR (CHCl3): ? 2955 (s), 1582 (m), 1475 (s), 1444 (s), 1365 (m), 1247 (s), 1141 (s), 1081 
(s), 869 (m) cm-1. 
 
Optical rotation: [a]D = -10.8 (c 0.45, CH2Cl2) 
 
MS (EI, 70 eV) m/z (relative intensity, %): 361 [M+] (1), 252 (22), 207 (100), 150 (47), 
123 (57), 97 (77), 77 (13), 57 (35). 
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HRMS (EI, 70 eV): 
 
C20H27NOS2 calcd found 
 361.153347 361.153416 
 
 
6.7.3  (2S,3S,4R)-Ethyl 2-(1,1-dimethylethylsulfonamido)-3-phenyl-5-(S)-(N-methyl-
S-phenyl sulfonimidoyl)- 4-(phenylthio)pentanoate (39a) 
 
EtO2C
S
Ph
NH
Bus
O NMeS
Ph
39a  
 
 
To a solution of the vinyl sulfoximine 4a (904 mg, 1.84 mmol) in dry CH2Cl2 (1 ml) in a 
conical bottom flask cooled at 0 °C was added neat thiophenol (1.13 ml, 11.0 mmol).  
After the mixture was warmed to room temperature, it was stirred for 2 h. Then the 
mixture was diluted with water (5 ml) and extracted with CH2Cl2. The combined organic 
phases were dried (MgSO4) and the solvent was removed in vacuo. The excess 
thiophenol was seperated from the sulfide 39a by flash column chromatography 
(EtOAc/n-Hexane, 1:3). Isolation of the pure sulfide 39a was not possible even by 
preparative HPLC. The sulfide slowly decomposed for the formation of the starting 
material 4a. Column chromatography gave a mixture (973 mg, 88%) of sulfide 39a and 
sulfoximine 4a in a ratio of ³97:3, respectively, according to 1H NMR.  
 
1H-NMR (400 MHz, CDCl3): d = 1.29 (t, J = 7.14 Hz, 3 H, CH2CH3), 1.47 (s, 9 H, 
C(CH3)3), 2.62 (s, 3 H, NCH3), 3.12 (m, 2 H, SOCH2), 3.34 (dd, J = 2.75, J = 11.54 Hz, 1 
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H, NCHCH)), 4.19 (m, 4 H, NH/PhSCH/OCH2), 5.54 (dd, J = 2.75, J = 10.71 Hz, 1 H, 
NCH), 7.02 (m, 2 H, Ph), 7.31 (m, 8 H, Ph), 7.59 (m, 3 H, Ph), 7.84 (m, 2 H, Ph). 
 
13C-NMR (100 MHz, CDCl3): d = 14.1 (d), 24.5 (d), 29.4 (d), 42.5 (d), 51.6 (d), 56.2 
(u), 57.6 (d), 60.6 (u), 62.0 (u), 128.6 (d,), 129.1 (d), 129.2 (d), 129.4 (d), 129.9 (d), 133.0 
(d), 134.7 (u), 136.9 (u), 137.0 (d), 138.4 (u), 171. 8 (u). 
 
IR (CHCl3): ? 3340 (m), 2982 (s), 2936 (m), 1739 (s), 1583 (w), 1448 (s), 1325 (s), 1243 
(s), 1125 (s), 1022 (m), 906 (m), 859 (m) cm-1. 
 
MS (CI, isobutame) m/z (relative intensity, %): 603 [M+ + 1] (3), 493 (67), 338 (8), 272 
(100), 222 (63), 156 (22), 117 (29), 102 (38). 
 
6.7.4  (2S,3S,4R)-Ethyl 2-(1,1-dimethylethylsulfonamido)-3-isopropyl-5-(S)-(N-
methyl-S-phenylsulfonimidoyl)-4-(phenylthio)pentanoate (39b and epi-39b) 
 
 
EtO2C
S
Ph
NH
Bus
O NMeS
Ph
EtO2C
S
Ph
NH
Bus
O NMeS
Ph
39b epi-39b  
 
 
To a solution of the vinyl sulfoximine 4b (830 mg, 1.81 mmol) in dry CH2Cl2 (1 ml) in a 
conical bottom flask at 0 °C was added neat thiophenol (0.75 ml, 7.25 mmol).  After the 
mixture was warmed to room temperature, it was stirred for 3 h. Then the mixture was 
diluted with water (5 ml) and extracted with CH2Cl2. The combined organic phases were 
dried (MgSO4) and the solvent was removed in vacuo. The excess thiophenol and the 
sulfides 39b and epi-39b were separated by flash column chromatography (EtOAc/n-
Hexane, 1:4). The sulfide 39b (730 mg, 71%) (Rf  = 0.28; EtOAc/n-Hexane, 1:4) and 
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sulfide epi-39b (133 mg, 13%) (Rf = 0.16; EtOAc:n-Hexane, 1:4) were isolated as colour 
less solids.  
 
Sulfide 39b:  
 
1H NMR (400 MHz, CDCl3): d 1.17 (d, J = 6.32 Hz, 3 H, CH(CH3)2), 1.23 (d, J = 6.59 
Hz, 3 H, CH(CH3)2), 1.27 (t, J = 7.14, 3 H, CH2CH3), 1.46 (s, 9 H, C(CH3)3), 2.19 (m, 1 
H, CH(CH3)2), 2.49 (dd, J = 10.71 Hz, J = 1.65 Hz, 1 H, CHCH(CH3)2), 2.62 (s, 3 H, 
NCH3), 3.29 (dd, J = 14.28 Hz, J = 2.48 Hz, 1 H, PhSCHCHH), 3.60 (dd, J = 14.28 Hz, J 
= 10.99 Hz, 1 H, PhSCHCHH), 4.21 (m, 2 H, CH2CH3), 4.34 (dd, J = 10.99 Hz, J = 2.2 
Hz, 1 H, PhSCH), 4.41 (dd, J = 7.69 Hz, J = 1.92 Hz, COCH), 7.24 (m, 4 H, Ph, NH), 
7.42 (m, 4 H, Ph), 7.52 (m, 3 H, Ph). 
 
 13C NMR (100 MHz, CDCl3): d 13.9 (d), 22.5 (d), 23.5 (d), 24.2 (d), 28.4 (d), 29.3 (d), 
42.5 (d), 51.4 (d), 57.1 (d), 60.0 (u), 61.4 (u), 61.5 (u), 127.5 (d), 128.8 (d), 129.1 (d), 
129.4 (d), 132.1 (d), 132.6 (u), 132.9 (d), 137.2 (u), 171.4 (u). 
 
IR (CHCl3): ? 3133 (s), 2974 (s), 2877 (s), 1724 (s), 1583 (m), 1481 (s), 1446 (s), 1403 
(m), 1369 (m), 1312 (s), 1239 (s), 1211 (s), 1128 (s), 1029 (m), 944 (m), 869 (s) cm-1. 
 
MS (EI, 70 eV) m/z (relative intensity, %): 569 [M+ + 1] (1), 459 (40), 413 (17), 340 (8), 
292 (93), 236 (88), 184 (22), 155 (27), 125 (76), 110 (100), 77 (18), 57 (95). 
 
Optical rotation: [a]D = +62.3 (c 0.13, CH2Cl2) 
 
 
HRMS (EI, 70 eV): 
 
C27H40N2O5S3-C6H5S calcd found 
 459.198705 459.198742 
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Sulfide epi-39b:  
 
1H NMR (400 MHz, CDCl3): d 1.17 (d, J = 6.59 Hz, 3 H, CH(CH3)2), 1.23 (d, J = 6.59 
Hz, 3 H, CH(CH3)2), 1.34 (t, J = 7.14, 3 H, CH2CH3), 1.45 (s, 9 H, C(CH3)3), 2.28 (m, 1 
H, CH(CH3)2), 2.62 (s, 3 H, NCH3), 3.05 (dd, J = 14.83 Hz, J = 2.19 Hz, 1 H, 
PhSCHCHH), 4.28 (m, 3 H, OCH2 , PhSCH), 4.55 (dd, J = 5.7 Hz, J = 1.38 Hz, COCH), 
4.61 (dd, J = 14.83 Hz, J = 11.26 Hz, 1 H, PhSCHCHH), 7.19-7.28 (m, 4 H, Ph), 7.50-
7.60 (m, 4 H, Ph), 7.75 (m, 2 H, Ph), 8.61 (m, 1 H, NH). 
 
13C NMR (100 MHz, CDCl3): d 13.8 (d), 21.2 (d), 22.0 (d), 24.2 (d) , 29.2 (d), 29.3 (d), 
41.9 (d), 52.3 (d), 56.4 (d), 57.2 (u), 59.8 (u), 61.8 (u), 126.8 (d), 128.6 (d), 129.2 (d), 
129.5 (d), 129.6 (d), 133.1 (d), 133.9 (u), 137.6 (u), 172. 3 (u). 
 
IR (CHCl3): ? 3130 (s), 2974 (s), 2882 (s), 1725 (s), 1582 (m), 1479 (s), 1401 (m), 1313 
(s), 1238 (s), 1128 (s), 1031 (s), 943 (m), 866 (s) cm-1. 
 
MS (EI, 70 eV) m/z (relative intensity, %): 569 [M+ + 1] (5), 459 (45), 413 (16), 339 (9), 
292 (100), 236 (66), 183 (22), 155 (22), 124 (51), 110 (61), 57 (67). 
 
Optical rotation: [a]D = -7.4 (c 0.22, CH2Cl2) 
 
HRMS (EI, 70 eV): 
 
C27H40N2O5S3-C6H5S calcd found 
 459.198794 459.198742 
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6.8  Substitution of sulfoximine by a Cl-atom 
 
6.8.1  (2S,3S,4R)-Ethyl 5-chloro-2-(1,1-dimethylethylsulfonamido)-3-isopropyl-4-
(phenylthio)pentanoate (43b) 
 
EtO2C
Cl
NH
Bus
S
Ph
 
 
ClCO2C(Cl)HMe (294 mg, 2.06 mmol) was added at 0 °C to a solution of sulfide 39b 
(584 mg, 1.03 mmol) in CH2Cl2  (8 mL). After the mixture was stirred at room 
temperature for 2 h, it was quenched with saturated aqueous NaCl  and extracted with 
CH2Cl2. The combined organic layers were concentrated in vacuo. Purification by flash 
chromatography (EtOAc/n-Hexane, 1:9) gave chloride 43b (344 mg, 75%) and 
sulfinamide 44 (255 mg, 88%) as colourless oils. 
 
1H-NMR (400 MHz, CDCl3): d = 1.08 (d, J = 4.95 Hz, 3 H, CHCH3), 1.10 (d, J = 4.94 
Hz, 3 H, CHCH3), 1.22 (t, J = 7.14 Hz, 3 H, CH2CH3), 1.33 (s, 9 H, C(CH3)3), 2.12 (m, 1 
H, CH(CH3)2), 2.24 (m, 1 H, NCHCH), 3.28 (ddd, J = 1.65, J = 4.95, J = 10.44 Hz, 1 H, 
SCH), 3.61 (dd, J = 4.94, J = 11.26 Hz, 1 H, ClCHH), 3.73 (dd, J = 10.71, J = 10.99 Hz, 
1 H, ClCHH), 4.13 (q, J = 7.14 Hz, 2 H, OCH2), 4.47 (dd, J = 3.30, J = 9.34 Hz, 1 H, 
NCH), 4.88 (d, J = 9.07 Hz, 1 H, NH), 7.24 (m, 3 H, Ph) , 7.42 (m, 2 H, Ph). 
 
13C-NMR (100 MHz, CDCl3): d = 14.1 (d), 22.5 (d), 23.1 (d), 24.3 (d), 27.9 (d), 46.7 
(u), 50.2 (d), 51.0 (d), 56.4 (d), 60.4 (u), 62.3 (u), 128.1 (d), 129.3 (d), 132.9 (d), 133.1 
(u), 171.8 (u). 
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IR (CHCl3): ? 3268 (m), 2980 (s), 1737 (s), 1582 (w), 1476 (m), 1372 (m), 1316 (m), 
1244 (s), 1197 (w), 1129 (s), 1045 (m), 938 (w), 884 (m) cm-1. 
 
MS (EI, 70 eV)  m/z (relative intensity, %): 449 [M+] (8), 413 (4), 328 (12), 292 (100), 
218 (21), 191 (23), 170 (19), 134 (11), 101 (39), 57 (48). 
 
Optical rotation: [a]D = +43.5 (c 1.02, CH2Cl2) 
 
HRMS (EI, 70 eV): 
 
C20H32ClNO4S2 calcd found 
 449.146203 449.146132 
 
6.8.2 (2S,3S,4R)-Ethyl 5-chloro-2-(1,1-dimethylethylsulfonamido)-3-phenyl-4-
(phenylthio)pentanoate (43a) 
 
EtO2C
Cl
NH
Bus
S
Ph
 
 
ClCO2C(Cl)HMe (281 mg, 1.97 mmol) was added at 0 °C to a solution of sulfide 39a 
(592 mg, 0.98 mmol) in CH2Cl2  (6 mL). After the mixture was stirred at room 
temperature for 2 h, it was quenched with saturated NaCl solution and extracted with 
dichloromethane. The combined organic layers were concentrated in vacuo. Preparative 
HPLC (EtOAc:n-Hexane, 1:9) gave the chloride 43a (370 mg, 78%) and sulfinamide 44  
(216 mg, 90%) as colourless oils. 
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1H-NMR (400 MHz, CDCl3): d = 1.25 (t, J = 7.14 Hz, 3 H, CH2CH3), 1.34 (s, 9 H, 
C(CH3)3), 3.20 (dd, J = 4.67, J = 12.09 Hz, 1 H, ClCHH), 3.36 (bdd, J = 2.47, J = 11.54 
Hz, 2 H, ClCHH /NCHCH), 3.90 (ddd, J = 2.74, J = 4.39, J = 11.54 Hz, 1 H, SCH), 4.15 
(m, 2 H, OCH2), 4.32 (d, J = 10.16 Hz, 1 H, NH), 5.32 (dd, J = 2.2, J = 10.17 Hz, 1 H, 
NCH), 7.07 (m, 2 H, Ph), 7.28 (m, 6 H, Ph), 7.68 (m, 2 H, Ph). 
 
13C-NMR (100 MHz, CDCl3): d = 14.4 (d), 24.5 (d), 45.5 (u), 50.5 (d), 51.1 (d), 58.3 
(d), 60.8 (u), 62.3 (u), 128.4 (d), 128.6 (d), 128.9 (d), 129.2 (d), 129.4 (d), 131.4 (u), 
134.2 (u), 135.1 (d), 171.2 (u). 
 
IR (CHCl3): ? 3573 (m), 3379 (s), 2983 (s), 1739 (s), 1670 (w), 1583 (m), 1439 (s), 1372 
(s), 1209 (s), 1127 (s), 1023 (s), 916 (s), 857 (w). 
 
MS (EI, 70 eV) m/z (relative intensity, %): 483 [M+] (29), 362 (32), 326 (48), 261 (61), 
252 (57), 222 (15), 192 (34), 170 (47), 146 (39), 134 (27), 117 (43), 108 (47), 102 (93), 
91 (33), 74 (10), 57 (100). 
Optical rotation: [a]D = -13.3 (c 0.66, CH2Cl2) 
 
HRMS (EI, 70 eV): 
 
C23H30ClNO4S2 calcd found 
 483.130493 483.130482 
 
 
6.9  Synthesis of prolines 
 
6.9.1 (2S,3S,4S)-Ethyl N-tert-butylsulfonyl-3-phenyl-4-(phenylthio) pyrrolidine -2-
carboxylate (50a) 
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N
EtO2C S
Bus
Ph
 
 
Cs2CO3 (74 mg, 0.22 mmol) was added at room temperature to a solution of chloride 43a 
(100 mg, 0.21 mmol) in DMF (5 mL). After the mixture was stirred at room temperature 
for 6 h, it was quenched with water and extracted with ether. The combined organic 
layers were concentrated under vacuo. Purification by flash chromatography (EtOAc:n-
Hexane, 2:8) gave proline 50a (81 mg, 87%) as a colourless liquid. 
 
1H-NMR (300 MHz, CDCl3): d = 0.75 (t, J = 7.17 Hz, 3 H, CH2CH3), 1.52 (s, 9 H, 
C(CH3)3), 3.58 (dd, J = 7.13, J = 7.13 Hz, 1 H, NCHH), 3.74 (q, J = 7.17 Hz, 2 H, 
OCH2), 3.99 (m, 1 H, SCH), 4.10 (dd, J = 7.66, J = 7.92 Hz, 1 H, PhCH), 4.22 (dd, J = 
7.66, J = 11.12 Hz, 1 H, NCHH), 5.17 (d, J = 7.91 Hz, 1 H, COCH), 7.28 (m, 10 H, C-
Ph/SPh). 
 
13C-NMR (100 MHz, CDCl3): d = 13.5 (d), 24.6 (d), 50.0 (d), 51.2 (d), 56.1 (u), 60.8 
(u), 61.6 (u), 64.8 (d), 126.8 (d), 127.8 (d), 128.9 (d), 129.5 (d), 130.3 (d), 134.4 (u), 
135.3 (u), 168.8 (u). 
 
IR (CHCl3): ? 3022 (w), 1755 (w), 1391 (w), 1215 (m), 1125 (w), 1026 (w) cm-1. 
 
MS (EI, 70 eV) m/z (relative intensity, %): 447 [M+] (100), 374 (12), 326 (26), 310 (6), 
254 (90), 218 (27), 144 (47), 117 (48), 86 (9), 57 (38). 
 
Optical rotation: [a]D = -32.3 (c 0.72, CH2Cl2) 
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HRMS (EI, 70 eV): 
 
C23H29NO4S2 calcd found 
 447.153731 447.153804 
 
6.9.2  (2S,3S,4S)-Ethyl N-tert-butylsulfonyl-3-isopropyl-4-(phenylthio) pyrrolidine -2-
carboxylate (50b) 
 
N
EtO2C S
Bus
Ph
 
 
Cs2CO3 (160 mg, 0.49 mmol) was added at room temperature to a solution of chloride 
43b (200 mg, 0.44 mmol) in DMF (5 mL). After the mixture was stirred at 40 °C for 3 h, 
it was quenched with water and extracted with ether. The combined organic layers were 
concentrated under vacuo. Purification by flash chromatography (EtOAc/n-Hexane, 2:8) 
gave proline 50b (166 mg, 90%) as a colourless liquid. 
 
 
1H-NMR (400 MHz, CDCl3): d = 0.98 (d, J = 6.86 Hz, 3 H, CHCH3), 1.14 (d, J = 6.87 
Hz, 3 H, CHCH3), 1.29 (t, J = 7.14 Hz, 3 H, CH2CH3), 1.33 (s, 9 H, C(CH3)3), 1.83 (sept, 
J = 7.14 Hz, 1 H, CH(CH3)2), 2.18 (m, 1 H, iPrCH), 3.66 (m, 1 H, NCHH), 3.79 (m, 1 H, 
SCH), 4.20 (m, 3 H, OCH2/ NCHH), 4.46 (bd, J = 7.42 Hz, 1 H, COCH), 7.24-7.38 (m, 5 
H, Ph). 
 
13C-NMR (100 MHz, CDCl3): d = 14.2 (d), 21.1 (d), 21.4 (d), 24.4 (d), 28.1 (d), 46.8 
(d), 54.6 (d), 57.9 (u), 61.3 (u), 61.7 (u), 65.1 (d), 127.2 (d), 129.1 (d), 131.3 (d), 134.5 
(u), 171.8 (u). 
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IR (CHCl3): ? 2973 (s), 1738 (s), 1583 (w), 1476 (s), 1393 (m), 1374 (m), 1323 (s), 188 
(s), 1132 (s), 1086 (m), 1018 (s), 838 (w) cm-1. 
 
MS (EI, 70 eV)  m/z (relative intensity, %): 413 [M+] (38), 340 (21), 292 (63), 220 (100), 
183 (11), 139 (7), 110 (23), 68 (11), 57 (27). 
 
Optical rotation: [a]D = +87.2 (c 0.56, CH2Cl2) 
 
HRMS (EI, 70 eV): 
 
C20H31NO4S2 calcd found 
 413.169213 413.169454 
 
6.9.3  (2S,3S,4S)-Ethyl 3-isopropyl-4-(phenylthio)pyrrolidine -2-carboxylate (51) 
 
N
EtO2C S
H
Ph
 
 
The N-Bus proline 50b (80 mg, 0.19 mmol) and anisole (168 mg, 1.55 mmol) were added 
to a solution of CF3SO3H (116 mg, 0.77 mmol) in CH2Cl2 (30 mL) at 0 °C. After the 
mixture was stirred at 0 °C for 3 h, it was neutralized with 0.1 N NaOH to a pH of 8. 
Then, the mixture was extracted with CH2Cl2, and the combined organic layers were 
concentrated under vacuo. Purification by flash chromatography (EtOAc:n-Hexane, 3:7) 
afforded proline 51 (49 mg, 86%) as a colourless liquid. 
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1H-NMR (400 MHz, CDCl3): d = 0.91 (d, J = 6.6 Hz, 3 H, CHCH3), 1.02 (d, J = 6.87 
Hz, 3 H, CHCH3), 1.29 (t, J = 7.15 Hz, 3 H, CH2CH3), 1.86 (bm, 2 H, CH(CH3)2/NH), 
2.09 (m, 1 H, iPrCH), 3.02 (m, 1 H, NHH), 3.61 (m, 1 H, SCH), 3.70 (m, 1 H, NHH), 
4.02 (bd, J = 7.69 Hz, 1 H, COCH), 4.19 (q, J = 7.14 Hz, 2 H, OCH2), 7.22-7.38 (m, 5 H, 
Ph). 
 
13C-NMR (100 MHz, CDCl3): d = 14.3 (d), 20.7 (d), 22.4 (d), 28.6 (d), 47.7 (d), 55.1 
(u), 55.5 (d), 60.8 (u), 63.8 (d), 126.6 (d), 128.9 (d), 130.6 (d), 136.1 (u), 173.1 (u). 
 
IR (CHCl3): ? 3394 (w), 2961 (s), 1730 (s), 1583 (m), 1472 (s), 1374 (m), 1340 (w), 
1185 (s), 1093 (w), 1029 (m), 856 (w) cm-1. 
 
MS (EI, 70 eV) m/z (relative intensity, %): [M+ + 1] 294 (91), 264 (50), 220 (100), 184 
(9), 140 (11), 110 (31), 68 (38). 
 
Optical rotation: [a]D = +53.4 (c 0.55, CH2Cl2) 
 
HRMS (EI, 70 eV): 
 
C16H23NO2S2 calcd found 
 293.144923 293.144952 
 
6.10 Thiophenol Michael addition to sulfoximine substituted homoallylic 
alcohols 
 
6.10.1 tert-Butyl((3S,4R,Z)-4-isopropyl-2-methyl-6-(N-methyl-S-phenyl sulfonimido 
yl) hex-5-en-3-yloxy)dimethylsilane ( Z-41) 
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S
Ph
OMeN
OTBS
 
 
 
A solution of the alcohol 40 (806 mg, 2.61 mmol) in DCM (10 mL) was treated with 
imidazole (709 mg, 10.4 mmol) at 0 °C. After the mixture was stirred at 0 °C for 30 min, 
ClSiMe2t-Bu (1.179 g, 7.8 mmol) was added at 0 °C. The mixture was stirred at room 
temperature for 4 h. It was then washed with water and extracted with CH2Cl2. The 
combined organic layers were concentrated under vacuo. Purification by flash 
chromatography (EtOAc/n-hexane, 2:8) gave the silyl ether Z-41 (1.048 g, 95%) as a 
colourless liquid. 
 
1H-NMR (400 MHz, CDCl3): d = -0.1 (s, 3 H, SiCH3), 0.2 (s, 3 H, SiCH3), 0.39 (d, J = 
6.87 Hz, 3 H, CHCH3), 0.82 (d, J = 6.59 Hz, 3 H, CHCH3), 0.84 (s, 9 H, C(CH3)3), 1.51 
(m, 1 H, CH(CH3)2), 1.79 (m, 1 H, OCHCH(CH3)2), 2.63 (s, 3 H, NCH3), 3.32 (ddd, J = 
9.07, J = 8.79, J = 1.1 Hz, 1 H, OCHCH), 3.57 (dd, J = 1.09, J = 6.32 Hz, 1 H, OCH), 
6.30 (d, J = 11.54 Hz, 1 H, SCH), 6.37 (dd, J = 11.27, J = 11.26 Hz, 1 H, SCHCH), 7.49 
(m, 3 H, Ph), 7.83 (m, 2 H, Ph). 
 
13C-NMR (100 MHz, CDCl3): d = -3.9 (d), -3.4 (d), 18.7 (u), 18.9 (d), 19.4 (d), 20.6 
(d), 21.3 (d), 26.3 (d), 29.1 (d), 29.4 (d), 33.8 (d), 45.2 (d), 77.7 (d), 128.9 (d), 129.1 (d), 
129.8 (d), 132.3 (d), 140.5 (u), 148.5 (d). 
 
IR (CHCl3): ? 3385 (w), 2955 (s), 1731 (w), 1467 (m), 1381 (w), 1251 (s), 1149 (m), 
1072 (s), 840 (s) cm-1. 
 
MS (CI, Methane) m/z (relative intensity, %): [M+ + 1] 424 (100), 380 (54), 366 (40), 
269 (5), 237 (20), 187 (7), 155 (4), 73 (8). 
 
Optical rotation: [a]D = -146.34 (c 1.04, CH2Cl2) 
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HRMS (EI, 70 eV): 
 
C23H41NO2SSi calcd found 
 423.262766 423.262731 
 
6.10.2 tert-Butyl((3S,4R,E)-4-isopropyl-2-methyl-6-(N-methyl-S-phenylsulfonimido 
yl)hex-5-en-3-yloxy)dimethylsilane (E-41) 
 
OTBS
S
Ph
O NMe
 
 
To a solution of the silyl ethe r Z-41 (844 mg, 1.99 mmol) in THF (15 mL) was added at - 
78° C n-BuLi (1.36 mL, 1.6 M in hexanes, 2.19 mmol) and the mixture was slowly 
allowed to warm to 0 °C and stirred for 1 h. It was then cooled to - 78° C and quenched 
with saturated aqueous NH4Cl (10 mL) and extracted with ethyl acetate. The combined 
organic layers were concentrated under vacuo. Purification by flash chromatography 
(EtOAc/n-Hexane, 2:8) gave the silyl ether E-41  (830 mg, 98% yield) as a colourless 
liquid. 
 
1H-NMR (400 MHz, CDCl3): d = -0.1 (s, 3 H, SiCH3), 0.02 (s, 3 H, SiCH3), 0.59 (d, J = 
6.87 Hz, 3 H, CH(CH3)), 0.72 (d, J = 6.87 Hz, 3 H, CH(CH3)), 0.80 (d, J = 6.86 Hz, 3 H, 
CHCH3), 0.83 (s, 9 H, C(CH3)3), 0.92 (d, J = 6.6 Hz, 3 H, CHCH3), 1.50 (m, 1 H, 
CH(CH3)2), 1.75 (m, 1 H, CH(CH3)2), 1.93 (ddd, J = 1.93, J = 8.52, J = 8.79 Hz, 1 H, 
OCHCH), 2.75 (s, 3 H, NCH3), 3.59 (dd, J = 2.2, J = 5.77 Hz, 1 H, OCH), 6.22 (d, J = 
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15.38 Hz, 1 H, SCH), 6.79 (dd, J = 10.71, J = 15.38 Hz, 1 H, SCHCH), 7.50 (m, 3 H, 
Ph), 7.85 (m, 2 H, Ph). 
 
13C-NMR (75 MHz, CDCl3): d = -3.9 (d), -3.8 (d), 18.2 (d), 18.3 (u), 18.9 (d), 21.1 (d), 
21.4 (d), 26.0 (d), 28.5 (d), 29.5 (d), 33.6 (d), 51.9 (d), 77.4 (d), 128.6 (d), 129.1 (d), 
131.2  (d), 132.2 (d), 139.7 (u), 148.6 (d). 
 
IR (CHCl3): ? 2957 (s), 1627 (w), 1466 (s), 1383 (m), 1249 (s), 1148 (s), 1079 (s), 996 
(w), 928 (w), 838 (s) cm-1.  
 
MS (EI, 70 eV) m/z (relative intensity, %): [M+] 423 (5), 380 (32), 366 (100), 294 (10), 
237 (63), 212 (46), 187 (27), 166 (7), 155 (7), 134 (11), 124 (13), 115 (11), 73 (62). 
 
Optical rotation: [a]D = +64.6 (c 0.33, CH2Cl2) 
 
HRMS (EI, 70 eV): 
 
C23H41NO2SSi calcd found 
 423.262676 423.262731 
 
6.10.3 tert-Butyl((3S,4R)-4-isopropyl-2-methyl-6-(N-methyl-S-phenylsulfonimidoyl)-
5-(phenylthio)hexan-3-yloxy)dimethylsilane (42 and epi-42) 
 
OTBS
S
Ph
O NMeS
Ph
 
 
 
To a solution of the vinyl sulfoximine E-41 (250 mg, 0.59 mmol) in dry CH2Cl2 (1 mL), 
in a conical bottom flask, was added at 0 °C neat thiophenol (0.37 ml, 3.55 mmol).  After 
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the mixture was warmed to room temperature, it was stirred for 4 h. The mixture was 
diluted with water (5 ml) and extracted with CH2Cl2. The combined organic phases were 
dried (MgSO4) and the solvent was removed in vacuo. The excess thiophenol and the 
sulfides (92% yield) were separated by flash column chromatography (EtOAc:n-Hexane, 
1:9). Pure sulfide 42 (183 mg, 58%) (Rf  = 0.21; EtOAc:n-Hexane, 1:9) and sulfide epi-42  
(104 mg, 33%) (Rf = 0.14; EtOAc:n-Hexane, 1:9) as a colour less oils.  
 
Sulfide 42: 
 
1H-NMR (500 MHz, CDCl3): d = 0.16 (s, 3 H, SiCH3), 0.30 (s, 3 H, SiCH3), 1.04 (s, 9 
H, C(CH3)3), 1.11 (d, J = 6.41 Hz, 3 H, CHCH3), 1.12 (d, J = 6.41 Hz, 3 H, CHCH3), 
1.16 (d, J = 6.72 Hz, 3 H, CHCH3), 1.21 (d, J = 6.72 Hz, 3 H, CHCH3), 2.19 (m, 1 H, 
CH(CH3)2), 2.38 (m, 1 H, CH(CH3)2), 2.69 (m, 1 H, SCHCHiPr), 2.75 (s, 3 H, NCH3), 
3.49 (m, 2 H, SOCH2), 3.91 (m, 1 H, OCH), 4.96 (m, 1 H, SCH), 6.94 (m, 4 H, Ph), 7.08 
(m, 2 H, Ph), 7.54 (m, 2 H, Ph), 7.73 (m, 2 H, Ph).   
 
13C-NMR (125 MHz, CDCl3): d = -3.8 (d), -2.5 (d), 18.5 (d), 18.9 (u), 21.1 (d), 21.8 
(d), 24.7 (d), 26.9 (d), 28.0 (d), 29.2 (d), 32.6 (d), 41.2 (d), 48.4 (d), 60.7 (u), 78.2 (d), 
125.6 (d), 128.2 (d), 129.3 (d), 129.4 (d), 132.3 (d), 136.7 (u), 140.6 (u). 
 
IR (CHCl3): ? 2954 (s), 1581 (m), 1470 (s), 1446 (s), 1385 (w), 1247 (s), 1144 (s), 1080 
(s), 1022 (w), 871 (m) cm-1. 
 
MS (EI, 70 eV) m/z (relative intensity, %): [M+] 533 (2), 490 (4), 476 (5), 424 (3), 379 
(5), 321 (70), 249 (48), 212 (20), 187 (100), 73 (45). 
 
Optical rotation: [a]D = +43.3 (c 0.64, CH2Cl2) 
 
HRMS (EI, 70 eV): 
 
C29H47NO2S2Si-C4H9 = C25H38NO2S2Si calcd found 
 476.211455 476.211329 
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Sulfide epi-42: 
 
1H-NMR (400 MHz, CDCl3): d = 0.01 (s, 3 H, SiCH3), 0.07 (s, 3 H, SiCH3), 0.55 (d, J = 
6.86 Hz, 3 H, CHCH3), 0.68 (d, J = 6.86 Hz, 3 H, CHCH3), 0.86 (s, 9 H, C(CH3)3), 0.87 
(d, J = 6.59 Hz, 3 H, CHCH3), 0.91 (d, J = 6.59 Hz, 3 H, CHCH3), 1.70 (m, 1 H, 
CH(CH3)2), 1.91 (m, 1 H, SCHCH), 1.96 (m, 1 H, CH(CH3)2), 2.48 (s, 3 H, NCH3), 3.34 
(dd, J = 14.84, J = 7.69 Hz, 1 H, SOCHH), 3.59 (m, 1 H, OCH), 3.83 (m, PhSCH), 4.19 
(dd, J = 14.84, J = 5.22 Hz, 1 H, SOCHH), 7.08 (m, 3 H, Ph), 7.17 (m, 2 H, Ph), 7.34 (m, 
2 H, Ph), 7.42 (m, 1 H, Ph), 7.66 (m, 2 H, Ph). 
 
13C-NMR (100 MHz, CDCl3): d = -4.1 (d), -2.5 (d), 18.3 (d), 18.9 (u), 19.5 (d), 21.9 
(d), 22.7 (d), 26.8 (d), 27.5 (d), 29.5 (d), 34.0 8d), 44.4 (d), 49.2 (d), 59.8 (u), 127.1 (d), 
128.8 (d), 128.9 (d), 129.3 (d), 132.2 (d), 132.3 (d), 135.4 (u), 138.6 (u). 
 
IR (CHCl3): ? 2955 (s), 1739 (w), 1582 (w), 1469 (s), 1384 (m), 1249 (s), 1148 (s), 1059 
(s), 905 (w), 840 (s) cm-1.  
 
MS (CI, isobutame) m/z (relative intensity, %): [M+ + 1] 534 (100), 476 (4), 379 (67), 
321 (12), 247 (87), 187 (37), 156 (7). 
 
Optical rotation: [a]D = -26.6 (c 0.55, CH2Cl2) 
 
HRMS (EI, 70 eV): 
 
C29H47NO2S2Si-C4H9 = C25H38NO2S2Si calcd found 
 476.211455 476.211329 
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7  Crystal Structure Analysis 
 
7.1  Crstal structure of (2S,3S,4R)-Ethyl 2-(1,1-dimethylethylsulfonamido)-3- 
        isopropyl-5-(N-methyl-S-phenylsulfonimidoyl)-4-(phenylthio)pentanoate     
        (39b) 
 
 
 
 
 
 
 
 
 
 
 
Experimental Details 
Crystal data: 
Chemical formula  : C27H39N2O5S3  
formula weight   : 567.82 
Crystal system  : orthorhombic 
Space group (No.)  :  P212121 (19) 
Z     : 4 
a (Å)    : 10.857(2) 
b (Å)    : 15.020(2) 
c (Å)    : 18.797(2) 
a  (°)    : 90.0 
ß  (°)    : 90.0 
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? (°)    : 90.0 
cell volume   : 3065.3(8)Å3 
Density calc.   : 1.230g/cm3 
Radiation    : CuKa (1.54179Å) 
Range for lattice parameters  : 12.87E<T  <18.83E 
Absorption coefficient  : 2.509mm-1 
Temperature   : 298K 
Crystal source    : recrystallized from   
Crystal colour    : colourless 
Crystal shape   : irregular 
Crystal size   : ca. 0.3x0.3.x0.3mm 
Data Collection 
Diffractometer type   : Enraf-Nonius CAD4 
collection method  : w/2J scans 
Absorption correction  : none 
No. of reflections measured : 6225 
No. of independent reflections: 5493 
No. of observed reflections  : 4978 
 T  max  (E)   : 67.76 
hmin 6 hmax   :   - 13    6   12 
kmin 6 kmax   :   - 18    6   18 
lmin 6  lmax   :   - 22    6   22 
Criterion for observed  : I > 2s (I ) 
Rint    : 0.020(34) 
Standard reflections   : -3    -3   2, -3   -2    4, -2    -3    2 
Variation   : 1402(44) 883(29) 4509(118) 
 
Refinement:  
On    : F 
Treatment of hydrogens  : Calculated in idealized positions. Us  
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     fixed at 1.5×U of the corresponding  
     heavy atom. No refinement of hydrogen  
     parameters    
 
R    : 0.048 
Rw    : 0.062 
Weighting scheme   : w=1/s2(F) 
No. of parameters refined  : 334 
No. of reflections in refmnt.  : 4964 
Residual electron density  : -0.38/0.40e/Å3  
r*[1]      : not refined 
XABS[2]     : -0.00001(310)  
Goodness of fit   : 2.346 
Solution    : XTAL3.7[3] 
Remarks     :  
 
Definitions: 
Ueq = 1/3SiSjUijai*a j*a i aj 
The anisotropic displacement factor in the structure factor expression is: 
t = exp[-2p2(SiSjUijhihjai*a j* )] 
 
Atomic Positional and Isotropic Displacement Parameters                 
 -----------------------------------------------------                           
 Atom      x/a         y/b          z/c         Ueq/Å2                           
 -----------------------------------------------------                           
 S1    0.56132(9)  0.35197(6)  0.45288(5) * 0.0466(5)                            
 S2    0.4559(1)   0.68146(6)  0.41512(5) * 0.0522(5)                            
 S3    0.6633(1)   0.60420(7)  0.22420(5) * 0.0519(5)                            
 O1    0.7431(2)   0.4236(2)   0.3120(1)  * 0.054(2)                             
 O2    0.6297(3)   0.3496(2)   0.2316(1)  * 0.072(2)                             
 O3    0.6130(3)   0.2816(2)   0.4109(2)  * 0.067(2)                             
 O4    0.6247(3)   0.3845(2)   0.5140(1)  * 0.062(2)                             
 O5    0.3256(3)   0.6634(2)   0.4111(2)  * 0.074(2)                             
 N1    0.5423(3)   0.4358(2)   0.4010(1)  * 0.046(2)                             
 N2    0.5407(4)   0.6217(2)   0.4575(2)  * 0.056(2)                             
 C1    0.9637(5)   0.4197(4)   0.3132(4)  * 0.104(5)                             
 C2    0.8524(5)   0.3944(4)   0.2725(3)  * 0.089(4)                             
 C3    0.6375(4)   0.3948(2)   0.2845(2)  * 0.048(2)                             
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 C4    0.5250(4)   0.4262(2)   0.3241(2)  * 0.044(2)                             
 C5    0.4727(4)   0.5162(2)   0.2948(2)  * 0.048(2)                             
 C6    0.5699(3)   0.5902(2)   0.3040(2)  * 0.044(2)                             
 C7    0.5222(4)   0.6807(3)   0.3279(2)  * 0.055(2)                             
 C8    0.4703(4)   0.7960(2)   0.4417(2)  * 0.056(2)                             
 C9    0.5848(4)   0.8264(3)   0.4623(3)  * 0.067(3)                             
 C10   0.5965(6)   0.9130(3)   0.4840(3)  * 0.085(4)                             
 C11   0.4943(8)   0.9662(3)   0.4822(3)  * 0.106(5)                             
 C12   0.3812(7)   0.9360(4)   0.4625(3)  * 0.094(4)                             
 C13   0.3689(5)   0.8489(3)   0.4411(3)  * 0.078(3)                             
 C14   0.8095(4)   0.6355(2)   0.2580(2)  * 0.048(2)                             
 C15   0.9026(4)   0.6414(3)   0.2083(2)  * 0.060(2)                             
 C16   1.0205(4)   0.6612(4)   0.2292(2)  * 0.074(3)                             
 C17   1.0489(5)   0.6760(3)   0.2993(3)  * 0.074(3)                             
 C18   0.9582(5)   0.6719(3)   0.3479(2)  * 0.069(3)                             
 C19   0.8366(4)   0.6523(3)   0.3287(2)  * 0.057(2)                             
 C20   0.4138(4)   0.5052(3)   0.2203(2)  * 0.061(3)                             
 C21   0.3668(5)   0.5937(4)   0.1923(3)  * 0.092(4)                             
 C22   0.3123(5)   0.4365(4)   0.2204(3)  * 0.094(4)                             
 C23   0.4101(4)   0.3155(3)   0.4828(2)  * 0.054(2)                             
 C24   0.3531(5)   0.3899(4)   0.5245(3)  * 0.082(3)                             
 C25   0.3318(5)   0.2880(4)   0.4186(3)  * 0.080(3)                             
 C26   0.4309(6)   0.2347(3)   0.5316(3)  * 0.089(4)                             
 C27   0.5195(5)   0.6175(3)   0.5354(2)  * 0.073(3)                             
 H5    0.4029(-)   0.5337(-)   0.3225(-)  * 0.059(-)                             
 H4    0.4665(-)   0.3798(-)   0.3150(-)  * 0.055(-)                             
 H6    0.6196(-)   0.5686(-)   0.3424(-)  * 0.057(-)                             
 H25a  0.3183(-)   0.3389(-)   0.3885(-)  * 0.120(-)                             
 H25b  0.2525(-)   0.2677(-)   0.4342(-)  * 0.120(-)                             
 H25c  0.3706(-)   0.2429(-)   0.3927(-)  * 0.120(-)                             
 H19   0.7729(-)   0.6498(-)   0.3636(-)  * 0.074(-)                             
 H20   0.4752(-)   0.4869(-)   0.1878(-)  * 0.076(-)                             
 H7a   0.4607(-)   0.6995(-)   0.2939(-)  * 0.070(-)                             
 H7b   0.5885(-)   0.7230(-)   0.3253(-)  * 0.070(-)                             
 H12   0.3067(-)   0.9735(-)   0.4637(-)  * 0.116(-)                             
 H9    0.6555(-)   0.7866(-)   0.4596(-)  * 0.088(-)                             
 H2a   0.8563(-)   0.4233(-)   0.2274(-)  * 0.113(-)                             
 H2b   0.8513(-)   0.3316(-)   0.2651(-)  * 0.113(-)                             
 H13   0.2886(-)   0.8246(-)   0.4248(-)  * 0.098(-)                             
 H15   0.8826(-)   0.6331(-)   0.1591(-)  * 0.076(-)                             
 H17   1.1345(-)   0.6889(-)   0.3128(-)  * 0.097(-)                             
 H26a  0.4787(-)   0.2496(-)   0.5712(-)  * 0.133(-)                             
 H26b  0.4702(-)   0.1872(-)   0.5062(-)  * 0.133(-)                             
 H26c  0.3521(-)   0.2120(-)   0.5477(-)  * 0.133(-)                             
 H18   0.9733(-)   0.6843(-)   0.3963(-)  * 0.084(-)                             
 H24a  0.4032(-)   0.4069(-)   0.5639(-)  * 0.125(-)                             
 H24b  0.2732(-)   0.3739(-)   0.5421(-)  * 0.125(-)                             
 H24c  0.3421(-)   0.4429(-)   0.4957(-)  * 0.125(-)                             
 H10   0.6728(-)   0.9367(-)   0.5001(-)  * 0.110(-)                             
 H16   1.0852(-)   0.6639(-)   0.1931(-)  * 0.091(-)                             
 H11   0.4934(-)   1.0295(-)   0.4959(-)  * 0.140(-)                             
 H21a  0.3311(-)   0.5864(-)   0.1470(-)  * 0.137(-)                             
 H21b  0.4321(-)   0.6357(-)   0.1898(-)  * 0.137(-)                             
 H21c  0.3047(-)   0.6168(-)   0.2237(-)  * 0.137(-)                             
 H1a   1.0357(-)   0.4015(-)   0.2907(-)  * 0.154(-)                             
 H1b   0.9589(-)   0.3903(-)   0.3591(-)  * 0.154(-)                             
 H1c   0.9639(-)   0.4819(-)   0.3215(-)  * 0.154(-)                             
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 H22a  0.2756(-)   0.4280(-)   0.1765(-)  * 0.145(-)                             
 H22b  0.2492(-)   0.4512(-)   0.2547(-)  * 0.145(-)                             
 H22c  0.3454(-)   0.3786(-)   0.2361(-)  * 0.145(-)                             
 H27a  0.4758(-)   0.6709(-)   0.5507(-)  * 0.110(-)                             
 H27b  0.5925(-)   0.6126(-)   0.5601(-)  * 0.110(-)                             
 H27c  0.4659(-)   0.5680(-)   0.5464(-)  * 0.110(-)                    
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